
<html lang="en"     class="pb-page"  data-request-id="fc77238d-c182-4a5e-b3ff-15b0973891ba"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01357;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold" /></meta><meta name="dc.Creator" content="He  Li" /></meta><meta name="dc.Creator" content="Qi  Huang" /></meta><meta name="dc.Creator" content="Cheng  Chen" /></meta><meta name="dc.Creator" content="Bin  Xu" /></meta><meta name="dc.Creator" content="He-Yao  Wang" /></meta><meta name="dc.Creator" content="Ya-Qiu  Long" /></meta><meta name="dc.Description" content="The free fatty acid receptor GPR40 is predominantly expressed in pancreatic β-cells and enhances insulin secretion in a glucose dependent manner. Therefore, GPR40 agonists are possible novel insuli..." /></meta><meta name="Description" content="The free fatty acid receptor GPR40 is predominantly expressed in pancreatic β-cells and enhances insulin secretion in a glucose dependent manner. Therefore, GPR40 agonists are possible novel insuli..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 17, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01357" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01357" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01357" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01357" /></link>
        
    
    

<title>Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01357" /></meta><meta property="og:title" content="Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0021.jpeg" /></meta><meta property="og:description" content="The free fatty acid receptor GPR40 is predominantly expressed in pancreatic β-cells and enhances insulin secretion in a glucose dependent manner. Therefore, GPR40 agonists are possible novel insulin secretagogues with reduced or no risk of hypoglycemia for the treatment of type 2 diabetes mellitus (T2DM). Chemically and structurally diverse GPR40 agonists with high safety are pursued for the clinical development of GPR40-based pharmacotherapeutics. Herein we report our design and discovery of a new chemotype of GPR40 agonists free of the typical phenylpropanoic acid scaffold. The thiophen-2-ylpropanoic acid containing GPR40 modulators functioned as full agonists with high-efficacy response (Emax) and reduced lipophilicity. Significantly, the lead compound in this series, (R)-7k, exhibited more potent in vitro glucose-stimulated insulin secretion and in vivo glucose-lowering effects (10 mg/kg, po) than the GPR40 partial agonist TAK-875, which was once in phase III clinical trials, and high selectivity over the relevant receptors GPR120 and PPARγ." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01357"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01357">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01357&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01357&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01357&amp;href=/doi/10.1021/acs.jmedchem.6b01357" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2697-2717</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01317" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01489" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=He++Li">He Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Huang">Qi Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Chen">Cheng Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bin++Xu">Bin Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-9251-6930" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=He-Yao++Wang">He-Yao Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ya-Qiu++Long">Ya-Qiu Long</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-9209-0503" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">University of Chinese Academy of Sciences, Beijing 100049, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Chemistry, Shanghai University, 99 Shangda Road, Shanghai 200444, China</span></div><div class="corresp-info"><strong>*</strong>For Y.-Q.L.: phone/fax, 86-21-50806876; E-mail, <a href="/cdn-cgi/l/email-protection#b5ccc4d9dadbd2f5c6dcd8d89bd4d69bd6db"><span class="__cf_email__" data-cfemail="e69f978a898881a6958f8b8bc88785c88588">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For H.-Y.W.: phone, +86-50805785; Fax, +86-21-50807088; E-mail, <a href="/cdn-cgi/l/email-protection#51392826303f361122383c3c7f30327f323f"><span class="__cf_email__" data-cfemail="d2baaba5b3bcb592a1bbbfbffcb3b1fcb1bc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01357&amp;href=/doi/10.1021%2Facs.jmedchem.6b01357" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2697–2717</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 9, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 September 2016</li><li><span class="item_label"><b>Published</b> online</span>17 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01357</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2697%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHe%2BLi%252C%2BQi%2BHuang%252C%2BCheng%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D7%26contentID%3Dacs.jmedchem.6b01357%26title%3DDiscovery%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BGPR40%2BFull%2BAgonists%2BBearing%2BThiophen-2-ylpropanoic%2BAcid%2BScaffold%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2717%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01357"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2138</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01357" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;He&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Bin&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;He-Yao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ya-Qiu&quot;,&quot;last_name&quot;:&quot;Long&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2697-2717&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01357&quot;},&quot;abstract&quot;:&quot;The free fatty acid receptor GPR40 is predominantly expressed in pancreatic β-cells and enhances insulin secretion in a glucose dependent manner. Therefore, GPR40 agonists are possible novel insulin secretagogues with reduced or no risk of hypoglycemia for the treatment of type 2 diabetes mellitus (T2DM). Chemically and structurally diverse GPR40 agonists with high safety are pursued for the clinical development of GPR40-based pharmacotherapeutics. Herein we report our design and discovery of a new chemotype of GPR40 agonists free of the typical phenylpropanoic acid scaffold. The thiophen-2-ylpropanoic acid containing GPR40 modulators functioned as full agonists with high-efficacy response (Emax) and reduced lipophilicity. Significantly, the lead compound in this series, (R)-7k, exhibited more potent in vitro glucose-stimulated insulin secretion and in vivo glucose-lowering effects (10 mg/kg, po) than the GPR40 partial agonist TAK-875, which was once in phase III clinical trials, and high selectivity over the&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01357&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01357" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01357&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01357" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01357&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01357" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01357&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01357&amp;href=/doi/10.1021/acs.jmedchem.6b01357" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01357" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01357" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01357%26sid%3Dliteratum%253Aachs%26pmid%3D28277660%26genre%3Darticle%26aulast%3DLi%26date%3D2017%26atitle%3DDiscovery%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BGPR40%2BFull%2BAgonists%2BBearing%2BThiophen-2-ylpropanoic%2BAcid%2BScaffold%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D2697%26epage%3D2717%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The free fatty acid receptor GPR40 is predominantly expressed in pancreatic β-cells and enhances insulin secretion in a glucose dependent manner. Therefore, GPR40 agonists are possible novel insulin secretagogues with reduced or no risk of hypoglycemia for the treatment of type 2 diabetes mellitus (T2DM). Chemically and structurally diverse GPR40 agonists with high safety are pursued for the clinical development of GPR40-based pharmacotherapeutics. Herein we report our design and discovery of a new chemotype of GPR40 agonists free of the typical phenylpropanoic acid scaffold. The thiophen-2-ylpropanoic acid containing GPR40 modulators functioned as full agonists with high-efficacy response (<i>E</i><sub>max</sub>) and reduced lipophilicity. Significantly, the lead compound in this series, (<i>R</i>)-<b>7k</b>, exhibited more potent in vitro glucose-stimulated insulin secretion and in vivo glucose-lowering effects (10 mg/kg, po) than the GPR40 partial agonist <b>TAK-875</b>, which was once in phase III clinical trials, and high selectivity over the relevant receptors GPR120 and PPARγ.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Type 2 diabetes mellitus (T2DM) is a serious metabolic disorder characterized by insulin resistance and insufficient insulin secretion from the pancreas. GPR40 (also referred to as free fatty acid receptor 1, FFA1) belongs to the class A family of G-protein coupled receptors (GPCR) and is mainly expressed in pancreatic β-cells<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and enteroendocrine cells.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Activation of GPR40 by its endogenous ligands elicits the enhancement of glucose-stimulated insulin secretion (GSIS) in a glucose dependent manner.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> GPR40 agonists stimulate insulin secretion only in the presence of elevated glucose levels. On the basis of this mechanism, GPR40 has emerged as a promising antidiabetic drug target posing little or no risk of hypoglycemia.</div><div class="NLM_p">In the past decade, a number of potent synthetic GPR40 agonists have been developed.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> and the most advanced compound was <b>1</b> (<b>TAK-875</b>)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> from Takeda, which was once under clinical trial phase III and provided clinical proof-of-concept for the GPR40 agonist as an effective treatment for T2DM. On the basis of the mode of action, the GPR40 agonists can be divided into partial agonists and full agonists (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), and most of the current GPR40 agonists published in the literature belong to partial agonists [e.g., <b>1</b>,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a><b>2</b> (<b>AMG 837</b>)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>]. The termination of <b>1</b> in phase III clinical trials for the hepatotoxicity issue threw doubt over the long-term safety of targeting GPR40. Structurally diverse and new mechanism GPR40 agonists with high safety are needed to address these concerns and give new insights into the receptor’s basic biology and physiological roles. The recently reported GPR40 full agonists as potential antidiabetic drugs by Amgen stimulated our intensive interest. GPR40 full agonists endow attractive therapeutic characteristics, exemplified by <b>3</b> (<b>AM 1638</b>)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and <b>AM 5262</b><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (for the structures, see <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), showing superior in vivo efficacy to the partial agonist (i.e., <b>2</b>), as well as the significant advantage of stimulating incretin secretion (GLP-1 and GIP) simultaneously.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> Moreover, the full agonists may bind to a different site from that of the partial agonists, offering the potential of positive functional cooperativity to deliver synergistic therapeutic benefits.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Therefore, GPR40 full agonists might afford access to a robust mechanism for maintaining glycemic control and clinical potential for the treatment of type 2 diabetic patients. However, <b>3</b> suffered from the issue of high lipophilicity which might result in lipotoxicity<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and off-target effects in CNS.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> We therefore aimed to develop novel GPR40 full agonists with improved physicochemical properties.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative GPR40 partial agonists and full agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initially, by analyzing the structures of various synthetic GPR40 agonists reported, we concluded the typical pharmacophore of GPR40 agonists, which have also been explored by various groups,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> comprising phenylpropanoic acid core, linker, and aromatic fragment (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). According to the cocrystal structure of GPR40 in complex with <b>1</b>,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> the carboxylic acid head interacts with the key residues, Arg183, Arg258, Tyr240, and Tyr91 of the receptor, while the linker and the aromatic moiety both mimic the hydrophobic tail of the endogenous ligands. For the few GPR40 full agonists reported by Amgen,<a onclick="showRef(event, 'ref5 ref18'); return false;" href="javascript:void(0);" class="ref ref5 ref18">(5, 18)</a> they bear the similar modular structures to the GPR40 partial agonists, yet they function differently and bind to distinct binding sites, probably due to the different spatial arrangement. The comparison of the partial and full agonists in the modular structure framework indicated that the modification of the phenylpropanoic core might lead to the agonist type transformation. For example, changing the middle ether linkage from the <i>para</i> to the <i>meta</i>-position of the phenyl core along with switching the stereochemistry at the β-position and relocating the biphenyl linkage from the 3- to 4-position of <b>2</b> led to the identification of <b>3</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a potent GPR40 full agonist.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Typical pharmacophore model for GPR40 agonist and our design of new structure GPR40 full agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Therefore, we were intrigued to design and discover a new structure series of GPR40 full agonists with low lipophilicity, focused on the variation of the phenylpropanoic core. Starting from the template compound <b>4</b>,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> the precursor of <b>1</b>, replacement of the phenyl core with polar heterocycle along with further chemical modifications on the aromatic tail and the propanoic acid head delivered a new class of GPR40 agonists free of phenylpropanoic acid (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), with the lead compound being demonstrated as full agonist by plasmid titration experiments.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Notably, the choice of the five-membered heteroaromatic ring was based on the notion that 2,5-disubstituted heteroaromatic structure could mimic the <i>meta</i>-substitution pattern of the phenyl core of Amgen’s full agonists (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) with respect to the spatial orientation. Significantly, after a global structural modification, the thiophen-2-ylpropanoic acid-based GPR40 full agonist exhibited more potent in vitro GSIS and in vivo glucose-lowering activity than <b>1</b> and high selectivity over GPR120 and PPARγ, holding promise for further clinical development.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Starting from a simple model GPR40 agonist <b>4</b>, a mechanism-based drug design and systematic SAR study was undertaken to furnish new structure GPR40 full agonists (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The first round of structural modification was focused on the central aromatic ring. As mentioned in the introduction section, a polar five-membered heteroaromatic ring was incorporated to mimic the <i>meta</i>-substitution pattern of the phenylpropanoic acid core of Amgen’s full agonists with reduced lipophilicity. Thus, triazole- and thiophene-based various analogues were synthesized and screened. On the basis of the outcome of the first round of SAR study, the thiophen-2-ylpropanoic acid scaffold was chosen for further structural modification on the aromatic tail and the β-position to the carboxylic acid to improve the activity and PK property (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural exploration of the new structure GPR40 full agonists starting from a model compound <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 1<i>H</i>-1,2,3-triazole-based compounds <b>5a</b>–<b>c</b> were constructed by employing CuAAC (copper-catalyzed azide–alkyne cycloaddition) and Suzuki coupling as the key reactions (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). For example, the preparation of the 3-(1/4-((2′,6′-dimethylbiphenyl-3-yloxy)methyl)-1<i>H</i>-1,2,3-triazol-4-yl)propanoic acid (<b>5a</b>/<b>5b</b>) was commenced with 3-bromophenol, which was converted to the azide/alkyne (<b>9</b>/<b>11</b>) followed by a sequential CuAAC with the corresponding alkyne/azide and a Suzuki coupling with 2,6-dimethylphenylboronic acid. For the 3-(4-((2′,6′-dimethylbiphenyl-3-yl)methoxy)-1<i>H</i>-1,2,3-triazol-1-yl)propanoic acid (<b>5c</b>), convergent synthesis was employed by the alkylation of two building blocks <b>14</b> and <b>16</b>, which were prepared by Suzuki coupling and CuAAC, respectively.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, NaI, (chloromethyl) (methyl)sulfane, DMF, 0 °C–rt, 72%; (b) SO<sub>2</sub>Cl<sub>2</sub>, DCM, −78 °C; (c) NaN<sub>3</sub>, DMSO, rt; (d) pent-4-ynoic acid, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <sup><i>t</i></sup>BuOH/H<sub>2</sub>O = 1:1, MW. 80 °C, 75%; (e) 2,6-dimethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O = 3:1, 100 °C; (f) 3-bromoprop-1-yne, K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 78%; (g) methyl 3-azidopropanoate, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <sup><i>t</i></sup>BuOH/H<sub>2</sub>O = 1:1, MW 80 °C, 84% for <b>12</b>, 28% for <b>15</b>; (h) PBr<sub>3</sub>, DCM, 0 °C (i) BBr<sub>3</sub>, DCM, rt, 94%; (j) Cs<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 73%; (k) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt, 78%.</p></p></figure><div class="NLM_p">The thiophen-2-ylpropanoic acid-based analogues (<b>5d</b>–<b>f</b>, <b>5i</b>–<b>l</b>, <b>6a</b>–<b>h</b>) were furnished from the formylation of the substituted thiophene with <sup><i>n</i></sup>BuLi/DMF or LDA/DMF followed by Wittig reaction to introduce the propanoic acid moiety and the Suzuki coupling to install the aromatic fragment (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> for compound <b>5</b> series, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> for compound <b>6</b> series). The substituted thiophene (<b>17d</b>, <b>17f</b>, <b>17i</b>) was readily prepared from the coupling of bromobenzyl alcohol with iodothiophene.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Notably, the preparation of the 5-(oxymethyl)thiophen-2-ylpropanoic acid (<b>5e</b>) was different from that of the 5-(methyloxy)thiophen-2-ylpropanoic acid (<b>5d</b>, <b>5f</b>, <b>5i</b>, <b>6a</b>–<b>h</b>) in the reaction sequence. Specifically, the formylation occurred at the 5-position of the thiophene ring with Vilsmeier reagent to provide a handle for further introduction of aromatic tail. The resulting aldehyde (<b>21e</b>) was reduced with NaBH<sub>4</sub>, followed by the chlorination with SOCl<sub>2</sub> and subsequent alkylation of 2′,6′-dimethylbiphenyl-3-ol to give <b>5e</b>. It was worth noting that the synthetic route toward <b>5d</b>, <b>5f</b>, and <b>5i</b> could achieve higher yield than that toward <b>6a</b>–<b>h</b> with diversification on the terminal aryl ring. However, for the synthesis of the compounds collection with variation on the aromatic substitution, it is an efficient strategy to diversify at late stage from a common intermediate <b>26</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, 3,4,7,8-tetramethyl-1,10-phenanthroline, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C; (b) 2,6-dimethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O = 3:1, 100 °C; (c) <sup><i>n</i></sup>BuLi, DMF, THF, −78 °C; (d) methyl (triphenylphosphoranylidene) acetate, DMF, 60 °C; (e) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH/THF = 1:2, rt; (f) LiOH·H<sub>2</sub>O, THF/MeOH/H<sub>2</sub>O = 2:2:1, rt; (g) POCl<sub>3</sub>, DMF, 100 °C, 43%; (h) NaBH<sub>4</sub>, MeOH/toluene = 1:1, 0 °C–rt, 72%; (i) SOCl<sub>2</sub>, DCM, 0–50 °C; (j) 2′,6′-dimethylbiphenyl-3-ol, NaI, K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 34% yield over three steps of i, j, and f; (k) I<sub>2</sub>, PhI(O<sub>2</sub>CCF<sub>3</sub>)<sub>2</sub>, CCl<sub>4</sub>, rt, 62%; (l) Na<sub>2</sub>PdCl<sub>4</sub>, CuI, 2-(di-<i>tert</i>-butylphosphino)-1-phenylindole, TMEDA/H<sub>2</sub>O = 9:1, 80 °C, 65%; (m) triethoxymethane, NH<sub>4</sub>Cl, EtOH, 60 °C, 90%; (n) 2,2-dimethyl-1,3-dioxane-4,6-dione, DMAP, THF, rt, 64%; (o) 1-propynylmagnesium bromide, THF, −1 0°C–rt; (p) HCl (aq), rt; (q) DMF/H<sub>2</sub>O = 10:1, 90 °C, 52% over three steps; (r) spiro[indene-1,4′-piperidine], NaB(OAc)<sub>3</sub>H, HOAc, DCE, rt, 25%; (s) thiazolidine-2,4-dione, piperidine, EtOH, 120 °C, 48%; (t) Mg, MeOH, rt, 36%.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, DMF, THF, −78 °C, 48%; (b) ethyl (triphenylphosphoranylidene) acetate, DMF, 60 °C, 82%; (c) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH/THF = 1:2, rt, 73%; (d) R-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O = 3:1, 100 °C.</p></p></figure><div class="NLM_p">Several thiophen-2-ylpropanoic acid derivatives incorporated with privileged aromatic fragment, favorable β-substituent or carboxylic acid bioisosteres (<b>5j</b>–<b>l</b>) were synthesized to compare the SAR of thiophen-2-ylpropanoic acid-based GPR40 agonists with the phenylpropanoic acid prototype. The synthesis is outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> along with other thiophene series by employing the similar synthetic procedures to the known phenylpropanoic acid counterparts. Sonogashira coupling, condensation with Meldrum’s acid and 1,4-addition of Grignard reagent served as the key reactions. For the synthetic details of <b>5j</b>–<b>l</b>, please refer to the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p">The synthetic route toward thieno[3,2-<i>b</i>]thiophene derivatives with different length of carboxylic acid chains <b>5g</b>–<b>h</b> are depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Starting from thieno[3,2-<i>b</i>]thiophene, the introduction of formyl group through Vilsmeier reaction followed by sequential oxidation and esterification or sequential Wittig reaction and reduction gave the key intermediate 3-(thieno[3,2-<i>b</i>]thiophen-2-yl)propanoate <b>30g</b> or thieno[3,2-<i>b</i>]thiophene-2-carboxylate <b>30h</b>. Then iodination and coupling between iodothieno[3,2-<i>b</i>]thiophene and (2′,6′-dimethylbiphenyl-3-yl)methanol <b>13</b> followed by hydrolysis produced <b>5g</b> and <b>5h</b>, respectively.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, DCE, 90 °C, 59%; (b) methyl (triphenylphoranylidene)acetate, THF/H<sub>2</sub>O = 2:1, rt, 72%; (c) NaClO<sub>2</sub>, NaH<sub>2</sub>PO<sub>4</sub>, 2-methyl-2-butene, <sup><i>t</i></sup>BuOH, 77%; (d) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, THF/MeOH = 2:1, rt, 83%; (e) EDCI, HOBt, MeOH, DIEA, DCM; (f) PIFA, I<sub>2</sub>, CCl<sub>4</sub>, rt; (g) <b>13</b>, CuI, Me<sub>4</sub>Phen, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 80 °C; (h) 0.5 M NaOH in MeOH/THF/H<sub>2</sub>O = 2:2:1, rt.</p></p></figure><div class="NLM_p">The derivatization on the β-position to the carboxylic acid is illustrated in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. The diversified propanoic acid chain was synthesized from a common precursor <b>19d</b>. Condensation with Meldrum’s acid yielded the key intermediate <b>32</b>, from which were generated <b>7a</b>–<b>e</b> and <b>33</b> directly through 1,4-addition by corresponding Grignard reagents and decarboxylation. For raceme <b>7h</b>, the intermediate <b>32</b> was treated with KCN, followed by decarboxylation under the microwave-assisted FeCl<sub>3</sub>·6H<sub>2</sub>O catalysis conditions.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Further conversion was performed on <b>33</b> through sequential esterification, click reaction, and hydrolysis to give <b>7i</b>. On the other direction, the nucleophilic addition of an organozinc reagent to <b>19d</b> followed by Ag<sub>2</sub>O-promoted alkylation and hydrolysis delivered the β-alkoxy substituted derivatives <b>7g</b>–<b>h</b>. The synthesis of <b>7j</b> was accomplished according to the reported method<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> through Henry reaction between <b>19d</b> and nitromethane, Michael addition of (<i>S</i>)-3-acetyl-4-benzyl-2-oxazolidinone, formation of isoxazole under (Boc)<sub>2</sub>O/vinyl bromide/DMAP/Et<sub>3</sub>N conditions, and final removal of the oxazolidinone.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Meldrum’s acid, DMAP, THF, 45 °C, 72%; (b) RMgX, THF, −10 °C; (c) DMF/H<sub>2</sub>O = 10:1, 90 °C; (d) KCN, MeOH, rt, 89%; (e) FeCl<sub>3</sub>·6H<sub>2</sub>O, MeNO<sub>2</sub>/DMF = 3:2, H<sub>2</sub>O, MW 110 °C, 46%; (f) MeOH, EDCI, HOBt, Et<sub>3</sub>N, DCM, rt, 75%; (g) TMSN<sub>3</sub>, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <sup><i>t</i></sup>BuOH/H<sub>2</sub>O = 1:1, MW 80 °C, 39%; (h) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt; (i) (2-ethoxy-2-oxoethyl)zinc(II) bromide, THF, 0 °C, 52%; (j) RI, Ag<sub>2</sub>O, toluene, 80 °C; (k) MeNO<sub>2</sub>, NH<sub>4</sub>OAc, THF, 70 °C, 44%; (l) (<i>S</i>)-3-acetyl-4-benzyloxazolidin-2-one, TiCl<sub>4</sub>, DIEA, DCM, −78 °C, 40%; (m) vinyl bromide, (Boc)<sub>2</sub>O, DMAP, Et<sub>3</sub>N, THF, rt, 46%; (n) LiOH·H<sub>2</sub>O, H<sub>2</sub>O<sub>2</sub>, THF/H<sub>2</sub>O, 0 °C, 25%.</p></p></figure><div class="NLM_p">The chiral (<i>R</i>)-<b>7g</b> and (<i>S</i>)-<b>7g</b> were enantioselectively synthesized via Ru-catalyzed asymmetric reduction of carbonyl group, as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. After the construction of ethyl 3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-oxopropanoate <b>38</b>, the Ru-catalyzed asymmetric hydrogenation furnished the (<i>R</i>)-<b>34</b> in good enantioselectivity (98% ee).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Alkylation of the hydroxyl and hydrolysis gave (<i>R</i>)-<b>7g</b>, and the enantiomer (<i>S</i>)-<b>7g</b> was obtained according to the same procedure just by utilizing RuCl[(<i>S</i>,<i>S</i>)-Tsdpen](mesitylene) as the catalyst instead.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>n</i></sup>BuLi, CO<sub>2</sub> (g), THF, −78 °C, 84%; (b) CDI, THF (c) potassium ethyl malonate, MgCl<sub>2</sub>, Et<sub>3</sub>N, MeCN, 52% over two steps; (d) HCO<sub>2</sub>H, Et<sub>3</sub>N, RuCl[(<i>R</i>,<i>R</i>)-Tsdpen](mesitylene), 38 °C, 90%, 98% ee; (e) EtI, Ag<sub>2</sub>O, toluene, 80 °C; (f) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt.</p></p></figure><div class="NLM_p">The synthetic routes of raceme <b>7k</b>–<b>m</b> with modification on the terminal phenyl ring portion are shown in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. Starting from <b>17d</b>, the boronic acid <b>39</b> was prepared via lithium-bromide exchange and boronation. Suzuki coupling with 4-bromo-3,5-dimethylphenol followed by protecting the phenolic hydroxyl with TBSCl provided <b>40</b>. Then formylation and condensation with Meldrum’s acid generated <b>42</b>. The key intermediate <b>43</b> was produced through Michael addition, decarboxylation, esterification, and removal of the TBS protective group. Various hydrophilic side chains were coupled to <b>44</b> by substitution or Mitsunobu reactions followed by hydrolysis, affording the target compounds <b>7k</b>–<b>m</b>.</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>n</i></sup>BuLi, B(O<sup><i>i</i></sup>Pr)<sub>3</sub>, THF, −78 °C, 54%; (b) 4-bromo-3,5-dimethylphenol, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O = 3:1, 100 °C, 68%; (c) TBSCl, Et<sub>3</sub>N, DCM, rt, 89%; (d) <sup><i>n</i></sup>BuLi, DMF, THF, −78 °C, 77%; (e) Meldrum’s acid, DMAP, THF, 45 °C, 86%; (f) 1-propynyl magnesium bromide, THF, −10 °C; (g) DMF/H<sub>2</sub>O = 10:1, 90 °C; (h) MeOH, EDCI, HOBt, Et<sub>3</sub>N, DCM, rt 64% over three steps; (i) TBAF, THF, rt, 98%; (j) 3-(methylsulfonyl)propyl 4-methylbenzenesulfonate, K<sub>3</sub>PO<sub>4</sub>, DMF, 90 °C, 88%; (k) 3-(chloromethyl)-3-methyloxetane, KI, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 69%; (l) 1-methylpiperidin-4-ol, DEAD, PPh<sub>3</sub>, THF, 0 °C–rt, 54%; (m) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt; (n) (<i>S</i>)-2-methylbutan-1-ol, EDCI, HOBt, Et<sub>3</sub>N, DCM, rt, 56%; (o) resolution on chiral AD-H column; (p) 0.25 M NaOH in MeOH/THF/H<sub>2</sub>O = 2:2:1, rt.</p></p></figure><div class="NLM_p last">The direct resolution of raceme <b>7k</b> on the normal-phase chiral column was inefficient due to its high polarity. So the raceme <b>7k</b> was condensed with (<i>S</i>)-2-methyl-1-butanol to produce the separable diastereoisomer. Resolution on chiral AD-H column and hydrolysis with sodium hydroxide gave the optical pure enantiomer (<i>R</i>)-<b>7k</b> and (<i>S</i>)-<b>7k</b>, respectively.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The efforts to pursue new structure GPR40 full agonists with reduced lipophilicity was commenced with the lead compound <b>4</b>, from which was derived the drug candidate <b>1</b>.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> A systematic structural exploration was undertaken based on the pharmacophore model for the GPR40 agonists (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), with respect to the phenyl core, the aromatic tail, and the β-substitution on the propanoic acid portion.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Identification of 2,5-Disubstituted Thiophenylpropanoic Acid with 2′,6′-Dimethylbiphenyl-3-yl Tail Being an Optimal Scaffold</h3><div class="NLM_p">The first round of structural modification was focused on the phenyl ring of the phenylproponoic acid head. Considering that five-membered heterocycle might induce a similar conformation to the <i>meta</i>-substituted phenyl core of Amgen’s full agonists<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> as well as lowering the lipophilicity, various five-membered heteroaromatic rings were screened as the surrogate of the phenyl core in <b>4</b>. As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, the polar triazole was not tolerated (<b>5a</b>–<b>c</b>) regardless of the substitution pattern and the ether position, with an activity loss by at least 3 orders of magnitude. Then, we turned to the less polar thiophene ring. To our delight, the thiophene derivative <b>5d</b> almost maintained the GPR40 agonistic activity of the phenyl parent compound <b>4</b>, and significantly the maximal efficacy increased to 140% relative to <b>4</b>. As it was commonly observed with the classic phenylpropanoic acid-based GPR40 agonists, the inverted central linker remarkably affected the GPR40 agonistic activity, with the alkoxy/amino-substituted phenylpropanoic acid being superior to the oxy/aminoalkyl-substituted counterpart. In the case of thiophen-2-ylpropanoic acid-based GPR40 agonists, the alkoxy substituent on the thiophene core was indeed beneficial for the interaction with GPR40, displaying more than an order of magnitude more potent than the corresponding oxyalkyl thiophenylpropanoic acid (<b>5d</b> vs <b>5e</b>). The specific effect of the central linkers might be due to hydrogen bond interactions, conformational effects, or overall effects on the dipolar momentum. Even on the inferior triazole scaffold series (<b>5a</b>–<b>c</b>), the alkoxy linker exerted a boosting effect on the maximal efficacy of the GPR40 agonism compared to the oxyalkyl linker counterpart (<b>5c</b> vs <b>5b</b>) although both EC<sub>50</sub> values were mediocre.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Agonistic Activity of Five-Membered Heteroaryl Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0016.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Maximal efficacy (<i>E</i><sub>max</sub>) was determined compared to <b>4</b>.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">NA: No activity was observed at the concentration of 20 μM.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">NT: Not tested. Data are expressed as mean values with standard deviation from three independent experiments.</p></div></div><div></div></div><div class="NLM_p">Considering the fused-ring alkanoic acid conferred an improved PK profile of <b>1</b> and yet had slight effect on the activity,<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> we further investigated the thieno[3,2-<i>b</i>]thiophene derivatives (<b>5g</b>,<b>h</b>) with an enlarged aromatic ring which might gain more π–π interaction with the receptor.<a onclick="showRef(event, 'ref17 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref23">(17, 23)</a> The length of the acidic chain was also evaluated. However, the large rigid aromatic ring turned out disfavored within the 2,5-disubstituted thiophenylpropanoic acid framework. Furthermore, the favorable location of the biphenyl linkage at 4-position of <b>3</b> proved to be adverse for the 2,5-disubstituted thiophenylpropanoic acid scaffold. The switch of 2,6-dimethylphenyl from <i>meta</i>- to <i>para</i>-position led to a complete loss of the activity (<b>5i</b>).</div><div class="NLM_p">In addition, we tested whether the thiophene replacement for the phenyl core could be applied to other structure types of potent GPR40 agonists reported. However, the corresponding thiophene derivatives <b>5j</b> and <b>5k</b> were much less potent than the phenyl counterpart <b>TUG-488</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and <b>LY2881835</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> indicating the importance of the compatibility of lipophilic tail and aryl alkanoic acid head. However, the carboxylic acid function could be replaced by a bioisostere, e.g., 2,4-thiazolidinedione with GPR40 agonistic activity almost remaining (<b>5l</b>).</div><div class="NLM_p">Fixing the 2,5-disubstitued thiophenylpropanoic acid as an optimal scaffold, further structure–activity relationship study was focused on the terminal aryl fragment. A range of aromatic rings with various substituents were screened. However, none of these analogues exhibited satisfactory activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). All results indicated that the orthogonal conformation of the biaryl rings was an important factor for the agonistic function, which was in agreement with Takeda’s previous report.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The less hindered <i>ortho</i>-monosubstituted derivatives exhibited lowered activity (<b>6a</b>,<b>b</b>, <b>6h</b>) and some even lost the activity (<b>6c</b>–<b>e</b>). The analogues lacking the <i>ortho</i>-substituent were completely inactive (<b>6f</b>,<b>g</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Exploration of the Terminal Aryl Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">NA = No agonism activity was observed at the initial concentration of 10 μM. Data are expressed as mean values with standard deviation from three independent experiments.</p></div></div><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Optimal Combination of Chiral β-Substituent and the Terminal Polar Chain Affording Potent Thiophenylpropanoic Acid-Based GPR40 Full Agonist</h3><div class="NLM_p">After identification of the 2,6-dimethylbiphenyl-3-yl moiety as the favored aromatic fragment, further structural modification was switched to the substitution at the β-position to the carboxylic acid with the notion that introduction of small residues could reduce the potential of β-oxidation.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, propynyl (raceme <b>7e</b>) was preferred to the small alkyl (raceme <b>7a</b>–<b>c</b>) or cyclopropyl (raceme <b>7d</b>) group at R<sup>2</sup>. But a further increase in the size of R<sup>2</sup> to five-membered heteroaromatic rings (raceme <b>7i</b>–<b>j</b>) resulted in a complete loss in activity. However, the introduction of hydrogen bond acceptor with suitable size (raceme <b>7g</b>–<b>h</b>) led to additional gain in activity relative to the propynyl counterpart (<b>7e</b>). The chirality of the β-substituent was reported to be critical for the GPR40 interaction. So we continued to obtain the two enantiomers of raceme <b>7g</b> separately by asymmetric synthesis. Indeed, an increased activity was observed for the (<i>R</i>)-<b>7g</b> isomer, while the (<i>S</i>)-<b>7g</b> was almost inactive. Interestingly, the configuration of the more active isomer is opposite to that of the literature-reported GPR40 agonists.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Unfortunately, although the ethoxy or cyano substituted racemes were more potent, both of them were not chemically stable with elimination or hydrolysis liability. So our further structural optimization was focused on the propynyl substituted prototype.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. GPR40 Agonistic Activity of the 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid Derivatives with Variation on the β-Position and the Polar Side Chain</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0019.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0020.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">NA = No agonism activity was observed at the initial concentration of 10 μM.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last"><i>E</i><sub>max</sub> was 147% compared to <b>4</b>.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last"><i>E</i><sub>max</sub> was 244% compared to <b>4</b>.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">CLogP values were calculated by the BioByte’s algorithm as implemented in ChemBioDraw Ultra 11.0 (the “CLogP” option). Data are expressed as mean values with standard deviation from three independent experiments.</p></div></div><div></div></div><div class="NLM_p">On the basis of the previous SAR study<a onclick="showRef(event, 'ref6 ref14 ref24 ref25 ref30'); return false;" href="javascript:void(0);" class="ref ref6 ref14 ref24 ref25 ref30">(6, 14, 24, 25, 30)</a> and the cocrystal structure of hGPR40 and <b>1</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> the 4-position of the 2,6-dimethylphenyl moiety could tolerate various modification of different length and polarity to improve the physicochemical property and PK profile of the whole compound. Therefore, we assayed distinct types of polar chains at R<sup>1</sup> to reduce lipophilicity (raceme <b>7k</b>–<b>m</b>). Gratifyingly, the agonistic activity could be well retained with the mesylalkoxy substituted raceme <b>7k</b>. Then, further chiral separation of the raceme <b>7k</b> confirmed that (<i>R</i>)-<b>7k</b> isomer was superior to the (<i>S</i>)-<b>7k</b> in terms of the GPR40 agonistic potency. More significantly, even though the EC<sub>50</sub> values of thiophenylpropanoic acid-based GPR40 agonists <b>7k</b> and (<i>R</i>)<b>-7k</b> were higher (less potent) than the phenyl parent compound <b>4</b>, their maximal efficacy <i>E</i><sub>max</sub> values were improved by a factor of 1.5–2-fold relative to <b>4</b>, which suggested a possible different mechanism and in vivo pharmacological behavior. Furthermore, compared to the Amgen’s developed GPR40 full agonists (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), our compounds generally exhibited much lower lipophilicity (smaller cLogP values).</div><div class="NLM_p">As expected, preliminary mechanism study revealed that (<i>R</i>)-<b>7k</b> with high <i>E</i><sub>max</sub> value functioned as a GPR40 full agonist by plasmid titration experiments.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> HEK293T cells transfected with different quantities of GPR40 expression plasmids (5 and 0.05 μg) were used. When 5 μg of plasmids were transfected, DHA (docosahexaenoic acid, endogenous ligand), <b>1</b>, and (<i>R</i>)-<b>7k</b> displayed similar <i>E</i><sub>max</sub> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Under the 0.05 μg plasmid transfected condition, (<i>R</i>)-<b>7k</b> still showed comparable <i>E</i><sub>max</sub> to DHA while the maximal responses of <b>1</b> substantially decreased (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Definitely, the thiophenylpropanoic acid-derived lead compound (<i>R</i>)-<b>7k</b> acted as GPR40 full agonist. Although the hit in our thiophenyl series (<b>5d)</b> was also disclosed by Toda et al. in 2014,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> they did not pay further attention to its potential of intrinsic efficacy and structural derivatization due to its higher EC<sub>50</sub> value compared to the phenylpropanoic acid prototype, thus missing the discovery of its derived full agonists through the global optimization with the thiophenyl core, aromatic moiety, and the β-substitution on the propanoic acid chain.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plasmid titration experiments. (A) Effect of DHA, <b>1</b>, and (<i>R</i>)-<b>7k</b> in HEK293T cells transfected with 5 μg of GPR40 expression plasmid. (B) Effect of DHA, <b>1</b>, and (<i>R</i>)-<b>7k</b> in HEK293T cells transfected with 0.05 μg of GPR40 expression plasmid. Data are expressed as mean values with standard deviation from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Thiophen-2-ylpropanoic Acid-Based GPR40 Full Agonists Displaying Potent in Vitro Glucose-Stimulated Insulin Secretion and in Vivo Glucose-Lowering Effects</h3><div class="NLM_p">The GPR40 full agonist nature of the thiophen-2-ylpropanoic acid chemotype encouraged us to proceed with further biological evaluation. The glucose-stimulated insulin secretion of compounds <b>5d</b>, (<i>R</i>)-<b>7g</b>, and (<i>R</i>)-<b>7k</b> were examined in MIN6 cell line. (<i>R</i>)-<b>7k</b> showed higher enhancement of glucose-stimulated insulin secretion than <b>1</b>, while compounds <b>5d</b> and (<i>R</i>)-<b>7g</b> were less potent at the concentration of 10 μM in the presence of 25 mM glucose (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). As we mentioned, the unstability of (<i>R</i>)-<b>7g</b> might lead to the compromised cellular activity. Then the stimulation of insulin release under gradient concentrations of (<i>R</i>)-<b>7k</b> and <b>1</b> was tested, and (<i>R</i>)-<b>7k</b> turned out much more potent than <b>1</b> at the same concentration of 300 nM (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). On the other hand, (<i>R</i>)-<b>7k</b> produced no obvious increase in insulin secretion in the presence of 2 mM glucose compared to 2 mM glucose alone (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B), confirming that (<i>R</i>)-<b>7k</b> as a GPR40 agonist just induced a glucose-dependent insulin secretion.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Activity of compounds <b>5d</b>, (<i>R</i>)-<b>7g</b>, (<i>R</i>)-<b>7k</b>, and <b>1</b> in glucose-stimulated insulin secretion (GSIS) in MIN6 cell line. (B) The dose–GSIS activity relationship of <b>1</b> and (<i>R</i>)-<b>7k</b> at different concentrations of glucose; *, <i>p</i> < 0.05; **, <i>p</i> < 0.01, compared to DMSO; #, <i>p</i> < 0.05, compared to 0.3 μM <b>1</b> in the presence of 25 mM glucose. Data are expressed as mean values with standard deviation from four independent experiments (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Before the in vivo efficacy evaluation, we determined the PK properties of lead compound (<i>R</i>)-<b>7k</b> in SD rats. Encouragingly, the thiophenylpropanoic acid derivative displayed acceptable metabolic stability with a half-life of 3.9 ± 0.5 h. The blood concentration, the AUC, and MRT values are satisfactory, but the oral bioavailability (<i>F</i>) was just 13.3%, which needed improving by further structural optimization (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PK Parameters for (<i>R</i>)-<b>7k</b> in SD Rats<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK properties</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> ± sd (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0–<i>t</i></sub> ± sd (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±">MRT<sub>last</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv 1 mg/kg</td><td class="colsep0 rowsep0" align="char" char="±">2181.2 ± 534.6</td><td class="colsep0 rowsep0" align="char" char="±">3322.9 ± 783.5</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">13.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po 10 mg/kg</td><td class="colsep0 rowsep0" align="char" char="±">834.0 ± 278</td><td class="colsep0 rowsep0" align="char" char="±">4423.7 ± 1051.8</td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Administered at a dose of 1 mg/kg, iv; 10 mg/kg, po, in SD rats. The values for <i>C</i><sub>max</sub> and AUC were expressed as equivalent of anhydrous (<i>R</i>)-<b>7k</b>. Data are expressed as mean values with standard deviation from four independent experiments (<i>n</i> = 4).</p></div></div></div><div class="NLM_p">Because the lead compound (<i>R</i>)-<b>7k</b> possessed good PK properties, the in vivo efficacy of the thiophenylpropanoic acid-based GPR40 full agonist was demonstrated by an oral glucose tolerance test (OGTT) in ICR mice. The compounds were orally administered 30 min prior to a glucose challenge (2.5 g/kg). (<i>R</i>)-<b>7k</b> significantly lowered the blood glucose at both tested doses (10 and 20 mg/kg) and showed higher potency than <b>1</b> at the same dose (10 mg/kg) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), even though the oral bioavailability of (<i>R</i>)-<b>7k</b> (<i>F</i>: 13.3% in rat) was much lower than that of <b>1</b> (<i>F</i>: 76% in rat).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The superior efficacy data proved the advantage of the full agonist over the partial agonist with respect to the in vivo overall glucose-lowering effect and glycemic control.</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo efficacy of (<i>R</i>)-<b>7k</b> during an OGTT in ICR mice. (A) Time-dependent changes of glucose levels. (B) Area under the curve (AUC<sub>0–120min</sub>) of plasma glucose. **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001, compared to Vehicle. Data are expressed as mean values with standard deviation from ten independent experiments (<i>n</i> = 10).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, the selectivity of the thiophenylpropanoic acid derivatives was examined. Compounds <b>5d</b>, (<i>R</i>)-<b>7g</b>, and (<i>R</i>)-<b>7k</b> exhibited very high selectivity over both GPR120 and PPARγ (EC<sub>50</sub> > 10 μM).</div><div class="NLM_p">Although the molecular basis of hepatotoxicity caused by <b>1</b> was unclear, recently Chen et al. speculated that the hepatobiliary transporter inhibition and long half-life in diabetic patients’ systemic circulation of <b>1</b> might contribute to cholestatic hepatotoxicity.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> So the selectivity of our compound (<i>R</i>)-<b>7k</b> over the hepatobiliary transporters was assessed. Similar to <b>1</b>, (<i>R</i>)-<b>7k</b> displayed moderate hepatobiliary transporter inhibition (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A), and inhibitory effect of (<i>R</i>)-<b>7k</b> on biliary excretion index (BEI) of d8-TCA was stronger than <b>1</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). The decreased BEI of d8-TCA demonstrated the inhibition of bile acids efflux into bile. The off-target inhibition might result from the alkanoic acid moiety, which is similar to the bile acid in structure. As the carboxylic acid head is an essential pharmacophore of GPR40 agonist, an alternative to reduce the hepatotoxicity risk might be accomplished by increasing the therapeutic window through developing potent full agonists and decreasing the over long half-life.</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitory effects of (<i>R</i>)-<b>7k</b> on hepatobiliary transporters. (A) Effect on hepatobiliary transporters. (B) Effect on BEI of d8-TCA. Data are expressed as mean values with standard deviation from three independent experiments (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we discovered a novel class of GPR40 agonists free of phenylpropanoic acid based on the pharmacophore model and protein structure. The modification on the key pharmacophore of <b>1</b> successfully transformed the GPR40 partial agonist to low lipophilic full agonist. Besides the robust glucose-stimulated insulin secretion effect in the cellular settings, the lead compound (<i>R</i>)-<b>7k</b> exhibited more potent in vivo glucose-lowering activity than <b>1</b> at the same dose (10 mg/kg, po) and high selectivity over the relevant receptors GPR120 and PPARγ. Our work highlighted the therapeutic advantage of GPR40 full agonist over the partial agonist and provided a new chemotype lead compound for the further development of safe and effective treatment for T2DM.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p">Unless otherwise specified, all reactions were carried out in oven-dried glassware with magnetic stirring. All reagents were weighed and handled in air at room temperature. Column chromatography was performed on silica gel (200–300 mesh). All new compounds were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and low/high resolution mass spectroscopy. NMR spectra were recorded on Bruker AVANCE 300 NMR spectrometer or Bruker AVANCE III 400 NMR spectrometer. Chemical shifts for proton magnetic resonance spectra (<sup>1</sup>H NMR) were quoted in parts per million (ppm) referenced to the signals of residual chloroform (7.26 ppm), dimethyl sulfoxide (2.50 ppm), or methanol (3.30 ppm). All <sup>13</sup>C NMR spectra are reported in ppm relative to deuterochloroform (77.23 ppm), dimethyl sulfoxide (39.52 ppm), or methanol (49.00 ppm). The following abbreviations were used to describe peak splitting patterns when appropriate: br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multriplet, dd = doublet of doublet. Mass spectra were recorded using an ESI ion source unless stated otherwise. Some products were isolated by semipreparative HPLC on a EasySepTM-1010 with XBridge Prep C18 reversed-phase column (19 mm × 150 mm) in the solvent systems of solvent A, 0.1% TFA in water; solvent B, 0.1% TFA in acetonitrile; flow rate, 8 mL/min; UV detector, 254 nm. All melting points were measured using a Büchi510 melting point apparatus.</div><div class="NLM_p">The yields in this paper refer to isolated yields of compounds estimated to be ≥95% pure as determined by <sup>1</sup>H NMR or HPLC on Waters 1525EF with Denali C18 reversed-phase column (4.6 mm × 250 mm) in the solvent systems of solvent A, 0.1% TFA in water; solvent B, 0.1% TFA in acetonitrile with the gradient 10–90% B over 8 min, 90% B over 20 min, flow rate 1 mL/min, UV detector 254 nm.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> General Procedure A for Azide–Alkyne Click Reactions</h4><div class="NLM_p last">Azide (1.1 equiv), alkyne (1 equiv), CuSO<sub>4</sub>·5H<sub>2</sub>O (0.1 equiv), and sodium ascorbate (0.5 equiv) were dissolved in <sup><i>t</i></sup>BuOH/H<sub>2</sub>O = 1:1 (0.1–0.2 M) and heated at 80 °C under microwave for 2 h. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Procedure B for Suzuki Coupling Reactions</h4><div class="NLM_p last">Aryl halide (1 equiv), aryl boronic acid (1.2 equiv), Na<sub>2</sub>CO<sub>3</sub> (3 equiv), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv) were protected by N<sub>2</sub>. 1,4-Dioxane/H<sub>2</sub>O = 3:1 (0.1 M) was added by syringe, and the solution was stirred at 100 °C overnight. After cooling to room temperature, the reaction mixture was acidified by diluted HCl (aq) and extracted with ethyl acetate three times. Usual workup and purification by silica gel column chromatography or HPLC afforded the product.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Procedure C for Hydrolysis of Methyl Esters</h4><div class="NLM_p last">To the solution of methyl ester (1 equiv) in MeOH/THF/H<sub>2</sub>O = 2:2:1 (0.1 M) was added LiOH·H<sub>2</sub>O (3 equiv), and the mixture was stirred at room temperature for 4 h. The reaction mixture was acidified by diluted HCl (aq) and extracted with ethyl acetate three times. Usual workup and purification by silica gel column chromatography or HPLC afforded the product.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure D for CuI/Me<sub>4</sub>Phen Catalyzed Coupling Reactions</h4><div class="NLM_p last">CuI (0.1 equiv), 3,4,7,8-tetramethyl-1,10-phenanthroline (Me<sub>4</sub>Phen, 0.2 equiv), and Cs<sub>2</sub>CO<sub>3</sub> (1.5 equiv) were protected by N<sub>2</sub>. Iodothiophene (1 equiv) and (3-bromophenyl)methanol (2 M) were added by syringe, and the slurry was heated at 80 °C overnight. After cooling to room temperature, the resulting mixture was filtered through a plug of silica gel and further eluted with additional ethyl acetate. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel chromatography to afford the product.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure E for Formylation via <sup><i>n</i></sup>BuLi/DMF</h4><div class="NLM_p last">Thiophene derivative (1 equiv) was protected by N<sub>2</sub> and anhydrous THF (0.1 M) was added by syringe. The solution was cooled to −78 °C, and <sup><i>n</i></sup>BuLi (2.5 M in hexanes, 1 equiv) was added dropwise. After stirring at −78 °C for 2 h, DMF (1.1 equiv) in anhydrous THF was added dropwise and the resulting mixture was stirred at −78 °C overnight. The reaction was quenched by aqueous NH<sub>4</sub>Cl and warmed to room temperature. The reaction mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was crystallized from DCM/PE or purified by silica gel column chromatography to afford the product.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure F for Wittig Reaction</h4><div class="NLM_p last">To the solution of aldehyde (1 equiv) in DMF (0.1 M) was added methyl (triphenylphosphoranylidene) acetate (1.5 equiv), and the reaction mixture was stirred at 60 °C overnight. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure G for Reduction of Aryl Acrylates</h4><div class="NLM_p last">Aryl acrylate (1 equiv) and CoCl<sub>2</sub>·6H<sub>2</sub>O (0.1 equiv) were dissolved in MeOH/THF = 1:2 (0.1 M). NaBH<sub>4</sub> (2.5–4 equiv) was added in portions at room temperature. After the starting material was completely consumed, aqueous NH<sub>4</sub>Cl was added. Usual workup and purification by silica gel column chromatography afforded the product.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure H for Iodination via I<sub>2</sub>/PIFA</h4><div class="NLM_p last">Thiophene derivative (1 equiv) was dissolved in CCl<sub>4</sub> (0.5 M). I<sub>2</sub> (0.5 equiv) and PhI(O<sub>2</sub>CCF<sub>3</sub>)<sub>2</sub> (PIFA, 0.55 equiv) were added in portions, and the mixture was stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate. The resulting mixture was washed with Na<sub>2</sub>SO<sub>3</sub> (aq) and brine three times respectively, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to afford the product.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Procedure I for Condensation of Aldehydes and Meldrum’S Acid</h4><div class="NLM_p last">To the solution of aldehyde (1 equiv) in THF (0.2 M) was added Meldrum’s acid (1.3 equiv) and DMAP (0.1 equiv). The reaction mixture was stirred at 45 °C until the starting material was completely consumed. The resulting mixture was diluted with ethyl acetate and washed with diluted HCl (aq) and brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was purified by slurrying in acetone/water. The product was isolated by filtration and dried under vacuum.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure J for 1,4-Addition and Decarboxylation</h4><div class="NLM_p last">Substrate (1 equiv) was protected by N<sub>2</sub>, and anhydrous THF (0.1 M) was added by syringe. The solution was cooled to −10 °C, and Grignard reagent (2 equiv) was added dropwise. After the starting material was completely consumed, the reaction was quenched by diluted HCl and warmed to room temperature. The reaction mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was dissolved in DMF/H<sub>2</sub>O = 10:1, and the solution was stirred at 90 °C for 2 h. After cooling to room temperature, the mixture was acidified by diluted HCl (aq) and extracted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure K for Alkylation of Secondary Alcohol with Iodoalkane</h4><div class="NLM_p last">To the solution of secondary alcohol (1 equiv) in toluene (0.1 M) was added iodoalkane (5 equiv) and Ag<sub>2</sub>O (5 equiv), and the reaction mixture was stirred at 80 °C for 3 h. Then the mixture was cooled to room temperature, and iodoalkane (5 equiv) and Ag<sub>2</sub>O (5 equiv) were added. The reaction mixture was stirred at 80 °C for additional 3 h. After cooling to room temperature, the resulting mixture was filtered through a plug of silica gel and further eluted with ethyl acetate. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel chromatography to afford the product.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Procedure L for Esterification</h4><div class="NLM_p last">To the solution of acid (1 equiv) in DCM (0.1 M) was added EDCI (1.2 equiv), HOBt (1.5 equiv), and Et<sub>3</sub>N (2 equiv), and the mixture was stirred at room temperature for additional 30 min. Alcohol (1.2 equiv) was added to the active ester, and the reaction mixture was stirred overnight. Usual workup and purification by silica gel column chromatography afforded the product.</div></div><div id="sec5_1_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-(1-((2′,6′-Dimethylbiphenyl-3-yloxy)methyl)-1<i>H</i>-1,2,3-triazol-4-yl)propanoic Acid (<b>5a</b>)</h4><div class="NLM_p last">Following general procedure B, target product <b>5a</b> was obtained from intermediate <b>10</b> as white solid, mp 81–85 °C, yield 67%, purity 96.2% (<i>t</i><sub>R</sub> = 13.9 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.60 (s, 1H), 7.34 (t, <i>J</i> = 7.9 Hz, 1H), 7.20–6.98 (m, 4H), 6.84 (d, <i>J</i> = 7.6 Hz, 1H), 6.79 (dd, <i>J</i> = 2.4, 1.4 Hz, 1H), 3.05 (t, <i>J</i> = 7.2 Hz, 2H), 2.78 (t, <i>J</i> = 7.2 Hz, 2H), 1.98 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 352.1 ([M + H]<sup>+</sup>), 350.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.2, 156.1, 147.0, 143.0, 140.9, 135.9, 130.0, 127.4, 127.3, 124.2, 121.4, 117.1, 114.5, 76.4, 33.2, 20.7, 20.6.</div></div><div id="sec5_1_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-(4-((2′,6′-Dimethylbiphenyl-3-yloxy)methyl)-1<i>H</i>-1,2,3-triazol-1-yl)propanoic Acid (<b>5b</b>)</h4><div class="NLM_p last">Following general procedure B, target product <b>5b</b> was obtained from intermediate <b>12</b> as colorless oil, yield 71%, purity 97.0% (<i>t</i><sub>R</sub> = 14.8 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.38 (s, 1H), 7.76 (s, 1H), 7.38–7.29 (m, 1H), 7.19–7.05 (m, 3H), 6.95 (ddd, <i>J</i> = 8.3, 2.5, 1.1 Hz, 1H), 6.79–6.72 (m, 2H), 5.19 (s, 2H), 4.64 (t, <i>J</i> = 6.4 Hz, 2H), 3.01 (t, <i>J</i> = 6.4 Hz, 2H), 2.02 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 352.1 ([M + H]<sup>+</sup>), 350.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 175.4, 158.5, 144.1, 142.8, 141.6, 136.1, 129.8, 127.5, 127.3, 124.1, 122.4, 115.5, 113.1, 61.8, 46.2, 35.2, 20.9.</div></div><div id="sec5_1_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-(4-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)-1<i>H</i>-1,2,3-triazol-1-yl)propanoic Acid (<b>5c</b>)</h4><div class="NLM_p last">To the solution of <b>14</b> (15.7 mg, 0.057 mmol) and <b>16</b> (6.5 mg, 0.038 mmol) in 0.35 mL of acetone was added Cs<sub>2</sub>CO<sub>3</sub> (25 mg, 0.076 mol), and the reaction mixture was stirred at 60 °C overnight. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded methyl 3-(4-((2′,6′-dimethylbiphenyl-3-yl)methoxy)-1<i>H</i>-1,2,3-triazol-1-yl)propanoate as colorless oil, yield 73%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.47–7.38 (m, 2H), 7.22 (s, 1H), 7.19–7.06 (m, 5H), 5.33 (s, 2H), 4.55 (d, <i>J</i> = 6.3 Hz, 2H), 3.70 (s, 3H), 2.94 (d, <i>J</i> = 6.3 Hz, 2H), 2.01 (s, 6H). Following general procedure C, <b>5c</b> was obtained as white solid, mp 122–126 °C, yield 78%, purity 95.3% (<i>t</i><sub>R</sub> = 14.1 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.46–7.37 (m, 2H), 7.21 (s, 1H), 7.18–7.07 (m, 5H), 5.31 (s, 2H), 4.54 (t, <i>J</i> = 6.4 Hz, 2H), 2.97 (t, <i>J</i> = 6.4 Hz, 2H), 2.00 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 352.1 ([M + H]<sup>+</sup>), 350.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 174.5, 160.4, 141.4, 136.5, 136.0, 129.0, 128.7, 128.5, 127.3, 127.2, 126.2, 107.7, 72.2, 46.2, 34.4 29.7, 20.9.</div></div><div id="sec5_1_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>5d</b>)</h4><div class="NLM_p last">Following general procedure G, methyl 3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoate was obtained from the intermediate <b>20d</b> as colorless oil, yield 87%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.44 (t, <i>J</i> = 7.4 Hz, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.21–7.04 (m, 5H), 6.39 (d, <i>J</i> = 3.9 Hz, 1H), 6.05 (d, <i>J</i> = 3.7 Hz, 1H), 5.07 (s, 2H), 3.68 (s, 3H), 2.99 (t, <i>J</i> = 7.8 Hz, 2H), 2.61 (t, <i>J</i> = 7.6 Hz, 2H), 2.01 (s, 6H). Following general procedure C, <b>5d</b> was obtained as white solid, mp 73–77 °C, yield 71%, purity 99.2% (<i>t</i><sub>R</sub> = 14.9 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48–7.35 (m, 2H), 7.22–7.07 (m, 5H), 6.42 (d, <i>J</i> = 3.7 Hz, 1H), 6.06 (d, <i>J</i> = 3.7 Hz, 1H), 5.07 (s, 2H), 3.00 (t, <i>J</i> = 7.5 Hz, 2H), 2.67 (t, <i>J</i> = 7.5 Hz, 2H), 2.02 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 366.9 ([M + H]<sup>+</sup>), 364.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 178.3, 163.2, 141.6, 136.5, 136.2, 129.8, 129.3, 128.9, 128.8, 127.5, 127.4, 126.4, 121.9, 105.8, 75.9, 35.8, 25.5, 21.1.</div></div><div id="sec5_1_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yloxy)methyl)thiophen-2-yl)propanoic Acid (<b>5e</b>)</h4><div class="NLM_p last">Following general procedure C, <b>5e</b> was obtained from intermediate <b>23e</b> as colorless oil, yield 55%, purity 96.3% (<i>t</i><sub>R</sub> = 14.9 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.32 (t, <i>J</i> = 7.4 Hz, 1H), 7.17–7.07 (m, 3H), 6.94 (d, <i>J</i> = 8.4 Hz, 1H), 6.89 (d, <i>J</i> = 3.2 Hz, 1H), 6.76–6.70 (m, 3H), 5.12 (s, 2H), 3.13 (t, <i>J</i> = 7.4 Hz, 2H), 2.72 (t, <i>J</i> = 7.5 Hz, 2H), 2.02 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 364.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 178.3, 158.6, 144.4, 142.7, 141.7, 137.5, 136.2, 129.7, 127.4, 127.3, 127.1, 124.6, 122.2, 115.7, 113.7, 65.3, 36.1, 25.4, 20.9.</div></div><div id="sec5_1_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(4-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>5f</b>)</h4><div class="NLM_p last">Following general procedure G, methyl 3-(4-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic acid was obtained from the intermediate <b>20f</b> as colorless oil, yield 91%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.44 (t, <i>J</i> = 7.2 Hz, 1H), 7.38 (d, <i>J</i> = 7.7 Hz, 1H), 7.21–7.06 (m, 5H), 6.57 (s, 1H), 6.10 (s, 1H), 5.02 (s, 2H), 3.69 (s, 3H), 3.06 (t, <i>J</i> = 7.7 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H), 2.02 (s, 6H). Following general procedure C, <b>5f</b> was obtained as colorless oil, yield 58%, purity 95.1% (<i>t</i><sub>R</sub> = 14.7 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.48–7.34 (m, 2H), 7.19–7.09 (m, 5H), 6.59 (s, 1H), 6.10 (s, 1H), 5.02 (s, 2H), 3.06 (t, <i>J</i> = 7.4 Hz, 2H), 2.71 (t, <i>J</i> = 7.6 Hz, 2H), 2.02 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 365.1 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.2, 156.7, 141.9, 141.7, 141.5, 137.2, 136.2, 128.9, 128.9, 128.4, 127.5, 127.3, 126.0, 118.0, 96.3, 72.0, 35.4, 25.6, 21.1.</div></div><div id="sec5_1_12_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thieno[3,2-<i>b</i>]thiophen-2-yl)propanoic Acid (<b>5g</b>)</h4><div class="NLM_p last">Following general procedure D, starting from the intermediate <b>31g</b>, the benzyl alcohol was specified to (2′,6′-dimethylbiphenyl-3-yl)methanol (1.5 equiv) in toluene (2 M), affording the mixture of target product and coupling product with ester functionality. Then the mixture was dissolved in 0.5 M NaOH in MeOH/THF/H<sub>2</sub>O = 2:2:1 and stirred until the carboxylate was completely hydrolyzed. The reaction mixture was acidified by diluted HCl (aq) and extracted with ethyl acetate three times. Usual workup and purification by silica gel column chromatography afforded the product <b>5g</b> as light-yellow solid, yield over two steps 3%, mp 136–139 °C, purity 95.1% (<i>t</i><sub>R</sub> = 15.5 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.48–7.35 (m, 2H), 7.19 (s, 1H), 7.16–7.04 (m, 4H), 6.82 (s, 1H), 6.43 (s, 1H), 5.13 (s, 2H), 3.17 (t, <i>J</i> = 7.4 Hz, 2H), 2.74 (t, <i>J</i> = 7.4 Hz, 2H), 1.99 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 445.1 ([M + Na]<sup>+</sup>), 421.1 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.6, 165.1, 141.7, 141.5, 141.3, 136.2, 136.1, 134.0, 129.4, 129.0, 128.9, 127.5, 127.4, 126.6, 126.5, 117.4, 100.3, 76.4, 36.3, 29.9, 26.1, 21.1.</div></div><div id="sec5_1_12_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thieno[3,2-<i>b</i>]thiophene-2-carboxylic Acid (<b>5h</b>)</h4><div class="NLM_p last">Following the procedure for preparation of <b>5g</b>, <b>5h</b> was obtained from the intermediate <b>31h</b> as light-yellow solid, yield over two steps 7%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.69 (s, 1H), 7.37–7.27 (m, 2H), 7.09 (s, 1H), 7.06–6.95 (m, 4H), 6.39 (s, 1H), 5.10 (s, 2H), 1.87 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 170.6, 167.8, 143.9, 141.9, 141.3, 136.2, 135.4, 129.7, 129.3, 129.2, 128.9, 128.2, 127.6, 127.5, 127.2, 126.4, 99.4, 76.0, 21.1.</div></div><div id="sec5_1_12_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(5-((2′,6′-Dimethylbiphenyl-4-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>5i</b>)</h4><div class="NLM_p last">Following general procedure G, methyl 3-(5-((2′,6′-dimethylbiphenyl-4-yl)methoxy)thiophen-2-yl)propanoate was obtained from the intermediate <b>20i</b> as colorless oil, yield 72%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.47 (d, <i>J</i> = 7.8 Hz, 2H), 7.21–7.06 (m, 5H), 6.43 (d, <i>J</i> = 3.1 Hz, 1H), 6.11 (d, <i>J</i> = 3.3 Hz, 1H), 5.08 (s, 3H), 3.70 (s, 3H), 3.02 (t, <i>J</i> = 7.4 Hz, 2H), 2.64 (t, <i>J</i> = 7.6 Hz, 2H), 2.03 (s, 6H). Following general procedure C, <b>5i</b> was obtained as white solid, mp 98–102 °C, yield 85%, purity 99.2% (<i>t</i><sub>R</sub> = 14.9 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.47 (d, <i>J</i> = 7.8 Hz, 2H), 7.21–7.05 (m, 5H), 6.45 (d, <i>J</i> = 3.2 Hz, 1H), 6.12 (d, <i>J</i> = 3.6 Hz, 1H), 5.08 (s, 2H), 3.03 (t, <i>J</i> = 7.3 Hz, 2H), 2.70 (t, <i>J</i> = 7.5 Hz, 2H), 2.03 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 364.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 178.4, 163.5, 141.54, 141.48, 136.2, 134.5, 129.7, 129.5, 128.3, 127.5, 127.4, 122.0, 105.4, 75.8, 35.9, 25.6, 21.1.</div></div><div id="sec5_1_12_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(5-((2′-Fluoro-5′-methoxybiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>6a</b>)</h4><div class="NLM_p last">Following general procedure B, <b>6a</b> was obtained from the intermediate <b>26</b> as colorless oil, yield 26%, purity 99.5% (<i>t</i><sub>R</sub> = 13.8 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 7.53 (d, <i>J</i> = 7.5 Hz, 1H), 7.49–7.40 (m, 2H), 7.07 (t, <i>J</i> = 9.5 Hz, 1H), 6.94 (dd, <i>J</i> = 6.2, 3.2 Hz, 1H), 6.84 (dt, <i>J</i> = 8.8, 3.4 Hz, 1H), 6.43 (d, <i>J</i> = 3.7 Hz, 1H), 6.08 (d, <i>J</i> = 3.7 Hz, 1H), 5.09 (s, 2H), 3.83 (s, 3H), 3.01 (t, <i>J</i> = 7.5 Hz, 2H), 2.68 (t, <i>J</i> = 7.5 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 385.1 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.9, 163.1, 155.8 (d, <i>J</i> = 1.8 Hz), 154.2 (d, <i>J</i> = 240.9 Hz), 136.3, 136.2, 129.6, 129.2 (d, <i>J</i> = 15.1 Hz), 129.0 (d, <i>J</i> = 2.6 Hz), 128.7, 128.5 (d, <i>J</i> = 2.6 Hz), 127.3, 121.8, 116.7 (d, <i>J</i> = 24.8 Hz), 115.5 (d, <i>J</i> = 3.0 Hz), 114.1 (d, <i>J</i> = 8.1 Hz), 105.3, 75.5, 55.9, 35.6, 25.3.</div></div><div id="sec5_1_12_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(5-((2′-(Trifluoromethyl)biphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>6b</b>)</h4><div class="NLM_p last">Following general procedure B, <b>6b</b> was obtained from the intermediate <b>26</b> as white solid, mp 125–129 °C, yield 13%, purity 98.4% (<i>t</i><sub>R</sub> = 14.4 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 7.60–7.27 (m, 7H), 6.42 (d, <i>J</i> = 3.7 Hz, 1H), 6.06 (d, <i>J</i> = 3.8 Hz, 1H), 5.07 (s, 2H), 3.01 (t, <i>J</i> = 7.6 Hz, 2H), 2.68 (t, <i>J</i> = 7.5 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 405.1 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 176.8, 163.3, 141.1, 140.3, 135.9, 132.2, 131.5, 129.8, 129.2, 128.7 (q, <i>J</i> = 30.1 Hz), 128.7, 128.2, 127.7, 127.3, 126.3 (q, <i>J</i> = 5.3 Hz), 124.3 (d, <i>J</i> = 274.4 Hz), 121.9, 105.6, 75.7, 35.6, 25.5.</div></div><div id="sec5_1_12_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(5-((2′-Cyanobiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>6c</b>)</h4><div class="NLM_p last">Following general procedure B, <b>6c</b> was obtained from the intermediate <b>26</b> as white solid, mp 131–134 °C, yield 9%, purity 96.1% (<i>t</i><sub>R</sub> = 13.3 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.77 (d, <i>J</i> = 7.7 Hz, 1H), 7.65 (t, <i>J</i> = 7.7 Hz, 1H), 7.60–7.40 (m, 6H), 6.43 (d, <i>J</i> = 3.6 Hz, 1H), 6.09 (d, <i>J</i> = 3.7 Hz, 1H), 5.11 (s, 2H), 3.00 (t, <i>J</i> = 7.4 Hz, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 362.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 178.2, 163.2, 145.3, 138.7, 136.9, 134.0, 133.1, 130.3, 129.8, 129.2, 129.0, 128.4, 128.3, 128.0, 122.0, 118.8, 111.5, 105.6, 75.4, 35.8, 25.5.</div></div><div id="sec5_1_12_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(5-((2′-Carbamoylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>6d</b>)</h4><div class="NLM_p last">Following general procedure B (2-cyanophenylboronic acid was used as starting material), <b>6d</b> was obtained from the intermediate <b>26</b> as white solid, mp 155–158 °C, yield 15%, purity 95.3% (<i>t</i><sub>R</sub> = 11.9 min). <sup>1</sup>H NMR (300 MHz, DMSO) δ 7.67 (s, 1H), 7.53–7.27 (m, 9H), 6.46 (d, <i>J</i> = 3.4 Hz, 1H), 6.19 (d, <i>J</i> = 3.7 Hz, 1H), 5.09 (s, 2H), 2.85 (t, <i>J</i> = 7.3 Hz, 2H), 2.50 (t, <i>J</i> = 7.3 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 380.1 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, DMSO) δ 173.4, 171.0, 162.2, 140.7, 138.5, 137.3, 136.0, 129.9, 129.7, 129.3, 128.3, 128.3, 127.9, 127.6, 127.1, 126.8, 121.8, 104.9, 74.6, 35.4, 25.1.</div></div><div id="sec5_1_12_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(5-((2′-Methoxybiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>6e</b>)</h4><div class="NLM_p last">Following general procedure B, <b>6e</b> was obtained from the intermediate <b>26</b> as colorless oil, yield 26%, purity 96.4% (<i>t</i><sub>R</sub> = 13.9 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 7.51 (dt, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.47–7.28 (m, 4H), 7.05 (d, <i>J</i> = 7.4 Hz, 1H), 6.99 (d, <i>J</i> = 8.6 Hz, 1H), 6.43 (d, <i>J</i> = 3.7 Hz, 1H), 6.08 (d, <i>J</i> = 3.8 Hz, 1H), 5.08 (s, 2H), 3.81 (s, 3H), 3.01 (t, <i>J</i> = 7.5 Hz, 2H), 2.68 (t, <i>J</i> = 7.5 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 368.8 ([M + H]<sup>+</sup>), 366.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 179.4, 157.6, 156.6, 139.0, 136.9, 132.7, 131.1, 130.6, 129.4, 129.4, 128.9, 128.9, 128.4, 126.2, 121.0, 115.1, 111.4, 70.3, 55.7, 36.1, 29.9.</div></div><div id="sec5_1_12_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(5-((4′-(Trifluoromethyl)biphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>6f</b>)</h4><div class="NLM_p last">Following general procedure B, <b>6f</b> was obtained from the intermediate <b>26</b> as white solid, mp 117–120 °C, yield 24%, purity 96.6% (<i>t</i><sub>R</sub> = 14.8 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.70 (s, 4H), 7.63 (s, 1H), 7.60–7.54 (m, 1H), 7.52–7.40 (m, 2H), 6.43 (d, <i>J</i> = 3.7 Hz, 1H), 6.09 (d, <i>J</i> = 3.8 Hz, 1H), 5.10 (s, 2H), 3.01 (t, <i>J</i> = 7.5 Hz, 2H), 2.68 (t, <i>J</i> = 7.5 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 405.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 178.1, 163.2, 144.5, 140.4, 137.1, 129.9, 129.8 (q, <i>J</i> = 32.4 Hz), 129.5, 127.8, 127.7, 127.5, 126.9, 126.0 (q, <i>J</i> = 3.7 Hz), 124.5 (q, <i>J</i> = 272.7 Hz), 122.0, 105.6, 75.6, 35.8, 25.5.</div></div><div id="sec5_1_12_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-(5-(3-(2,6-Dichloropyridin-4-yl)benzyloxy)thiophen-2-yl)propanoic Acid (<b>6g</b>)</h4><div class="NLM_p last">Following general procedure B, <b>6g</b> was obtained from the intermediate <b>26</b> as light-yellow oil, yield 19%, purity 97.3% (<i>t</i><sub>R</sub> = 14.4 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.62 (s, 1H), 7.59–7.50 (m, 3H), 7.47 (s, 2H), 6.43 (d, <i>J</i> = 3.7 Hz, 1H), 6.09 (d, <i>J</i> = 3.7 Hz, 1H), 5.10 (s, 2H), 3.01 (t, <i>J</i> = 7.4 Hz, 2H), 2.68 (t, <i>J</i> = 7.4 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 405.9 ([M-H]<sup>−</sup>), 408.0 ([M+2-H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 178.6, 157.3, 153.9, 151.3, 138.8, 136.3, 133.2, 129.9, 129.6, 129.4, 126.9, 126.2, 121.1, 115.1, 69.7, 36.0, 30.0.</div></div><div id="sec5_1_12_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(5-(3-(3-Chloropyridin-4-yl)benzyloxy)thiophen-2-yl)propanoic Acid (<b>6h</b>)</h4><div class="NLM_p last">Following general procedure B, <b>6h</b> was obtained from the intermediate <b>26</b> as white solid, mp 115–117 °C, yield 11%, purity 98.9% (<i>t</i><sub>R</sub> = 12.5 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.54 (d, <i>J</i> = 4.9 Hz, 1H), 7.55–7.41 (m, 4H), 7.30 (d, <i>J</i> = 5.0 Hz, 1H), 6.43 (d, <i>J</i> = 3.8 Hz, 1H), 6.08 (d, <i>J</i> = 3.4 Hz, 1H), 5.10 (s, 2H), 3.02 (t, <i>J</i> = 7.5 Hz, 2H), 2.68 (t, <i>J</i> = 7.5 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 371.9 ([M – H]<sup>−</sup>), 373.9 ([M + 2-H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 176.7, 163.0, 150.1, 147.8, 147.7, 137.0, 136.8, 130.5, 130.2, 129.1, 129.0, 128.6, 128.5, 125.7, 121.9, 105.7, 75.4, 35.7, 25.7.</div></div><div id="sec5_1_12_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)butanoic Acid (<b>7a</b>)</h4><div class="NLM_p last">Following general procedure J, <b>7a</b> was obtained from the intermediate <b>32</b> as yellow oil, yield 57%, purity 95.0% (<i>t</i><sub>R</sub> = 15.2 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.44 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 7.21–7.06 (m, 5H), 6.42 (d, <i>J</i> = 3.7 Hz, 1H), 6.04 (d, <i>J</i> = 3.8 Hz, 1H), 5.07 (s, 2H), 3.47–3.31 (m, 1H), 2.68 (dd, <i>J</i> = 15.8, 6.7 Hz, 1H), 2.52 (dd, <i>J</i> = 15.7, 7.7 Hz, 1H), 2.01 (s, 6H), 1.33 (d, <i>J</i> = 6.8 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 379.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.7, 162.9, 141.6, 141.6, 136.5, 136.5, 136.2, 129.2, 128.9, 128.8, 127.5, 127.4, 126.4, 120.0, 105.4, 75.8, 43.6, 32.3, 22.5, 21.1.</div></div><div id="sec5_1_12_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)pentanoic Acid (<b>7b</b>)</h4><div class="NLM_p last">Following general procedure J, <b>7b</b> was obtained from the intermediate <b>32</b> as yellow oil, yield 55%, purity 95.1% (<i>t</i><sub>R</sub> = 15.9 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.44 (t, <i>J</i> = 7.5 Hz, 1H), 7.37 (d, <i>J</i> = 7.9 Hz, 1H), 7.20–7.06 (m, 5H), 6.41 (d, <i>J</i> = 3.8 Hz, 1H), 6.04 (d, <i>J</i> = 3.8 Hz, 1H), 5.07 (s, 2H), 3.20–3.05 (m, 1H), 2.60 (d, <i>J</i> = 7.9 Hz, 2H), 2.01 (s, 6H), 1.77–1.48 (m, 2H), 0.87 (t, <i>J</i> = 7.3 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 392.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.7, 163.0, 141.60, 141.56, 136.5, 136.2, 134.5, 129.2, 128.9, 128.8, 127.5, 127.4, 126.4, 121.4, 105.3, 75.7, 42.1, 39.7, 30.0, 29.9, 21.1, 11.9.</div></div><div id="sec5_1_12_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)hexanoic Acid (<b>7c</b>)</h4><div class="NLM_p last">Following general procedure J, <b>7c</b> was obtained from the intermediate <b>32</b> as yellow oil, yield 55%, purity 95.9% (<i>t</i><sub>R</sub> = 16.3 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.43 (t, <i>J</i> = 7.5 Hz, 1H), 7.36 (d, <i>J</i> = 7.6 Hz, 1H), 7.21–7.04 (m, 5H), 6.40 (d, <i>J</i> = 3.7 Hz, 1H), 6.02 (d, <i>J</i> = 3.7 Hz, 1H), 5.06 (s, 2H), 3.28–3.12 (m, 1H), 2.58 (d, <i>J</i> = 7.3 Hz, 2H), 2.00 (s, 6H), 1.66–1.41 (m, 2H), 1.36–1.14 (m, 2H), 0.87 (t, <i>J</i> = 7.3 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 408.9 ([M + H]<sup>+</sup>), 407.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 176.0, 163.0, 141.61, 141.55, 136.5, 136.2, 134.7, 129.2, 128.9, 128.8, 127.5, 127.4, 126.4, 121.4, 105.3, 75.7, 42.1, 39.3, 37.9, 21.1, 20.5, 14.0.</div></div><div id="sec5_1_12_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3-Cyclopropyl-3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>7d</b>)</h4><div class="NLM_p last">Following general procedure J, <b>7d</b> was obtained from the intermediate <b>32</b> as colorless oil, yield 52%, purity 95.7% (<i>t</i><sub>R</sub> = 17.5 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.47–7.32 (m, 2H), 7.20–7.03 (m, 5H), 6.43 (d, <i>J</i> = 3.8 Hz, 1H), 6.05 (d, <i>J</i> = 3.8 Hz, 1H), 5.06 (s, 2H), 2.75 (d, <i>J</i> = 7.2 Hz, 2H), 2.49 (dd, <i>J</i> = 16.6, 7.6 Hz, 1H), 2.00 (s, 6H), 1.04–0.89 (m, 1H), 0.58–0.51 (m, 2H), 0.33–0.21 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 405.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.0, 163.2, 141.60, 141.56, 136.5, 136.2, 134.4, 129.2, 128.9, 128.8, 127.5, 127.4, 126.4, 120.6, 105.3, 75.7, 42.7, 41.6, 21.1, 18.2, 5.3, 5.0.</div></div><div id="sec5_1_12_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoic Acid (<b>7e</b>)</h4><div class="NLM_p last">Following general procedure J, <b>7e</b> was obtained from the intermediate <b>32</b> as light-yellow oil, yield 56%, purity 97.9% (<i>t</i><sub>R</sub> = 15.1 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.48–7.33 (m, 2H), 7.20–7.05 (m, 5H), 6.55 (d, <i>J</i> = 3.8 Hz, 1H), 6.04 (d, <i>J</i> = 3.8 Hz, 1H), 5.06 (s, 2H), 4.23–4.18 (m, 1H), 2.86–2.70 (m, 2H), 2.00 (s, 6H), 1.81 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 404.9 ([M + H]<sup>+</sup>), 402.8 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 177.0, 163.8, 141.6, 141.5, 136.4, 136.2, 131.1, 129.3, 128.9, 128.7, 127.5, 127.4, 126.4, 121.8, 105.6, 79.5, 78.6, 75.8, 43.4, 29.7, 21.0, 3.8.</div></div><div id="sec5_1_12_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-methoxypropanoic Acid (<b>7f</b>)</h4><div class="NLM_p last">Following general procedure K, ethyl 3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-methoxypropanoate was obtained from the intermediate <b>34</b> as colorless oil, yield 70%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.49–7.35 (m, 2H), 7.21–7.06 (m, 5H), 6.62 (d, <i>J</i> = 3.8 Hz, 1H), 6.10 (d, <i>J</i> = 3.8 Hz, 1H), 5.10 (s, 2H), 4.70 (dd, <i>J</i> = 8.7, 5.0 Hz, 1H), 4.15 (q, <i>J</i> = 7.1 Hz, 2H), 3.24 (s, 3H), 2.84 (dd, <i>J</i> = 15.4, 8.8 Hz, 1H), 2.64 (dd, <i>J</i> = 15.2, 5.1 Hz, 1H), 2.01 (s, 6H), 1.24 (t, <i>J</i> = 7.1 Hz, 3H). Then following general procedure C, <b>7f</b> was obtained as colorless oil, yield 47%, purity 95.1% (<i>t</i><sub>R</sub> = 14.6 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.49–7.36 (m, 2H), 7.22–7.07 (m, 5H), 6.64 (d, <i>J</i> = 3.3 Hz, 1H), 6.10 (d, <i>J</i> = 3.8 Hz, 1H), 5.11 (s, 2H), 4.69 (dd, <i>J</i> = 9.1, 4.3 Hz, 1H), 3.27 (s, 3H), 2.89 (dd, <i>J</i> = 15.8, 9.0 Hz, 1H), 2.72 (dd, <i>J</i> = 15.7, 4.6 Hz, 1H), 2.01 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 394.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 176.1, 165.3, 141.6, 141.5, 136.20, 136.19, 130.2, 129.3, 129.0, 128.7, 127.5, 127.4, 126.4, 124.0, 105.1, 76.2, 75.7, 56.5, 43.5, 21.1.</div></div><div id="sec5_1_12_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-ethoxypropanoic Acid (<b>7g</b>)</h4><div class="NLM_p last">Following general procedure K, ethyl 3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-ethoxypropanoate was obtained from the intermediate <b>34</b> as colorless oil, yield 76%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.45 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.20–7.07 (m, 5H), 6.59 (d, <i>J</i> = 3.8 Hz, 1H), 6.08 (d, <i>J</i> = 3.8 Hz, 1H), 5.09 (s, 2H), 4.81 (dd, <i>J</i> = 8.7, 5.2 Hz, 1H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 3.56–3.31 (m, 2H), 2.84 (dd, <i>J</i> = 15.3, 8.7 Hz, 1H), 2.63 (dd, <i>J</i> = 15.3, 5.3 Hz, 1H), 2.01 (s, 6H), 1.24 (t, <i>J</i> = 7.1 Hz, 3H), 1.14 (t, <i>J</i> = 7.0 Hz, 3H). Then following general procedure C, <b>7g</b> was obtained as colorless oil, yield 43%, purity 96.5% (<i>t</i><sub>R</sub> = 17.0 min, mobile phase without additive was used). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.45 (t, <i>J</i> = 7.0 Hz, 1H), 7.38 (d, <i>J</i> = 7.3 Hz, 1H), 7.22–7.08 (m, 5H), 6.62 (d, <i>J</i> = 3.5 Hz, 1H), 6.09 (d, <i>J</i> = 3.4 Hz, 1H), 5.10 (s, 2H), 4.81 (dd, <i>J</i> = 8.7, 4.4 Hz, 1H), 3.57–3.33 (m, 2H), 2.89 (dd, <i>J</i> = 16.0, 8.1 Hz, 1H), 2.72 (dd, <i>J</i> = 15.8, 4.5 Hz, 1H), 2.01 (s, 6H), 1.16 (t, <i>J</i> = 7.0 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 432.8 ([M + Na]<sup>+</sup>), 408.9 ([M – H]<sup>−</sup>).</div></div><div id="sec5_1_12_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>R</i>)-3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-ethoxypropanoic Acid ((<i>R</i>)-<b>7g</b>)</h4><div class="NLM_p last">According to the same procedure of <b>7g</b>, (<i>R</i>)-<b>7g</b> was obtained using (<i>R</i>)-<b>34</b> as precursor, overall yield over two steps: 33%, 98% ee [HPLC condition: CHIRALPAK IB 4.6 mm × 250 mm column by isocratic elution: 0.1% TFA in hexane/0.1% TFA in 2-propanol = 90/10 (v/v) at a flow rate of 1.0 mL/min, with UV detection at 254 nm]. Retention time: minor product (<i>S</i>)-<b>7g</b> 8.0 min, major product (<i>R</i>)-<b>7g</b> 24.4 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.45 (t, <i>J</i> = 7.0 Hz, 1H), 7.38 (d, <i>J</i> = 7.3 Hz, 1H), 7.22–7.08 (m, 5H), 6.62 (d, <i>J</i> = 3.5 Hz, 1H), 6.09 (d, <i>J</i> = 3.4 Hz, 1H), 5.10 (s, 2H), 4.81 (dd, <i>J</i> = 8.7, 4.4 Hz, 1H), 3.57–3.33 (m, 2H), 2.89 (dd, <i>J</i> = 16.0, 8.1 Hz, 1H), 2.72 (dd, <i>J</i> = 15.8, 4.5 Hz, 1H), 2.01 (s, 6H), 1.16 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 175.3, 165.0, 141.6, 141.5, 136.2, 136.1, 130.9, 129.3, 128.9, 128.7, 127.5, 127.3, 126.3, 123.4, 115.1, 105.0, 75.6, 74.1, 64.3, 43.3, 21.0, 15.1. HRMS (ESI) calcd for C<sub>24</sub>H<sub>25</sub>O<sub>4</sub>S [M – H]<sup>−</sup>: 409.1474, found 409.1476. [α]<sub>D</sub> + 28.4° (<i>c</i> 0.175, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec5_1_12_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-Cyano-3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)propanoic Acid (<b>7h</b>)</h4><div class="NLM_p last">To the solution of <b>32</b> (19 mg, 0.042 mmol) in 0.8 mL of MeOH was added KCN (3.3 mg, 0.051 mmol) and stirred at room temperature for 2 h. The reaction mixture was diluted with ethyl acetate and washed with brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure to afford 2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-2-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)acetonitrile which could be used for next step without further purification, yield 89%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.36–7.26 (m, 2H), 7.08–6.92 (m, 5H), 6.54 (d, <i>J</i> = 3.2 Hz, 1H), 5.94 (d, <i>J</i> = 3.4 Hz, 1H), 5.21 (s, 1H), 5.01–4.93 (m, 1H), 4.92 (s, 2H), 1.88 (s, 6H), 1.52 (s, 6H). To the solution of 2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-2-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)acetonitrile (190 mg, 0.4 mmol) in 5 mL of MeNO<sub>2</sub>/DMF = 3:2 was added FeCl<sub>3</sub>·6H<sub>2</sub>O (0.54 mg, 0.002 mmol) and H<sub>2</sub>O (7.2 μL, 0.4 mmol). The reaction mixture was stirred at 110 °C under microwave for 5 min. After cooling to room temperature, the mixture was acidified by diluted HCl (aq) and extracted with ethyl acetate three times. Usual workup and purification by silica gel column chromatography afforded the product as light-yellow oil, yield 46%, purity 96.2% (<i>t</i><sub>R</sub> = 15.6 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46 (t, <i>J</i> = 7.5 Hz, 1H), 7.37 (d, <i>J</i> = 7.7 Hz, 1H), 7.21–7.07 (m, 5H), 6.72 (d, <i>J</i> = 3.9 Hz, 1H), 6.11 (d, <i>J</i> = 3.9 Hz, 1H), 5.10 (s, 2H), 4.36 (t, <i>J</i> = 7.3 Hz, 1H), 3.07 (dd, <i>J</i> = 17.2, 7.8 Hz, 1H), 2.94 (dd, <i>J</i> = 17.2, 6.8 Hz, 1H), 2.01 (s, 6H). HRMS (ESI) calcd for C<sub>23</sub>H<sub>20</sub>NO<sub>3</sub>S [M – H]<sup>−</sup>: 390.1164, found 390.1175. <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 173.7, 165.3, 141.7, 141.4, 136.2, 135.8, 129.5, 129.1, 128.8, 127.6, 127.4, 126.4, 124.6, 122.3, 118.9, 105.9, 76.0, 39.6, 28.9, 21.1.</div></div><div id="sec5_1_12_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-(1<i>H</i>-1,2,3-triazol-4-yl)propanoic Acid (<b>7i</b>)</h4><div class="NLM_p last">Following general procedure J and L in sequence, methyl 3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)pent-4-ynoate was obtained as yellow oil, yield 53%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.49–7.34 (m, 2H), 7.19–7.09 (m, 5H), 6.60 (dd, <i>J</i> = 3.8, 0.8 Hz, 1H), 6.07 (d, <i>J</i> = 3.8 Hz, 1H), 5.08 (s, 2H), 4.30–4.24 (m, 1H), 3.70 (s, 3H), 2.89–2.73 (m, 2H), 2.30 (d, <i>J</i> = 3.1 Hz, 1H), 2.01 (s, 6H). Following general procedure A (the amount of TMSN<sub>3</sub> was increased to 2 equiv and reaction time was increased to 24 h), methyl 3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-(1<i>H</i>-1,2,3-triazol-4-yl)propanoate was obtained as yellow oil, yield 39%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.51 (s, 1H), 7.44 (t, <i>J</i> = 7.5 Hz, 1H), 7.36 (d, <i>J</i> = 7.1 Hz, 1H), 7.21–7.06 (m, 5H), 6.49 (d, <i>J</i> = 3.9 Hz, 1H), 6.06 (d, <i>J</i> = 3.8 Hz, 1H), 5.06 (s, 2H), 4.79 (t, <i>J</i> = 7.4 Hz, 1H), 3.65 (s, 3H), 3.17 (dd, <i>J</i> = 16.0, 8.4 Hz, 1H), 2.99 (dd, <i>J</i> = 16.0, 7.3 Hz, 1H), 2.00 (s, 6H). Following general procedure C, <b>7i</b> was obtained as yellow oil, yield 72%, purity 95.3% (<i>t</i><sub>R</sub> = 13.6 min). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.61 (s, 1H), 7.44 (t, <i>J</i> = 7.5 Hz, 1H), 7.36 (d, <i>J</i> = 7.6 Hz, 1H), 7.16–7.00 (m, 5H), 6.50 (d, <i>J</i> = 3.8 Hz, 1H), 6.09 (d, <i>J</i> = 3.8 Hz, 1H), 5.08 (s, 2H), 4.74 (t, <i>J</i> = 7.6 Hz, 1H), 3.10 (dd, <i>J</i> = 16.1, 7.9 Hz, 1H), 2.96 (dd, <i>J</i> = 16.0, 7.5 Hz, 1H), 1.93 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 431.9 ([M – H]<sup>−</sup>).</div></div><div id="sec5_1_12_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-(isoxazol-3-yl)propanoic Acid (<b>7j</b>)</h4><div class="NLM_p">To the solution of <b>36</b> (104 mg, 0.18 mmol) and DMAP (2.2 mg, 0.018 mmol) in vinyl bromide (1 M in THF, 1.8 mL, 1.8 mmol) was added (Boc)<sub>2</sub>O (28 mg, 0.27 mmol). The reaction mixture was stirred at room temperature overnight. Then vinyl bromide (1 M in THF, 1.8 mL, 1.8 mmol) and (Boc)<sub>2</sub>O (28 mg, 0.27 mmol) were added and the mixture was stirred for additional 24 h. The resulting mixture was diluted with ethyl acetate and washed with brine. Usual workup and purification by silica gel column chromatography or HPLC afforded (<i>S</i>)-4-benzyl-3-((<i>R</i>)-3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-(isoxazol-3-yl)propanoyl)oxazolidin-2-one as colorless oil, yield 46%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.30 (s, 1H), 7.44 (t, <i>J</i> = 7.5 Hz, 1H), 7.39–7.27 (m, 4H), 7.20–7.09 (m, 7H), 6.55 (d, <i>J</i> = 3.8 Hz, 1H), 6.26 (s, 1H), 6.08 (d, <i>J</i> = 3.8 Hz, 1H), 5.07 (s, 2H), 4.92 (t, <i>J</i> = 7.3 Hz, 1H), 4.65 (ddd, <i>J</i> = 13.1, 6.9, 3.2 Hz, 1H), 4.22–4.08 (m, 2H), 3.94 (dd, <i>J</i> = 17.5, 8.0 Hz, 1H), 3.60 (dd, <i>J</i> = 17.5, 6.6 Hz, 1H), 3.21 (dd, <i>J</i> = 13.4, 2.9 Hz, 1H), 2.75 (dd, <i>J</i> = 13.3, 9.4 Hz, 1H), 2.00 (s, 6H).</div><div class="NLM_p last">To the solution of (<i>S</i>)-4-benzyl-3-((<i>R</i>)-3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-(isoxazol-3-yl)propanoyl)oxazolidin-2-one (45 mg, 0.076 mmol) in 1 mL of THF and hydrogen peroxide (30%, 8.2 μL, 0.27 mmol) in an ice bath was added LiOH·H<sub>2</sub>O (6.4 mg, 0.15 mmol) in 0.3 mL of H<sub>2</sub>O. The reaction mixture was stirred at 0 °C for 1 h and quenched by aqueous Na<sub>2</sub>SO<sub>3</sub>. After warming to room temperature, the mixture was acidified by diluted HCl (aq) and extracted with ethyl acetate three times. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 25%, purity 96.7% (<i>t</i><sub>R</sub> = 14.6 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.29 (s, 1H), 7.44 (t, <i>J</i> = 7.5 Hz, 1H), 7.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.20–7.06 (m, 5H), 6.52 (d, <i>J</i> = 3.5 Hz, 1H), 6.19 (s, 1H), 6.06 (d, <i>J</i> = 3.8 Hz, 1H), 5.06 (s, 2H), 4.72 (t, <i>J</i> = 7.4 Hz, 1H), 3.28 (dd, <i>J</i> = 16.6, 7.8 Hz, 1H), 3.01 (dd, <i>J</i> = 16.6, 7.4 Hz, 1H), 1.99 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 456.1 ([M + Na]<sup>+</sup>), 431.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 176.1, 164.4, 163.9, 158.8, 141.6, 141.5, 136.2, 129.9, 129.3, 129.0, 128.7, 127.5, 127.4, 126.4, 122.9, 105.7, 104.1 75.8, 40.0, 35.5, 21.0.</div></div><div id="sec5_1_12_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-(5-((2′,6′-Dimethyl-4′-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoic Acid (<b>7k</b>)</h4><div class="NLM_p last">Following general procedure C, <b>7k</b> was obtained from the intermediate <b>45k</b> as colorless oil, yield 61%, purity 98.1% (<i>t</i><sub>R</sub> = 13.7 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.43 (t, <i>J</i> = 7.5 Hz, 1H), 7.36 (d, <i>J</i> = 7.6 Hz, 1H), 7.15 (s, 1H), 7.10 (d, <i>J</i> = 7.3 Hz, 1H), 6.65 (s, 2H), 6.57 (d, <i>J</i> = 3.8 Hz, 1H), 6.05 (d, <i>J</i> = 3.8 Hz, 1H), 5.07 (s, 2H), 4.20 (t, <i>J</i> = 7.3 Hz, 1H), 4.13 (t, <i>J</i> = 5.7 Hz, 2H), 3.34–3.20 (m, 2H), 2.97 (s, 3H), 2.90–2.66 (m, 2H), 2.35 (td, <i>J</i> = 11.7, 5.8 Hz, 2H), 1.99 (s, 6H), 1.82 (d, <i>J</i> = 2.0 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 563.0 ([M + Na]<sup>+</sup>), 539.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 175.9, 163.8, 157.3, 141.2, 137.8, 136.3, 134.9, 131.2, 129.8, 129.3, 128.9, 126.3, 121.8, 113.4, 105.5, 79.4, 78.7, 75.8, 65.5, 52.0, 43.3, 41.0, 22.9, 21.3, 3.8, 1.2.</div></div><div id="sec5_1_12_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>R</i>)-3-(5-((2′,6′-Dimethyl-4′-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoic Acid ((<i>R</i>)-<b>7k</b>)</h4><div class="NLM_p last">The diastereoisomer <b>46k</b> was separated by HPLC using a CHIRALPAK AD-H semipreparative column (10 mm × 250 mm) [Conditions: isocratic elution, hexane/EtOH/MeOH = 35/26/39 (v/v/v) at a flow rate of 4.0 mL/min, with UV detection at 254 nm] to afford (<i>R</i>)-<b>46k</b> with a retention time of 23 min. (<i>R</i>)-<b>46k</b> was hydrolyzed in 0.25 M NaOH in MeOH/THF/H<sub>2</sub>O = 2:2:1 to obtained (<i>R</i>)-<b>7k</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46–7.32 (m, 2H), 7.15 (s, 1H), 7.10 (d, <i>J</i> = 7.3 Hz, 1H), 6.65 (s, 2H), 6.57 (d, <i>J</i> = 3.8 Hz, 1H), 6.05 (d, <i>J</i> = 3.7 Hz, 1H), 5.07 (s, 2H), 4.20 (t, <i>J</i> = 7.3 Hz, 1H), 4.13 (t, <i>J</i> = 5.7 Hz, 2H), 3.34–3.20 (m, 2H), 2.97 (s, 3H), 2.89–2.68 (m, 2H), 2.35 (td, <i>J</i> = 11.3, 5.8 Hz, 2H), 1.99 (s, 6H), 1.82 (d, <i>J</i> = 2.3 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 176.1, 163.8, 157.3, 141.2, 137.8, 136.3, 134.9, 131.1, 129.8, 129.3, 128.9, 126.3, 121.8, 113.4, 105.5, 79.5, 78.7, 75.8, 65.5, 52.0, 43.3, 41.0, 29.7, 22.9, 21.3, 3.8. HRMS (ESI) calcd for C<sub>29</sub>H<sub>31</sub>O<sub>6</sub>S<sub>2</sub> [M – H]<sup>−</sup>: 539.1562, found 539.1576. [α]<sub>D</sub> + 4.2° (<i>c</i> 0.210, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec5_1_12_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>S</i>)-3-(5-((2′,6′-Dimethyl-4′-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoic Acid ((<i>S</i>)-<b>7k</b>)</h4><div class="NLM_p last">The diastereoisomer <b>46k</b> was separated by HPLC using a CHIRALPAK AD-H semipreparative column (10 mm × 250 mm) [Conditions: isocratic elution, hexane/EtOH/MeOH = 35/26/39 (v/v/v) at a flow rate of 4.0 mL/min, with UV detection at 254 nm] to afford (<i>S</i>)-<b>46k</b> with a retention time of 15 min. (<i>S</i>)-<b>46k</b> was hydrolyzed in 0.25 M NaOH in MeOH/THF/H<sub>2</sub>O = 2:2:1 to give (<i>S</i>)-<b>7k</b>. [α]<sub>D</sub> −5.1° (<i>c</i> 0.145, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec5_1_12_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 3-(5-((2′-Methyl-4′-((3-methyloxetan-3-yl)methoxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoic Acid (<b>7l</b>)</h4><div class="NLM_p last">Following general procedure C, <b>7l</b> was obtained from the intermediate <b>45l</b> as light-yellow oil, yield 82%, purity 96.4% (<i>t</i><sub>R</sub> = 14.9 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46–7.33 (m, 2H), 7.16 (s, 1H), 7.11 (d, <i>J</i> = 7.3 Hz, 1H), 6.71 (s, 2H), 6.57 (d, <i>J</i> = 3.8 Hz, 1H), 6.05 (dd, <i>J</i> = 3.7, 1.4 Hz, 1H), 5.07 (s, 2H), 4.65 (d, <i>J</i> = 5.9 Hz, 2H), 4.48 (d, <i>J</i> = 5.9 Hz, 2H), 4.20 (t, <i>J</i> = 6.8 Hz, 1H), 4.04 (s, 2H), 2.89–2.66 (m, 2H), 2.00 (s, 6H), 1.82 (d, <i>J</i> = 2.2 Hz, 3H), 1.45 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 527.0 ([M + Na]<sup>+</sup>), 502.9 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 174.9, 163.8, 158.1, 141.3, 137.8, 136.3, 134.6, 131.1, 129.9, 129.4, 128.9, 126.3, 121.9, 113.4, 105.6, 80.2, 79.5, 78.7, 75.9, 72.9, 43.1, 39.9, 29.8, 21.5, 21.3, 3.8.</div></div><div id="sec5_1_12_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-(5-((2′,6′-Dimethyl-4′-(1-methylpiperidin-4-yloxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoic Acid (<b>7m</b>)</h4><div class="NLM_p last">Following general procedure C, <b>7m</b> was obtained from the intermediate <b>45m</b> as white solid, mp 89–93 °C, yield 65%, purity 97.6% (<i>t</i><sub>R</sub> = 12.3 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.44–7.28 (m, 2H), 7.13 (s, 1H), 7.07 (d, <i>J</i> = 7.3 Hz, 1H), 6.62 (s, 2H), 6.58 (d, <i>J</i> = 3.8 Hz, 1H), 6.02 (d, <i>J</i> = 3.8 Hz, 1H), 5.04 (s, 2H), 4.48 (s, 1H), 4.24 (dd, <i>J</i> = 8.6, 6.4 Hz, 1H), 2.93 (s, 4H), 2.78–2.60 (m, 2H), 2.54 (s, 3H), 2.23–2.08 (m, 2H), 2.07–1.98 (m, 2H), 1.95 (s, 6H), 1.80 (d, <i>J</i> = 2.0 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 518.1 ([M + H]<sup>+</sup>), 516.0 ([M – H]<sup>−</sup>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 176.7, 163.3, 155.7, 141.1, 137.9, 136.6, 135.0, 133.1, 129.7, 129.3, 128.9, 126.3, 121.2, 114.8, 105.7, 105.5, 80.4, 78.1, 75.8, 50.3, 45.6, 44.2, 30.8, 28.4, 21.3, 4.0.</div></div><div id="sec5_1_12_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> ((3-Bromophenoxy)methyl)(methyl)sulfane (<b>8</b>)</h4><div class="NLM_p last">3-Bromophenol (613 μL, 5.8 mmol) and NaI (870 mg, 5.8 mmol) were dissolved in 50 mL of DMF and cooled in an ice bath. NaH (55%, 506 mg, 11.6 mmol) was added in small portions, and the reaction mixture was stirred for additional 30 min. (Chloromethyl)(methyl)sulfane (538 μL, 6.4 mmol) was added dropwise. Then the mixture was warmed to room temperature and stirred overnight. The reaction was quenched by ice–water and extracted with Et<sub>2</sub>O. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to afford the product as colorless oil, yield 72%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.20–7.09 (m, 3H), 6.89 (dt, <i>J</i> = 7.2, 2.3 Hz, 1H), 5.13 (s, 2H), 2.25 (d, <i>J</i> = 1.4 Hz, 3H).</div></div><div id="sec5_1_12_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-(Azidomethoxy)-3-bromobenzene (<b>9</b>)</h4><div class="NLM_p last">Compound <b>8</b> (1.0 g, 4.3 mmol) was dissolved in 15 mL of anhydrous DCM and cooled to −78 °C. SO<sub>2</sub>Cl<sub>2</sub> (350 μL, 4.3 mmol) in 5 mL of anhydrous DCM was added dropwise by syringe. The reaction mixture was stirred at −78 °C for additional 1 h. The mixture was concentrated under reduced pressure. The residue was dissolved in 20 mL of DMSO, and NaN<sub>3</sub> (559 mg, 8.6 mmol) was added. The reaction mixture was stirred at room temperature overnight. The mixture was diluted with Et<sub>2</sub>O and washed with aqueous NaHCO<sub>3</sub> and brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure to afford the crude <b>9</b> which could be used for next step without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.23–7.16 (m, 3H), 6.94 (dd, <i>J</i> = 7.6, 4.0 Hz, 1H), 5.15 (s, 2H).</div></div><div id="sec5_1_12_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-(1-((3-Bromophenoxy)methyl)-1<i>H</i>-1,2,3-triazol-4-yl)propanoic Acid (<b>10</b>)</h4><div class="NLM_p last">Following general procedure A, <b>10</b> was obtained as white solid, yield 75%. <sup>1</sup>H NMR (300 MHz, DMSO) δ 8.10 (s, 1H), 7.40 (s, 1H), 7.34–7.20 (m, 2H), 7.12 (d, <i>J</i> = 7.1 Hz, 1H), 6.36 (s, 2H), 2.86 (t, <i>J</i> = 7.4 Hz, 2H), 2.59 (t, <i>J</i> = 7.3 Hz, 2H).</div></div><div id="sec5_1_12_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-Bromo-3-(prop-2-ynyloxy)benzene (<b>11</b>)</h4><div class="NLM_p last">3-Bromophenol (613 μL, 5.8 mmol) was dissolved in 10 mL of acetone, and K<sub>2</sub>CO<sub>3</sub> (1.6 g, 11.6 mmol) was added. The reaction mixture was stirred at 60 °C for 1.5 h. After cooling to room temperature, the resulting mixture was diluted with Et<sub>2</sub>O. The mixture was washed with diluted NaOH (aq) and brine respectively, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 78%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.22–7.10 (m, 3H), 6.92 (d, <i>J</i> = 7.5 Hz, 1H), 4.68 (d, <i>J</i> = 2.2 Hz, 2H), 2.55 (t, <i>J</i> = 2.1 Hz, 1H).</div></div><div id="sec5_1_12_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Methyl 3-(4-((3-Bromophenoxy)methyl)-1<i>H</i>-1,2,3-triazol-1-yl)propanoate (<b>12</b>)</h4><div class="NLM_p last">Following general procedure A, <b>12</b> was obtained as white solid, yield 84%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.71 (s, 1H), 7.19–7.06 (m, 3H), 6.92 (d, <i>J</i> = 7.8 Hz, 1H), 5.17 (s, 2H), 4.66 (t, <i>J</i> = 6.3 Hz, 2H), 3.70 (s, 3H), 2.99 (t, <i>J</i> = 6.3 Hz, 2H).</div></div><div id="sec5_1_12_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (2′,6′-Dimethyl-biphenyl-3-yl)methanol (<b>13</b>)</h4><div class="NLM_p last">Following general procedure B, <b>13</b> was obtained as colorless oil, yield 76%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.48–7.30 (m, 2H), 7.21–7.04 (m, 5H), 4.74 (s, 2H), 2.03 (s, 6H).</div></div><div id="sec5_1_12_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3′-(Bromomethyl)-2,6-dimethylbiphenyl (<b>14</b>)</h4><div class="NLM_p last">Compound <b>13</b> (70 mg, 0.33 mmol) was dissolved in 2 mL of DCM and cooled in an ice bath. PBr<sub>3</sub> (31 μL, 0.33 mmol) was added to the solution, then the reaction mixture was warmed to room temperature. After the starting material was completely consumed, the reaction was quenched by ice–water and extracted with DCM. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure to afford the crude <b>14</b> which could be used for next step without further purification.</div></div><div id="sec5_1_12_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Methyl 3-(4-Ethoxy-1<i>H</i>-1,2,3-triazol-1-yl)propanoate (<b>15</b>)</h4><div class="NLM_p last">Following general procedure A, <b>15</b> was obtained as light-yellow oil, yield 28%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.05 (s, 1H), 4.54 (t, <i>J</i> = 6.5 Hz, 2H), 4.25 (q, <i>J</i> = 7.0 Hz, 2H), 3.69 (s, 3H), 2.93 (t, <i>J</i> = 6.5 Hz, 2H), 1.38 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec5_1_12_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Methyl 3-(4-Hydroxy-1<i>H</i>-1,2,3-triazol-1-yl)propanoate (<b>16</b>)</h4><div class="NLM_p last">Compound <b>15</b> (56 mg, 0.28 mmol) was dissolved in 3 mL of DCM and cooled in an ice bath. BBr<sub>3</sub> (4 M in DCM, 0.7 mL, 2.8 mmol) was added dropwise, then the reaction mixture was warmed to room temperature. After the starting material was completely consumed, the reaction was quenched by ice–water. Usual workup and purification by silica gel column chromatography afforded the product as light-yellow oil, yield 94%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.05 (s, 1H), 5.56 (s, 1H), 4.54 (t, <i>J</i> = 6.5 Hz, 2H), 3.71 (s, 3H), 2.94 (t, <i>J</i> = 6.5 Hz, 2H).</div></div><div id="sec5_1_12_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-(3-Bromobenzyloxy)thiophene (<b>17d</b>)</h4><div class="NLM_p last">Following general procedure D, <b>17d</b> was obtained as colorless oil, yield 61%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.53 (s, 1H), 7.46–7.38 (m, 1H), 7.33–7.26 (m, 1H), 7.21 (dd, <i>J</i> = 8.1, 7.4 Hz, 1H), 6.66 (dd, <i>J</i> = 5.8, 3.7 Hz, 1H), 6.56–6.50 (m, 1H), 6.22 (dt, <i>J</i> = 3.7, 1.9 Hz, 1H), 4.99 (s, 2H).</div></div><div id="sec5_1_12_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-(3-Bromobenzyloxy)thiophene (<b>17f</b>)</h4><div class="NLM_p last">Following general procedure D, <b>17f</b> was obtained as colorless oil, yield 61%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.58 (s, 1H), 7.45 (d, <i>J</i> = 7.9 Hz, 1H), 7.33 (d, <i>J</i> = 7.7 Hz, 1H), 7.24 (s, 1H), 7.22–7.15 (m, 1H), 6.80 (dd, <i>J</i> = 5.3, 1.5 Hz, 1H), 6.29 (dd, <i>J</i> = 3.0, 1.5 Hz, 1H), 4.97 (s, 2H).</div></div><div id="sec5_1_12_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-(4-Bromobenzyloxy)thiophene (<b>17i</b>)</h4><div class="NLM_p last">Following general procedure D, the (4-bromophenyl)methanol was dissolved in small amount of toluene. <b>17i</b> was obtained as colorless solid, yield 65%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.50 (d, <i>J</i> = 8.2 Hz, 2H), 7.28 (d, <i>J</i> = 8.2 Hz, 2H), 6.74–6.64 (m, 1H), 6.62–6.52 (m, 1H), 6.28–6.20 (m, 1H), 5.01 (s, 2H).</div></div><div id="sec5_1_12_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophene (<b>18d</b>)</h4><div class="NLM_p last">Following general procedure B, <b>18d</b> was obtained as colorless oil, yield 84%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.49–7.35 (m, 2H), 7.19–7.09 (m, 5H), 6.69 (dd, <i>J</i> = 5.8, 3.8 Hz, 1H), 6.55 (dd, <i>J</i> = 5.8, 1.4 Hz, 1H), 6.26 (dd, <i>J</i> = 3.7, 1.4 Hz, 1H), 5.11 (s, 2H), 2.01 (s, 6H).</div></div><div id="sec5_1_12_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophene (<b>18f</b>)</h4><div class="NLM_p last">Following general procedure B, <b>18f</b> was obtained as colorless oil, yield 85%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.50–7.37 (m, 2H), 7.24–7.07 (m, 6H), 6.82 (ddd, <i>J</i> = 5.2, 1.5, 0.5 Hz, 1H), 6.32 (dd, <i>J</i> = 3.0, 1.5 Hz, 1H), 5.08 (s, 2H), 2.03 (s, 6H).</div></div><div id="sec5_1_12_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-((2′,6′-Dimethylbiphenyl-4-yl)methoxy)thiophene (<b>18i</b>)</h4><div class="NLM_p last">Following general procedure B, <b>18i</b> was obtained as colorless solid, yield 63%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.49 (d, <i>J</i> = 7.8 Hz, 2H), 7.22–7.08 (m, 5H), 6.75 (dd, <i>J</i> = 5.4, 3.8 Hz, 1H), 6.59 (d, <i>J</i> = 5.5 Hz, 1H), 6.33 (d, <i>J</i> = 3.7 Hz, 1H), 5.13 (s, 2H), 2.04 (s, 6H).</div></div><div id="sec5_1_12_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophene-2-carbaldehyde (<b>19d</b>)</h4><div class="NLM_p last">Following general procedure E, <b>19d</b> was obtained as white solid, yield 86%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.65 (s, 1H), 7.52–7.35 (m, 3H), 7.20–7.09 (m, 5H), 6.40 (d, <i>J</i> = 4.3 Hz, 1H), 5.21 (s, 2H), 2.00 (s, 6H).</div></div><div id="sec5_1_12_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophene-2-carbaldehyde (<b>19f</b>)</h4><div class="NLM_p last">Following general procedure E, <b>19f</b> was obtained as white solid, yield 23%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.82 (s, 1H), 7.50–7.35 (m, 3H), 7.22–7.07 (m, 5H), 6.80 (s, 1H), 5.12 (s, 2H), 2.01 (s, 6H).</div></div><div id="sec5_1_12_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 5-((2′,6′-Dimethylbiphenyl-4-yl)methoxy)thiophene-2-carbaldehyde (<b>19i</b>)</h4><div class="NLM_p last">Following general procedure E, <b>19i</b> was obtained as white solid, yield 84%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.69 (s, 1H), 7.54 (d, <i>J</i> = 4.2 Hz, 1H), 7.49 (d, <i>J</i> = 7.8 Hz, 2H), 7.24–7.07 (m, 5H), 6.46 (d, <i>J</i> = 4.3 Hz, 1H), 5.23 (s, 2H), 2.03 (s, 6H).</div></div><div id="sec5_1_12_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>E</i>)-Methyl 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)acrylate (<b>20d</b>)</h4><div class="NLM_p last">Following general procedure F, <b>20d</b> was obtained as white solid, yield 82%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.63 (d, <i>J</i> = 15.6 Hz, 1H), 7.46 (t, <i>J</i> = 7.7 Hz, 1H), 7.39 (d, <i>J</i> = 7.6 Hz, 1H), 7.22–7.07 (m, 5H), 6.92 (d, <i>J</i> = 3.8 Hz, 1H), 6.22 (d, <i>J</i> = 4.1 Hz, 1H), 5.93 (d, <i>J</i> = 15.6 Hz, 1H), 5.16 (s, 2H), 3.76 (s, 3H), 2.01 (s, 6H).</div></div><div id="sec5_1_12_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>E</i>)-Methyl 3-(4-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)acrylate (<b>20f</b>)</h4><div class="NLM_p last">Following general procedure F, <b>20f</b> was obtained as white solid, yield 90%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.65 (d, <i>J</i> = 15.7 Hz, 1H), 7.46 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.7 Hz, 1H), 7.19–7.09 (m, 5H), 6.97 (d, <i>J</i> = 1.6 Hz, 1H), 6.38 (d, <i>J</i> = 1.5 Hz, 1H), 6.21 (d, <i>J</i> = 15.7 Hz, 1H), 5.07 (s, 2H), 3.79 (s, 3H), 2.01 (s, 6H).</div></div><div id="sec5_1_12_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (<i>E</i>)-Methyl 3-(5-((2′,6′-Dimethylbiphenyl-4-yl)methoxy)thiophen-2-yl)acrylate (<b>20i</b>)</h4><div class="NLM_p last">Following general procedure F, <b>20i</b> was obtained as white solid, yield 91%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.66 (dd, <i>J</i> = 15.5, 0.5 Hz, 1H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 7.22–7.14 (m, 3H), 7.11 (d, <i>J</i> = 7.5 Hz, 2H), 6.96 (d, <i>J</i> = 4.0 Hz, 1H), 6.27 (d, <i>J</i> = 4.0 Hz, 1H), 5.96 (d, <i>J</i> = 15.5 Hz, 1H), 5.17 (s, 2H), 3.77 (s, 3H), 2.03 (s, 6H).</div></div><div id="sec5_1_12_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Methyl 3-(5-Formylthiophen-2-yl)propanoate (<b>21e</b>)</h4><div class="NLM_p last">To the solution of methyl 3-(thiophen-2-yl)propanoate (1.08 g, 7.14 mmol) in 30 mL of DMF in an ice bath was added POCl<sub>3</sub> (1.16 mL, 12.7 mmol) dropwise. After warming to room temperature, the reaction mixture was stirred at 100 °C for 4 h. The mixture was cooled to room temperature and quenched by ice–water. The resulting mixture was extracted with ethyl acetate and washed with aqueous NaHCO<sub>3</sub> and brine. Usual workup and purification by silica gel column chromatography afforded the product as colorless solid, yield 43%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.80 (s, 1H), 7.59 (d, <i>J</i> = 3.7 Hz, 1H), 6.94 (d, <i>J</i> = 3.6 Hz, 1H), 3.68 (s, 3H), 3.20 (t, <i>J</i> = 7.4 Hz, 2H), 2.71 (t, <i>J</i> = 7.4 Hz, 2H).</div></div><div id="sec5_1_12_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Methyl 3-(5-(Hydroxymethyl)thiophen-2-yl)propanoate (<b>22e</b>)</h4><div class="NLM_p last">To the solution of methyl 3-(5-formylthiophen-2-yl) propanoate (542 mg, 2.74 mmol) in 6 mL of toluene/MeOH = 1:1 in an ice bath was added NaBH<sub>4</sub> (125 mg, 3.28 mmol) in small portions. The reaction mixture was stirred in an ice bath for additional 1 h, and aqueous NH<sub>4</sub>Cl was added. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 72%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.83 (d, <i>J</i> = 3.4 Hz, 1H), 6.70 (d, <i>J</i> = 3.4 Hz, 1H), 4.77 (d, <i>J</i> = 5.7 Hz, 2H), 3.71 (s, 3H), 3.15 (t, <i>J</i> = 7.6 Hz, 2H), 2.70 (t, <i>J</i> = 7.6 Hz, 2H), 1.80 (t, <i>J</i> = 6.0 Hz, 1H).</div></div><div id="sec5_1_12_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Methyl 3-(5-((2′,6′-Dimethylbiphenyl-3-yloxy)methyl)thiophen-2-yl)propanoate (<b>23e</b>)</h4><div class="NLM_p last">To the solution of <b>22e</b> (100 mg, 0.5 mmol) in 5 mL of DCM in an ice bath was added SOCl<sub>2</sub> (363 μL, 5 mmol). After warming to room temperature, the reaction mixture was stirred at 50 °C overnight. The mixture was concentrated under reduced pressure. The residue was dissolved in 5 mL of acetone, and NaI (75 mg, 0.5 mmol), 2′,6′-dimethylbiphenyl-3-ol (119 mg, 0.6 mmol), and K<sub>2</sub>CO<sub>3</sub> (138 mg, 1 mmol) were added. The reaction mixture was stirred at 60 °C for 8 h. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield over two steps 63%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.33 (t, <i>J</i> = 8.0 Hz, 1H), 7.17–7.06 (m, 3H), 6.93 (ddd, <i>J</i> = 8.3, 2.6, 1.0 Hz, 1H), 6.89 (d, <i>J</i> = 3.4 Hz, 1H), 6.78–6.72 (m, 2H), 6.69 (d, <i>J</i> = 3.4 Hz, 1H), 5.12 (s, 2H), 3.68 (s, 3H), 3.12 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H), 2.02 (s, 6H).</div></div><div id="sec5_1_12_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 5-(3-Bromobenzyloxy)thiophene-2-carbaldehyde (<b>24</b>)</h4><div class="NLM_p last">Following general procedure E, LDA (2 M in THF/heptane/ethylbenzene) was used instead of <sup><i>n</i></sup>BuLi. Compound <b>24</b> was obtained as dark-yellow solid, yield 48%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.68 (s, 1H), 7.59 (s, 1H), 7.55–7.48 (m, 2H), 7.35 (d, <i>J</i> = 7.5 Hz, 1H), 7.31–7.26 (m, 1H), 6.41 (d, <i>J</i> = 4.2 Hz, 1H), 5.14 (s, 2H).</div></div><div id="sec5_1_12_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (<i>E</i>)-Methyl 3-(5-(3-Bromobenzyloxy)thiophen-2-yl)acrylate (<b>25</b>)</h4><div class="NLM_p last">Following general procedure F, ethyl (triphenylphosphoranylidene)acetate was used as Wittig reagent. Compound <b>25</b> was obtained as white solid, yield 82%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.62 (d, <i>J</i> = 15.5 Hz, 1H), 7.57 (s, 1H), 7.50 (d, <i>J</i> = 7.4 Hz, 1H), 7.34 (d, <i>J</i> = 7.2 Hz, 1H), 7.27 (t, <i>J</i> = 7.7 Hz, 1H), 6.92 (d, <i>J</i> = 4.0 Hz, 1H), 6.21 (d, <i>J</i> = 3.9 Hz, 1H), 5.95 (d, <i>J</i> = 15.4 Hz, 1H), 5.08 (s, 2H), 4.22 (q, <i>J</i> = 6.9 Hz, 2H), 1.31 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_1_12_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Methyl 3-(5-(3-Bromobenzyloxy)thiophen-2-yl)propanoate (<b>26</b>)</h4><div class="NLM_p last">Following general procedure G, <b>26</b> was obtained as colorless oil, yield 73%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.56 (s, 1H), 7.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.36–7.21 (m, 2H), 6.40 (d, <i>J</i> = 3.6 Hz, 1H), 6.05 (d, <i>J</i> = 3.6 Hz, 1H), 4.99 (s, 2H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 2.99 (t, <i>J</i> = 7.6 Hz, 2H), 2.61 (t, <i>J</i> = 7.5 Hz, 2H), 1.25 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec5_1_12_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Thieno[3,2-<i>b</i>]thiophene-2-carbaldehyde (<b>27</b>)</h4><div class="NLM_p last">To the solution of thieno[3,2-<i>b</i>]thiophene (1 g, 7.14 mmol) in 25 mL of DCE in an ice bath were added DMF (550 μL, 7.14 mmol) and POCl<sub>3</sub> (2 mL, 21.4 mmol) dropwise. After warming to room temperature, the reaction mixture was stirred at 90 °C for 48 h. The mixture was cooled to room temperature and quenched by ice–water. Usual workup and purification by silica gel column chromatography afforded the product as white solid, yield 59%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.96 (s, 1H), 7.94 (s, 1H), 7.69 (d, <i>J</i> = 5.3 Hz, 1H), 7.32 (d, <i>J</i> = 5.3 Hz, 1H).</div></div><div id="sec5_1_12_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (<i>E</i>)-Methyl 3-(Thieno[3,2-<i>b</i>]thiophen-2-yl)acrylate (<b>28</b>)</h4><div class="NLM_p last">Following general procedure F at room temperature, THF/H<sub>2</sub>O = 2:1 was used as solvent. Compound <b>28</b> was obtained as white solid, yield 72%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.81 (d, <i>J</i> = 15.6 Hz, 1H), 7.46 (d, <i>J</i> = 5.3 Hz, 1H), 7.39 (s, 1H), 7.21 (d, <i>J</i> = 5.3 Hz, 1H), 6.22 (d, <i>J</i> = 15.6 Hz, 1H), 3.79 (s, 3H).</div></div><div id="sec5_1_12_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Thieno[3,2-<i>b</i>]thiophene-2-carboxylic Acid (<b>29</b>)</h4><div class="NLM_p last">To the solution of <b>27</b> (168 mg, 5 mmol) in 50 mL of <sup><i>t</i></sup>BuOH was added 2-methyl-2-butene (2 M in THF, 10 mL) and cooled in an ice bath. The solution of NaClO<sub>2</sub> (80%, 619 mg, 5.5 mmol) and NaH<sub>2</sub>PO<sub>4</sub>·2H<sub>2</sub>O (5.65 g) in 5 mL of H<sub>2</sub>O was added dropwise, and the reaction mixture was stirred at room temperature overnight. The resulting mixture was acidified with diluted HCl (aq) and extracted with ethyl acetate for three times. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was crystallized from DCM/PE to afford the product as pale-yellow solid, yield 77%. <sup>1</sup>H NMR (300 MHz, DMSO) δ 13.27–12.68 (m, 1H), 8.12 (s, 1H), 7.94 (d, <i>J</i> = 5.3 Hz, 1H), 7.52 (d, <i>J</i> = 5.3 Hz, 1H).</div></div><div id="sec5_1_12_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Methyl 3-(Thieno[3,2-<i>b</i>]thiophen-2-yl)propanoate (<b>30g</b>)</h4><div class="NLM_p last">Following general procedure G, <b>30g</b> was obtained as white solid, yield 83%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.28 (d, <i>J</i> = 5.2 Hz, 1H), 7.16 (d, <i>J</i> = 5.2 Hz, 1H), 6.99 (s, 1H), 3.69 (s, 3H), 3.21 (t, <i>J</i> = 7.5 Hz, 2H), 2.72 (t, <i>J</i> = 7.5 Hz, 2H).</div></div><div id="sec5_1_12_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Methyl Thieno[3,2-<i>b</i>]thiophene-2-carboxylate (<b>30h</b>)</h4><div class="NLM_p last">Following general procedure L, <b>30h</b> was obtained as light-yellow solid, yield 80%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.98 (s, 1H), 7.58 (d, <i>J</i> = 5.3 Hz, 1H), 7.27 (d, <i>J</i> = 5.3 Hz, 1H), 3.91 (s, 3H).</div></div><div id="sec5_1_12_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Methyl 3-(5-Iodothieno[3,2-<i>b</i>]thiophen-2-yl)propanoate (<b>31g</b>)</h4><div class="NLM_p last">Following general procedure H, <b>31g</b> was obtained as light-yellow solid, yield 49%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.31 (s, 1H), 6.92 (s, 1H), 3.68 (s, 3H), 3.18 (t, <i>J</i> = 7.4 Hz, 2H), 2.70 (t, <i>J</i> = 7.4 Hz, 2H).</div></div><div id="sec5_1_12_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Methyl 5-Iodothieno[3,2-<i>b</i>]thiophene-2-carboxylate (<b>31h</b>)</h4><div class="NLM_p last">Following general procedure H, <b>31h</b> was obtained as light-yellow solid, yield 71%. <sup>1</sup>H NMR (300 MHz, DMSO) δ 8.13 (s, 1H), 7.82 (s, 1H), 3.86 (s, 3H).</div></div><div id="sec5_1_12_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 5-((5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (<b>32</b>)</h4><div class="NLM_p last">Following general procedure I, <b>32</b> was obtained as yellow solid, yield 72%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.46 (s, 1H), 7.68 (d, <i>J</i> = 4.4 Hz, 1H), 7.49 (t, <i>J</i> = 7.5 Hz, 1H), 7.41 (d, <i>J</i> = 7.3 Hz, 1H), 7.24–7.07 (m, 5H), 6.57 (d, <i>J</i> = 4.5 Hz, 1H), 5.35 (s, 2H), 2.01 (s, 6H), 1.75 (s, 6H).</div></div><div id="sec5_1_12_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Ethyl 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-hydroxypropanoate (<b>34</b>)</h4><div class="NLM_p last">The solution of <b>19d</b> (595 mg, 1.85 mmol) in 20 mL of anhydrous THF was cooled in an ice bath, and freshly prepared (2-ethoxy-2-oxoethyl)zinc(II) bromide (about 0.5 M in THF, 11 mL, 5.5 mmol) was added dropwise by syringe. The reaction mixture was warmed to room temperature and stirred for 3 h. Then the mixture was cooled in an ice bath again and quenched by aqueous NH<sub>4</sub>Cl. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 52%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.45 (t, <i>J</i> = 7.1 Hz, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.20–7.07 (m, 5H), 6.58 (d, <i>J</i> = 3.9 Hz, 1H), 6.10 (d, <i>J</i> = 3.9 Hz, 1H), 5.23–5.13 (m, 1H), 5.09 (s, 2H), 4.19 (q, <i>J</i> = 7.1 Hz, 2H), 3.24 (d, <i>J</i> = 4.1 Hz, 1H), 2.81 (d, <i>J</i> = 3.6 Hz, 1H), 2.79 (d, <i>J</i> = 0.7 Hz, 1H), 2.01 (s, 6H), 1.27 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_1_12_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> (<i>R</i>)-Ethyl 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-hydroxypropanoate ((<i>R</i>)-<b>34</b>)</h4><div class="NLM_p last">Compound <b>38</b> (127 mg, 0.31 mmol) was protected by N<sub>2</sub>, and Et<sub>3</sub>N (216 μL, 1.6 mmol) was added. The mixture was stirred at 38 °C until the substrate was dissolved completely. RuCl[(<i>R</i>,<i>R</i>)-Tsdpen](mesitylene) (5 mg, 0.0078 mmol) in HCO<sub>2</sub>H (53 μL, 1.4 mmol) was added, and the reaction mixture was stirred at 38 °C for an additional 4.5 h. The mixture was diluted with diluted ethyl acetate. The resulting mixture was washed with brine, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to afford the product as colorless oil, yield 90%, 98% ee [HPLC condition: CHIRALPAK AD-H 4.6 mm × 250 mm column by isocratic elution: 0.1% TFA in hexane/0.1% TFA in EtOH = 95/5 (v/v) at a flow rate of 1.0 mL/min, with UV detection at 254 nm]. Retention time: minor product (<i>S</i>) 18.6 min, major product (<i>R</i>)-<b>34</b> (<i>R</i>) 20.7 min. [α]<sub>D</sub> + 5.3° (<i>c</i> 1.195, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec5_1_12_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> (<i>E</i>)-2-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)-5-(2-nitrovinyl)thiophene (<b>35</b>)</h4><div class="NLM_p last">To the solution of 5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophene-2-carbaldehyde (322 mg, 1 mmol) in 2 mL of THF was added 2 mL of MeNO<sub>2</sub> and NH<sub>4</sub>OAc (85 mg, 1.1 mmol) and stirred at 70 °C for 24 h. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product as yellow oil, yield 44%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.01 (d, <i>J</i> = 12.7 Hz, 1H), 7.50–7.42 (m, 1H), 7.38 (d, <i>J</i> = 7.2 Hz, 1H), 7.22–7.12 (m, 4H), 7.10 (d, <i>J</i> = 7.9 Hz, 2H), 6.35–6.28 (m, 1H), 5.20 (s, 2H), 2.00 (s, 6H).</div></div><div id="sec5_1_12_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> (<i>S</i>)-4-Benzyl-3-((<i>R</i>)-3-(5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-4-nitrobutanoyl)oxazolidin-2-one (<b>36</b>)</h4><div class="NLM_p last">The solution of (<i>S</i>)-3-acetyl-4-benzyloxazolidin-2-one (96 mg, 0.44 mmol) in 2.5 mL of anhydrous DCM was cooled at −78 °C, and TiCl<sub>4</sub> (1 M in DCM, 0.46 mL, 0.46 mmol) was added dropwise. Then DIEA (87 μL, 0.53 mmol) was added, and the mixture was stirred at −78 °C for additional 45 min. The solution of <b>35</b> (160 mg, 0.44 mmol) in 0.5 mL of anhydrous DCM was added. TiCl<sub>4</sub> (1 M in DCM, 0.46 mL, 0.46 mmol) was then added dropwise to the reaction. The mixture was stirred at −78 °C for another 2.5 h before it was slowly warmed to −10 °C and quenched by aqueous NH<sub>4</sub>Cl. The resulting mixture was extracted with ethyl acetate and washed with brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the drying agent, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to afford the product as yellow oil, yield 40%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.44 (t, <i>J</i> = 7.2 Hz, 1H), 7.39–7.27 (m, 4H), 7.22–7.06 (m, 7H), 6.57 (d, <i>J</i> = 3.9 Hz, 1H), 6.08 (d, <i>J</i> = 3.9 Hz, 1H), 5.07 (s, 2H), 4.77–4.55 (m, 3H), 4.31–4.14 (m, 3H), 3.48 (dd, <i>J</i> = 17.7, 7.5 Hz, 1H), 3.38–3.21 (m, 2H), 2.75 (dd, <i>J</i> = 13.3, 9.7 Hz, 1H), 2.01 (s, 6H).</div></div><div id="sec5_1_12_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophene-2-carboxylic Acid (<b>37</b>)</h4><div class="NLM_p last">2-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophene (237 mg, 0.81 mmol) was protected by N<sub>2</sub> and 8 mL of anhydrous THF was added by syringe. The solution was cooled to −78 °C and <sup><i>n</i></sup>BuLi (2.5 M in hexanes, 0.35 mL, 0.88 mmol) was added dropwise. After stirring at −78 °C for 2 h, the N<sub>2</sub> balloon was replaced with CO<sub>2</sub> balloon and the reaction mixture was stirred at −78 °C overnight. The reaction was quenched by aqueous NH<sub>4</sub>Cl and warmed to room temperature. The resulting mixture was acidified by diluted HCl (aq) and extracted with ethyl acetate three times. Usual workup and purification by silica gel column chromatography afforded the product as white solid, yield 84%. <sup>1</sup>H NMR (400 MHz, DMSO) δ 7.50 (t, <i>J</i> = 7.5 Hz, 1H), 7.48–7.43 (m, 2H), 7.22 (s, 1H), 7.19–7.09 (m, 4H), 6.49 (d, <i>J</i> = 4.2 Hz, 1H), 5.28 (s, 2H), 1.94 (s, 6H).</div></div><div id="sec5_1_12_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Ethyl 3-(5-((2′,6′-Dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)-3-oxopropanoate (<b>38</b>)</h4><div class="NLM_p last">Carbonyldiimidazole (43 mg, 0.24 mmol) was added to a solution of 5-((2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophene-2-carboxylic acid (82 mg, 0.24 mmol) in 0.5 mL of THF and stirred at room temperature for 12 h. A mixture of potassium ethyl malonate (82 mg, 0.48 mmol), MgCl<sub>2</sub> (58 mg, 0.62 mmol), and Et<sub>3</sub>N (101 μL, 0.73 mmol) in 1 mL of CH<sub>3</sub>CN was stirred for 4 h. Then to the suspension in an ice bath was added the solution of the active ester dropwise. The mixture was stirred for additional 12 h at room temperature and then quenched by diluted HCl (aq) at 0 °C. T Usual workup and purification by silica gel column chromatography afforded the product as brown oil, yield 52%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.51–7.43 (m, 2H), 7.39 (d, <i>J</i> = 7.5 Hz, 1H), 7.22–7.08 (m, 5H), 6.33 (d, <i>J</i> = 4.3 Hz, 1H), 5.20 (s, 2H), 4.20 (q, <i>J</i> = 7.1 Hz, 2H), 3.81 (s, 2H), 2.01 (s, 6H), 1.26 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_1_12_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 3-((Thiophen-2-yloxy)methyl)phenylboronic Acid (<b>39</b>)</h4><div class="NLM_p last">To the solution of 2-(3-bromobenzyloxy)thiophene (3 g, 11 mmol) in 50 mL of anhydrous THF under N<sub>2</sub> at −78 °C was added <sup><i>n</i></sup>BuLi (2.5 M in hexanes, 5 mL, 12 mmol) dropwise. After stirring at −78 °C for 2 h, B(O<sup><i>i</i></sup>Pr)<sub>3</sub> (3.9 mL, 16.7 mmol) in 10 mL of anhydrous THF was added dropwise and the resulting mixture was stirred at −78 °C overnight. The reaction was quenched by diluted HCl (aq) and warmed to room temperature. Usual workup and purification by silica gel column chromatography afforded the product as white solid, yield 54%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.22 (d, <i>J</i> = 8.7 Hz, 2H), 7.68 (d, <i>J</i> = 7.8 Hz, 1H), 7.54 (t, <i>J</i> = 7.4 Hz, 1H), 6.72 (dd, <i>J</i> = 5.8, 3.8 Hz, 1H), 6.57 (dd, <i>J</i> = 5.8, 1.4 Hz, 1H), 6.32 (dd, <i>J</i> = 3.7, 1.4 Hz, 1H), 5.19 (s, 2H).</div></div><div id="sec5_1_12_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> <i>tert</i>-Butyl (2,6-Dimethyl-3′-((thiophen-2-yloxy)methyl)biphenyl-4-yloxy)dimethylsilane (<b>40</b>)</h4><div class="NLM_p last">Following general procedure B, 2,6-dimethyl-3′-((thiophen-2-yloxy)methyl)biphenyl-4-ol was obtained as colorless oil, yield 68%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46–7.35 (m, 2H), 7.17 (s, 1H), 7.11 (d, <i>J</i> = 7.1 Hz, 1H), 6.70 (dd, <i>J</i> = 5.8, 3.7 Hz, 1H), 6.62–6.52 (m, 3H), 6.27 (dd, <i>J</i> = 3.8, 1.5 Hz, 1H), 5.11 (s, 2H), 4.68 (s, 1H), 1.97 (s, 6H). To the solution of 2,6-dimethyl-3′-((thiophen-2-yloxy)methyl)biphenyl-4-ol (1.03 g, 3.3 mmol) in 30 mL of DCM was added TBSCl (552 mg, 3.7 mmol) and Et<sub>3</sub>N (691 μL, 5 mmol), and the mixture was stirred at room temperature overnight. TBSCl (498 mg, 3.3 mmol) and Et<sub>3</sub>N (555 μL, 4 mmol) were added, and the reaction was quenched by aqueous NH<sub>4</sub>Cl after the starting material was consumed completely. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 89%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.47–7.33 (m, 2H), 7.19 (s, 1H), 7.12 (d, <i>J</i> = 7.2 Hz, 1H), 6.70 (dd, <i>J</i> = 5.7, 3.8 Hz, 1H), 6.61–6.52 (m, 3H), 6.27 (dd, <i>J</i> = 3.7, 1.4 Hz, 1H), 5.11 (s, 2H), 1.96 (s, 6H), 1.01 (s, 9H), 0.23 (s, 6H).</div></div><div id="sec5_1_12_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 5-((4′-(<i>tert</i>-Butyldimethylsilyloxy)-2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophene-2-carbaldehyde (<b>41</b>)</h4><div class="NLM_p last">Following general procedure E, <b>41</b> was obtained as white solid, yield 77%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.65 (s, 1H), 7.52–7.32 (m, 3H), 7.18 (s, 1H), 7.14 (d, <i>J</i> = 7.2 Hz, 1H), 6.57 (s, 2H), 6.39 (d, <i>J</i> = 4.3 Hz, 1H), 5.20 (s, 2H), 1.93 (s, 6H), 0.99 (s, 9H), 0.22 (s, 6H).</div></div><div id="sec5_1_12_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 5-((5-((4′-(<i>tert</i>-Butyldimethylsilyloxy)-2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (<b>42</b>)</h4><div class="NLM_p last">Following general procedure I, <b>42</b> was obtained as yellow solid, yield 86%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.46 (s, 1H), 7.68 (d, <i>J</i> = 4.5 Hz, 1H), 7.46 (t, <i>J</i> = 7.5 Hz, 1H), 7.39 (d, <i>J</i> = 7.4 Hz, 1H), 7.21 (s, 1H), 7.17 (d, <i>J</i> = 7.0 Hz, 1H), 6.59 (s, 2H), 6.57 (d, <i>J</i> = 4.5 Hz, 1H), 5.34 (s, 2H), 1.95 (s, 6H), 1.75 (s, 6H), 1.00 (s, 9H), 0.23 (s, 6H).</div></div><div id="sec5_1_12_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Methyl 3-(5-((4′-(<i>tert</i>-Butyldimethylsilyloxy)-2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoate (<b>43</b>)</h4><div class="NLM_p last">Following general procedure J and L in sequence, <b>43</b> was obtained as colorless oil, yield over three steps 64%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.45–7.31 (m, 2H), 7.16 (s, 1H), 7.13–7.07 (m, 1H), 6.57 (d, <i>J</i> = 5.8 Hz, 2H), 6.55 (dd, <i>J</i> = 3.8, 0.9 Hz, 1H), 6.05 (d, <i>J</i> = 3.9 Hz, 1H), 5.06 (s, 2H), 4.25–4.16 (m, 1H), 3.69 (s, 3H), 2.83–2.63 (m, 2H), 1.95 (s, 6H), 1.82 (d, <i>J</i> = 2.4 Hz, 3H), 1.00 (s, 9H), 0.23 (s, 6H).</div></div><div id="sec5_1_12_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Methyl 3-(5-((4′-Hydroxy-2′,6′-dimethylbiphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoate (<b>44</b>)</h4><div class="NLM_p last">To the solution of <b>43</b> (703 mg, 1.28 mmol) in 10 mL of THF was added TBAF (1 M in THF, 1.4 mL, 1.4 mmol), and the reaction mixture was stirred at room temperature for 2 h. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 98%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46–7.32 (m, 2H), 7.15 (s, 1H), 7.14–7.06 (m, 1H), 6.59 (s, 2H), 6.55 (d, <i>J</i> = 3.8 Hz, 1H), 6.05 (d, <i>J</i> = 3.8 Hz, 1H), 5.06 (s, 2H), 4.64 (s, 1H), 4.27–4.17 (m, 1H), 3.69 (s, 3H), 2.86–2.63 (m, 2H), 1.97 (s, 6H), 1.82 (d, <i>J</i> = 2.4 Hz, 3H).</div></div><div id="sec5_1_12_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Methyl 3-(5-((2′,6′-Dimethyl-4′-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoate (<b>45k</b>)</h4><div class="NLM_p last">To the solution of <b>44</b> (81 mg, 0.19 mmol) in 2 mL of DMF was added 3-(methylsulfonyl)propyl 4-methylbenzenesulfonate (73 mg, 0.25 mmol) and K<sub>3</sub>PO<sub>4</sub> (61 mg, 0.29 mmol), and the reaction mixture was stirred at 90 °C for 2.5 h. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 88%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42 (t, <i>J</i> = 7.3 Hz, 1H), 7.36 (d, <i>J</i> = 7.7 Hz, 1H), 7.15 (s, 1H), 7.09 (d, <i>J</i> = 7.3 Hz, 1H), 6.64 (s, 2H), 6.55 (dd, <i>J</i> = 3.8, 0.9 Hz, 1H), 6.05 (d, <i>J</i> = 3.8 Hz, 1H), 5.06 (s, 2H), 4.26–4.08 (m, 3H), 3.69 (s, 3H), 3.31–3.23 (m, 2H), 2.97 (s, 3H), 2.83–2.66 (m, 2H), 2.41–2.30 (m, 2H), 1.99 (s, 6H), 1.82 (d, <i>J</i> = 2.4 Hz, 3H).</div></div><div id="sec5_1_12_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Methyl 3-(5-((2′,6′-Dimethyl-4′-((3-methyloxetan-3-yl)methoxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoate (<b>45l</b>)</h4><div class="NLM_p last">To the solution of <b>44</b> (83 mg, 0.2 mmol) in 2 mL of DMF were added KI (36 mg, 0.22 mmol), K<sub>2</sub>CO<sub>3</sub> (55 mg, 0.4 mmol), and 3-(chloromethyl)-3-methyloxetane (33 μL, 0.3 mmol). The reaction mixture was stirred at 70 °C for 45 h. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 69%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.43 (t, <i>J</i> = 7.4 Hz, 1H), 7.36 (d, <i>J</i> = 7.9 Hz, 1H), 7.16 (s, 1H), 7.11 (d, <i>J</i> = 7.3 Hz, 1H), 6.71 (s, 2H), 6.55 (d, <i>J</i> = 3.8 Hz, 1H), 6.05 (d, <i>J</i> = 3.8 Hz, 1H), 5.07 (s, 2H), 4.65 (d, <i>J</i> = 5.8 Hz, 2H), 4.47 (d, <i>J</i> = 5.9 Hz, 2H), 4.21 (t, <i>J</i> = 8.7 Hz, 1H), 4.05 (s, 2H), 3.69 (s, 3H), 2.84–2.65 (m, 2H), 2.00 (s, 6H), 1.82 (d, <i>J</i> = 2.3 Hz, 3H), 1.45 (s, 3H).</div></div><div id="sec5_1_12_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Methyl 3-(5-((2′,6′-Dimethyl-4′-(1-methylpiperidin-4-yloxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoate (<b>45m</b>)</h4><div class="NLM_p last">The solution of <b>44</b> (90 mg, 0.21 mmol), 1-methylpiperidin-4-ol (38 μL, 0.32 mmol), and PPh<sub>3</sub> (90 mg, 0.34 mmol) in 2 mL of anhydrous THF was cooled in an ice bath, and DEAD (54 μL, 0.34 mmol) was added dropwise. Then the reaction mixture was warmed to room temperature and stirred overnight. 1-Methylpiperidin-4-ol (38 μL, 0.32 mmol), PPh<sub>3</sub> (90 mg, 0.34 mmol), and DEAD (54 μL, 0.34 mmol) were added to the mixture and stirred at room temperature for additional 24 h. The reaction was quenched by aqueous NH<sub>4</sub>Cl at 0 °C and extracted with ethyl acetate. Usual workup and purification by silica gel column chromatography afforded the product as colorless oil, yield 54%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 7.36 (s, 1H), 7.16 (s, 1H), 7.11 (d, <i>J</i> = 7.4 Hz, 1H), 6.66 (s, 2H), 6.55 (d, <i>J</i> = 3.8 Hz, 1H), 6.04 (d, <i>J</i> = 3.8 Hz, 1H), 5.06 (s, 2H), 4.40–4.14 (m, 2H), 3.69 (s, 3H), 2.96–2.63 (m, 4H), 2.39–2.24 (m, 5H), 2.09–1.94 (m, 8H), 1.94–1.72 (m, 5H).</div></div><div id="sec5_1_12_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> (<i>S</i>)-2-Methylbutyl 3-(5-((2′,6′-Dimethyl-4′-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)thiophen-2-yl)hex-4-ynoate (<b>46k</b>)</h4><div class="NLM_p last">Following general procedure L, <b>46k</b> was obtained as colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 7.36 (d, <i>J</i> = 7.1 Hz, 1H), 7.15 (s, 1H), 7.09 (d, <i>J</i> = 6.5 Hz, 1H), 6.64 (s, 2H), 6.55 (d, <i>J</i> = 3.5 Hz, 1H), 6.05 (d, <i>J</i> = 3.6 Hz, 1H), 5.06 (s, 2H), 4.25–4.16 (m, 1H), 4.13 (t, <i>J</i> = 5.5 Hz, 2H), 3.98 (dd, <i>J</i> = 10.6, 6.5 Hz, 1H), 3.90 (dd, <i>J</i> = 11.0, 6.7 Hz, 1H), 3.32–3.21 (m, 2H), 2.97 (s, 3H), 2.83–2.65 (m, 2H), 2.42–2.28 (m, 2H), 1.99 (s, 6H), 1.81 (s, 3H), 1.77–1.61 (m, 1H), 1.49–1.37 (m, 1H), 1.25–1.11 (m, 1H), 0.95 (t, <i>J</i> = 6.9 Hz, 3H), 0.89 (t, <i>J</i> = 7.1 Hz, 3H).</div></div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Calcium Influx Activity Assay</h3><div class="NLM_p last">For CHO cell lines stably expressing hGPR40 or hGPR120, cells were seeded in 96-well cell culture plates (Corning) and incubated overnight in 5% CO<sub>2</sub> at 37 °C. For plasmid titration experiments, HEK293T cells were transiently transfected with hGPR40 expression plasmids using X-tremeGENE HP DNA transfection reagent (Roche), followed by plating in poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated black clear 96-well plates (BD Falcon) and incubating for 24 h. These cells were then incubated in Hank’s Balanced Salt Solution (HBSS) containing 0.1% BSA, calcium sensitive dye Fluo 4-AM (3 μM), and probenecid (2.5 mM) for 90 min. The cells were then washed three times using HBSS and then subjected to equilibration for 10 min in HBSS containing probenecid before conducting the assay. Intracellular Ca<sup>2+</sup> concentrations were measured as the difference between 585/525 ratios before and after addition of the test compounds using a Flexstation 3.0 plate reader (Molecular Devices). EC<sub>50</sub> and <i>E</i><sub>max</sub> values for each curve were calculated by Prism 5.0 software (GraphPad Software).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> PPAR Transactivation Assay</h3><div class="NLM_p last">The activity of PPARγ was tested on HEK293T cells transfected with corresponding plasmids by X-tremeGENE HP DNA transfection reagent. Luciferase assay was conducted as described previously.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> MIN6 Insulin Secretion Assay</h3><div class="NLM_p last">MIN6 cells were preincubated for 2 h at 37 °C with Krebs–Ringer bicarbonate–HEPES buffer (116 mM NaCl, 4.7 mM KCl, 1.17 mM KH<sub>2</sub>PO<sub>4</sub>, 1.17 mM MgSO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 2.52 mM CaCl<sub>2</sub>, and 24 mM HEPES) containing 0.1% BSA. After discarding the preincubation buffer, cells were stimulated with 2 mM glucose and 25 mM glucose alone or in the presence of indicated reagents, and the plates were incubated for 1 h at 37 °C. For insulin content assay, supernatants were collected after incubation and secreted insulin concentrations of each well were measured using ELISA kit (Millipore) according to the manufacturer’s instruction.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Oral Glucose Tolerance Test</h3><div class="NLM_p last">All experimental protocols on animals were approved by the Shanghai Institute of Materia Medica Experimental Animal Care and Use Committee. Six-week-old male ICR mice were purchased from Slac Laboratory Animal (Shanghai, China) and maintained under a 12 h light/dark cycle with a normal chow diet and free access to water. After fasted for 16 h, mice were randomly divided into four groups with 10 mice in each group and were orally administered 0.5% methylcellulose with 20% PEG400 (vehicle), <b>1</b> (10 mg/kg), and (<i>R</i>)-<b>7k</b> (20 or 10 mg/kg). Then 30 min later, all the animals were given an oral glucose load (2.5 g/kg) by gavage. Blood glucose in the tail vein were measured using ACCU-CHEK (Roche) before drug administration (time −30 min), before glucose load (time 0), and time 30, 60, 90, and 120 min after the glucose load.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Pharmacokinetic Study</h3><div class="NLM_p">Male Sprague–Dawley (SD) rats (200 ± 20 g) were obtained from the Shanghai Laboratory Animal Center Co, Ltd. (Shanghai, China). The animals were housed in an air-conditioned room with a 12 h on and 12 h off light cycle, and they received powdered rodent chow and tap water by the bottle ad libitum. The rats were acclimated for 7 days before the experiment was conducted. Experiments were approved by the Institutional Animal Care and Use Committee of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences.</div><div class="NLM_p">Rats were randomly assigned to two groups and fasted overnight with free access to water before dosing. Eight rats were assigned to two groups (<i>n</i> = 4 for each group). Then 10 mg/kg of (<i>R</i>)-<b>7k</b> was administered to the rats in group A by oral gavage. Then 1 mg/kg (<i>R</i>)-<b>7k</b> was administered intravenously (iv) via the tail vein in group B. The two formulation was prepared by dissolving (<i>R</i>)-<b>7k</b> in DMSO, and then the stock solution was diluted into 1 mg/mL by 5% Tween 80 (DMSO final concentration was less than 1%). Approximately 300 μL of blood sample was collected from the orbital vein at 0.25, 0.5, 1, 2, 4, 8, and 24 h under light ether anesthesia. Food was withheld during this process, but water was freely provided. Plasma samples were obtained after centrifugation at 5000 rpm for 15 min and stored at −80 °C until analysis. The compound concentrations were measured using a Shimadzu LCMS-8030 triple quadrupole system (Shimadzu Corp., Japan) equipped with electrospray ionization (ESI).</div><div class="NLM_p last">Pharmacokinetic parameters of (<i>R</i>)-<b>7k</b> were calculated by a noncompartmental analysis (NCA) model using Phoenix WinNonlin (version 6.3; Pharsight, Cary, NC). The oral absolute bioavailability (<i>F</i>) was calculated using <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> below:<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/jm-2016-01357z_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Bile Acid (d8-TCA) Uptake and Biliary Excretion in Sandwich-Cultured Rat Hepatocytes (SCRHs)</h3><div class="NLM_p last">Rat hepatocytes were isolated from male SD rats according to the previously described method.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> A sandwich configuration model was established as previously described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The uptake and biliary excretion of d8-TCA was conducted in SCRHs.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In brief, after incubation with (<i>R</i>)-<b>7k</b>, <b>1</b>, or troglitazone in standard HBSS for 15 min, SCRHs were rinsed two times with warm standard HBSS or Ca<sup>2+</sup>-free HBSS and preincubated with the same buffer at 37 °C for 15 min. After removing the buffer, the hepatocytes were incubated with standard HBSS containing above compounds in the presence of 1 μM d8-TCA for another 15 min, respectively. After incubation, the solution was aspirated from the cells, uptake was terminated by washing three times with ice-cold PBS, and the samples were frozen until analysis. The d8-TCA concentration in hepatocytes was analyzed by liquid chromatography–mass spectrometry tandem mass spectrometry (LC-MS/MS).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Data Analysis</h3><div class="NLM_p">The biliary excretion index (BEI) was calculated as follows: BEI = [<i>A</i><sub>HBSS</sub> – <i>A</i><sub>HBSS</sub>(Ca<sup>2+</sup> free)]/<i>A</i><sub>HBSS</sub> × 100%, which was defined as the proportion of accumulated taurocholate excreted into bile canaliculi,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> where <i>A</i><sub>HBSS</sub> and <i>A</i><sub>HBSS</sub>(Ca<sup>2+</sup>-free) represent the amount of accumulated d8-TCA in the standard buffer treatment wells (hepatocytes + bile) and Ca<sup>2+</sup>-free buffer treatment wells (hepatocytes), respectively.</div><div class="NLM_p last">Data was presented as the mean ± standard deviation (SD) of three independent experiments. Statistical analysis was performed using GraphPad Prism 5.03 software. To test the statistical significance among groups, one-way ANOVA was employed. The difference between two groups was compared using the unpaired Student <i>t</i>-test. Differences were considered significant at <i>P</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01357">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01357" class="ext-link">10.1021/acs.jmedchem.6b01357</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic procedures and characterization data of target compounds <b>5j</b>–<b>l</b> and (<i>S</i>)-<b>7g</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_001.pdf">jm6b01357_si_001.pdf (1.06 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_002.csv">jm6b01357_si_002.csv (2.87 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01357" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">He-Yao Wang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#95ece4f9fafbf2d5e6fcf8f8bbf4f6bbf6fb"><span class="__cf_email__" data-cfemail="e891998487868fa89b818585c6898bc68b86">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ya-Qiu Long</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9209-0503" title="Orcid link">http://orcid.org/0000-0002-9209-0503</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6800111f09060f281b01050546090b460b06"><span class="__cf_email__" data-cfemail="2d45545a4c434a6d5e444040034c4e034e43">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">He Li</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Huang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Chen</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Shanghai University, 99 Shangda Road, Shanghai 200444, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bin Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Shanghai University, 99 Shangda Road, Shanghai 200444, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9251-6930" title="Orcid link">http://orcid.org/0000-0002-9251-6930</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>H.L. and Q.H. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6991-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The work was supported by the National Natural Science Foundation of China (81325020, 81361120410, 81321092, and 81473262) and the “Personalized Medicines—Molecular Signature-Based Drug Discovery and Development”, Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12040311).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i120" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i120"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i121" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i121"> Abbreviations Used</h2><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under curve</p></td></tr><tr><td class="NLM_term"><i>t</i>-BuOK</td><td class="NLM_def"><p class="first last">potassium <i>tert</i>-butoxide</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">copper-catalyzed azide–alkyne cycloaddition</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodiformate</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">docosahexaenoic acid</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide</p></td></tr><tr><td class="NLM_term">FFA1</td><td class="NLM_def"><p class="first last">free fatty acid receptor 1</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">gastric inhibitory polypeptide</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like peptide1</p></td></tr><tr><td class="NLM_term">GPR40</td><td class="NLM_def"><p class="first last">G protein-coupled receptor 40</p></td></tr><tr><td class="NLM_term">GSIS</td><td class="NLM_def"><p class="first last">glucose-stimulated insulin secretion</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotrizole</p></td></tr><tr><td class="NLM_term">ICR mice</td><td class="NLM_def"><p class="first last">Institute of Cancer Research mice</p></td></tr><tr><td class="NLM_term">LA</td><td class="NLM_def"><p class="first last">linoleic acid</p></td></tr><tr><td class="NLM_term">Me<sub>4</sub>Phen</td><td class="NLM_def"><p class="first last">3,4,7,8-tetramethyl-1,10-phenanthroline</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean retention time</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">N-STZ rats</td><td class="NLM_def"><p class="first last"><i>N</i>-streptozotocin rats</p></td></tr><tr><td class="NLM_term">OGTT</td><td class="NLM_def"><p class="first last">oral glucose tolerance test</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">PIFA</td><td class="NLM_def"><p class="first last">PhI(O<sub>2</sub>CCF<sub>3</sub>)<sub>2</sub></p></td></tr><tr><td class="NLM_term">PIntB</td><td class="NLM_def"><p class="first last">2-(di-<i>tert</i>-butylphosphino)-1-phenylindole</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">T2DM</td><td class="NLM_def"><p class="first last">type 2 diabetes mellitus</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">ZDF rats</td><td class="NLM_def"><p class="first last">Zucker diabetic fatty rats</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukusumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uejima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">422</span><span class="NLM_x"> (</span><span class="NLM_issue">6928</span><span class="NLM_x">) </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span><span class="refDoi"> DOI: 10.1038/nature01478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1038%2Fnature01478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=422&publication_year=2003&pages=173-176&issue=6928&author=Y.+Itohauthor=Y.+Kawamataauthor=M.+Haradaauthor=M.+Kobayashiauthor=R.+Fujiiauthor=S.+Fukusumiauthor=K.+Ogiauthor=M.+Hosoyaauthor=Y.+Tanakaauthor=H.+Uejimaauthor=H.+Tanakaauthor=M.+Maruyamaauthor=R.+Satohauthor=S.+Okuboauthor=H.+Kizawaauthor=H.+Komatsuauthor=F.+Matsumuraauthor=Y.+Noguchiauthor=T.+Shinoharaauthor=S.+Hinumaauthor=Y.+Fujisawaauthor=M.+Fujino&title=Free+fatty+acids+regulate+insulin+secretion+from+pancreatic+beta+cells+through+GPR40&doi=10.1038%2Fnature01478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01478%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DFukusumi%26aufirst%3DS.%26aulast%3DOgi%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DUejima%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DSatoh%26aufirst%3DR.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DKizawa%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DF.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DY.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DFree%2520fatty%2520acids%2520regulate%2520insulin%2520secretion%2520from%2520pancreatic%2520beta%2520cells%2520through%2520GPR40%26jtitle%3DNature%26date%3D2003%26volume%3D422%26issue%3D6928%26spage%3D173%26epage%3D176%26doi%3D10.1038%2Fnature01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Edfalk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steneberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, H.</span><span> </span><span class="NLM_article-title">GPR40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2287</span><span class="refDoi"> DOI: 10.2337/db08-0307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.2337%2Fdb08-0307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=2280-2287&issue=9&author=S.+Edfalkauthor=P.+Stenebergauthor=H.+Edlund&title=GPR40+is+expressed+in+enteroendocrine+cells+and+mediates+free+fatty+acid+stimulation+of+incretin+secretion&doi=10.2337%2Fdb08-0307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdb08-0307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb08-0307%26sid%3Dliteratum%253Aachs%26aulast%3DEdfalk%26aufirst%3DS.%26aulast%3DSteneberg%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DH.%26atitle%3DGPR40%2520is%2520expressed%2520in%2520enteroendocrine%2520cells%2520and%2520mediates%2520free%2520fatty%2520acid%2520stimulation%2520of%2520incretin%2520secretion%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26issue%3D9%26spage%3D2280%26epage%3D2287%26doi%3D10.2337%2Fdb08-0307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y.-Q.</span><span> </span><span class="NLM_article-title">GPR40 agonists for the treatment of type 2 diabetes mellitus: the biological characteristics and the chemical space</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">5603</span><span class="NLM_x">–</span> <span class="NLM_lpage">5612</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.bmcl.2016.10.074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5603-5612&issue=23&author=C.+Chenauthor=H.+Liauthor=Y.-Q.+Long&title=GPR40+agonists+for+the+treatment+of+type+2+diabetes+mellitus%3A+the+biological+characteristics+and+the+chemical+space&doi=10.1016%2Fj.bmcl.2016.10.074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLong%26aufirst%3DY.-Q.%26atitle%3DGPR40%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%253A%2520the%2520biological%2520characteristics%2520and%2520the%2520chemical%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5603%26epage%3D5612%26doi%3D10.1016%2Fj.bmcl.2016.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. Q.</span><span> </span><span class="NLM_article-title">Advances in small-molecule GPR40 agonists for treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Youji Huaxue</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span><span class="refDoi"> DOI: 10.6023/cjoc201511011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.6023%2Fcjoc201511011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFGrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=736-743&issue=4&author=H.+Liauthor=Y.+Q.+Long&title=Advances+in+small-molecule+GPR40+agonists+for+treatment+of+type+2+diabetes+mellitus&doi=10.6023%2Fcjoc201511011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in small-molecule GPR40 agonists for treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Li, He; Long, Yaqiu</div><div class="citationInfo"><span class="NLM_cas:title">Youji Huaxue</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">736-743</span>CODEN:
                <span class="NLM_cas:coden">YCHHDX</span>;
        ISSN:<span class="NLM_cas:issn">0253-2786</span>.
    
            (<span class="NLM_cas:orgname">Youji Huaxue Bianjibu</span>)
        </div><div class="casAbstract">A review.  Currently, the majority of the chemotherapy for type 2 diabetes mellitus (T2DM) functions through glycemic control by administration of oral or injectable hypoglycemic drugs.  Though a range of anti-diabetic drugs with different modes of action has been launched, there still is a significant need for development of effective and highly safe anti-diabetic agents for the increasing diabetic population.  GPR40 belongs to the GPCR family and the activation of GPR40 can amplify glucose-stimulated insulin secretion (GSIS).  Due to the advantage of minimizing the hypoglycemia risk, GPR40 has drawn more and more attention and emerged as a promising new target for T2DM treatment.  Therefore, the recent progress on the structural optimization and further development of small mol. GPR40 agonists as novel treatment for T2DM is reviewed, focusing on those under clin. trials or at preclin. stage.  A variety of small mol. GPR40 agonists are summarized from the literatures and patents based on the pharmacophore model, including the crit. phenylpropanoic acid core, the hydrophobic terminus and the linker.  The structural features and advantages of different sources of GPR40 agonists are analyzed and highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDtlDXl6JG1rVg90H21EOLACvtfcHk0liSmqrMqL8ujQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFGrtr4%253D&md5=c51646ead4d989fda7f2fa369db175a4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.6023%2Fcjoc201511011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6023%252Fcjoc201511011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DAdvances%2520in%2520small-molecule%2520GPR40%2520agonists%2520for%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DYouji%2520Huaxue%26date%3D2016%26volume%3D36%26issue%3D4%26spage%3D736%26epage%3D743%26doi%3D10.6023%2Fcjoc201511011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Defossa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, M.</span><span> </span><span class="NLM_article-title">Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2991</span><span class="NLM_x">–</span> <span class="NLM_lpage">3000</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.bmcl.2014.05.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2991-3000&issue=14&author=E.+Defossaauthor=M.+Wagner&title=Recent+developments+in+the+discovery+of+FFA1+receptor+agonists+as+novel+oral+treatment+for+type+2+diabetes+mellitus&doi=10.1016%2Fj.bmcl.2014.05.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DDefossa%26aufirst%3DE.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DRecent%2520developments%2520in%2520the%2520discovery%2520of%2520FFA1%2520receptor%2520agonists%2520as%2520novel%2520oral%2520treatment%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D14%26spage%3D2991%26epage%3D3000%26doi%3D10.1016%2Fj.bmcl.2014.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Discovery of TAK-875: a potent, selective, and orally bioavailable GPR40 agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1021/ml1000855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=290-294&issue=6&author=N.+Negoroauthor=S.+Sasakiauthor=S.+Mikamiauthor=M.+Itoauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=R.+Itoauthor=A.+Haradaauthor=K.+Takeuchiauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=T.+Odaniauthor=N.+Kanzakiauthor=M.+Funamiauthor=T.+Tanakaauthor=A.+Kogameauthor=S.+Matsunagaauthor=T.+Yasumaauthor=Y.+Momose&title=Discovery+of+TAK-875%3A+a+potent%2C+selective%2C+and+orally+bioavailable+GPR40+agonist&doi=10.1021%2Fml1000855"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fml1000855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000855%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKogame%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520TAK-875%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520GPR40%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26issue%3D6%26spage%3D290%26epage%3D294%26doi%3D10.1021%2Fml1000855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yabuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda-Nagasumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span> </span><span class="NLM_article-title">A novel antidiabetic drug, Fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e76280</span><span class="refDoi"> DOI: 10.1371/journal.pone.0076280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1371%2Fjournal.pone.0076280" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76280&issue=10&author=C.+Yabukiauthor=H.+Komatsuauthor=Y.+Tsujihataauthor=R.+Maedaauthor=R.+Itoauthor=K.+Matsuda-Nagasumiauthor=K.+Sakumaauthor=K.+Miyawakiauthor=N.+Kikuchiauthor=K.+Takeuchiauthor=Y.+Habataauthor=M.+Mori&title=A+novel+antidiabetic+drug%2C+Fasiglifam%2FTAK-875%2C+acts+as+an+ago-allosteric+modulator+of+FFAR1&doi=10.1371%2Fjournal.pone.0076280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0076280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0076280%26sid%3Dliteratum%253Aachs%26aulast%3DYabuki%26aufirst%3DC.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DR.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DMatsuda-Nagasumi%26aufirst%3DK.%26aulast%3DSakuma%26aufirst%3DK.%26aulast%3DMiyawaki%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DHabata%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26atitle%3DA%2520novel%2520antidiabetic%2520drug%252C%2520Fasiglifam%252FTAK-875%252C%2520acts%2520as%2520an%2520ago-allosteric%2520modulator%2520of%2520FFAR1%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D10%26spage%3De76280%26doi%3D10.1371%2Fjournal.pone.0076280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. Y. N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reagan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span> </span><span class="NLM_article-title">AMG 837: A novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">e27270</span><span class="refDoi"> DOI: 10.1371/journal.pone.0027270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1371%2Fjournal.pone.0027270" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27270&issue=11&author=D.+C.+H.+Linauthor=J.+Zhangauthor=R.+Zhuangauthor=F.+Liauthor=K.+Nguyenauthor=M.+Chenauthor=T.+Tranauthor=E.+Lopezauthor=J.+Y.+L.+Luauthor=X.+Y.+N.+N.+Liauthor=L.+Tangauthor=G.+R.+Tonnauthor=G.+Swaminathauthor=J.+D.+Reaganauthor=J.+L.+Chenauthor=H.+Tianauthor=Y.+J.+Linauthor=J.+B.+Houzeauthor=J.+Luo&title=AMG+837%3A+A+novel+GPR40%2FFFA1+agonist+that+enhances+insulin+secretion+and+lowers+glucose+levels+in+rodents&doi=10.1371%2Fjournal.pone.0027270"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0027270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0027270%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DJ.%2BY.%2BL.%26aulast%3DLi%26aufirst%3DX.%2BY.%2BN.%2BN.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DReagan%26aufirst%3DJ.%2BD.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.%2BJ.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DLuo%26aufirst%3DJ.%26atitle%3DAMG%2520837%253A%2520A%2520novel%2520GPR40%252FFFA1%2520agonist%2520that%2520enhances%2520insulin%2520secretion%2520and%2520lowers%2520glucose%2520levels%2520in%2520rodents%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D11%26spage%3De27270%26doi%3D10.1371%2Fjournal.pone.0027270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span> </span><span class="NLM_article-title">Discovery of AM-1638: a potent and orally bioavailable GPR40/FFA1 full agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1021/ml300133f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300133f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=726-730&issue=9&author=S.+P.+Brownauthor=P.+J.+Dransfieldauthor=M.+Vimolratanaauthor=X.+Y.+Jiaoauthor=L.+Zhuauthor=V.+Pattaropongauthor=Y.+Sunauthor=J.+Q.+Liuauthor=J.+Luoauthor=J.+Zhangauthor=S.+Wongauthor=R.+Zhuangauthor=Q.+Guoauthor=F.+Liauthor=J.+C.+Medinaauthor=G.+Swaminathauthor=D.+C.+H.+Linauthor=J.+B.+Houze&title=Discovery+of+AM-1638%3A+a+potent+and+orally+bioavailable+GPR40%2FFFA1+full+agonist&doi=10.1021%2Fml300133f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml300133f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300133f%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520AM-1638%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520GPR40%252FFFA1%2520full%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D9%26spage%3D726%26epage%3D730%26doi%3D10.1021%2Fml300133f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasparian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent GPR40 full agonists containing tricyclic spirocycles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1021/ml300427u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300427u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=551-555&issue=6&author=Y.+C.+Wangauthor=J.+W.+Liuauthor=P.+J.+Dransfieldauthor=L.+S.+Zhuauthor=Z.+Y.+Wangauthor=X.+H.+Duauthor=X.+Y.+Jiaoauthor=Y.+L.+Suauthor=A.+R.+Liauthor=S.+P.+Brownauthor=A.+Kasparianauthor=M.+Vimolratanaauthor=M.+Yuauthor=V.+Pattaropongauthor=J.+B.+Houzeauthor=G.+Swaminathauthor=T.+Tranauthor=K.+Nguyenauthor=Q.+Guoauthor=J.+Zhangauthor=R.+Zhuangauthor=F.+Liauthor=L.+Miaoauthor=M.+D.+Bartbergerauthor=T.+L.+Correllauthor=D.+Chowauthor=S.+Wongauthor=J.+Luoauthor=D.+C.+H.+Linauthor=J.+C.+Medina&title=Discovery+and+optimization+of+potent+GPR40+full+agonists+containing+tricyclic+spirocycles&doi=10.1021%2Fml300427u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles</span></div><div class="casAuthors">Wang, Yingcai; Liu, Jiwen; Dransfield, Paul J.; Zhu, Liusheng; Wang, Zhongyu; Du, Xiaohui; Jiao, Xianyun; Su, Yongli; Li, An-rong; Brown, Sean P.; Kasparian, Annie; Vimolratana, Marc; Yu, Ming; Pattaropong, Vatee; Houze, Jonathan B.; Swaminath, Gayathri; Tran, Thanhvien; Nguyen, Khanh; Guo, Qi; Zhang, Jane; Zhuang, Run; Li, Frank; Miao, Lynn; Bartberger, Michael D.; Correll, Tiffany L.; Chow, David; Wong, Simon; Luo, Jian; Lin, Daniel C.-H.; Medina, Julio C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">551-555</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR40 (FFAR1 or FFA1) is a target of high interest being pursued to treat type II diabetes due to its unique mechanism leading to little risk of hypoglycemia.  The authors recently reported the discovery of AM-1638 (I), a potent full agonist of GPR40.  In this report, they present the discovery of GPR40 full agonists contg. conformationally constrained tricyclic spirocycles and their structure-activity relationships leading to more potent agonists such as AM-5262 (II) with improved rat PK profile and general selectivity profile.  AM-5262 enhanced glucose stimulated insulin secretion (mouse and human islets) and improved glucose homeostasis in vivo (OGTT in HF/STZ mice) when compared to AM-1638.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgX9JpdxT4OrVg90H21EOLACvtfcHk0ljv2b8mNW9-RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOktLY%253D&md5=7f4681a65e80ba0f45642f63c6a33b22</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml300427u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300427u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DZhu%26aufirst%3DL.%2BS.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DDu%26aufirst%3DX.%2BH.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DSu%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DA.%2BR.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DKasparian%26aufirst%3DA.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520GPR40%2520full%2520agonists%2520containing%2520tricyclic%2520spirocycles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D6%26spage%3D551%26epage%3D555%26doi%3D10.1021%2Fml300427u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.</span><span> </span><span class="NLM_article-title">A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e46300</span><span class="refDoi"> DOI: 10.1371/journal.pone.0046300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1371%2Fjournal.pone.0046300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e46300&issue=10&author=J.+Luoauthor=G.+Swaminathauthor=S.+P.+Brownauthor=J.+Zhangauthor=Q.+Guoauthor=M.+Chenauthor=K.+Nguyenauthor=T.+Tranauthor=L.+Miaoauthor=P.+J.+Dransfieldauthor=M.+Vimolratanaauthor=J.+B.+Houzeauthor=S.+Wongauthor=M.+Totevaauthor=B.+Shanauthor=F.+Liauthor=R.+Zhuangauthor=D.+C.+Lin&title=A+potent+class+of+GPR40+full+agonists+engages+the+enteroinsular+axis+to+promote+glucose+control+in+rodents&doi=10.1371%2Fjournal.pone.0046300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046300%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.%26atitle%3DA%2520potent%2520class%2520of%2520GPR40%2520full%2520agonists%2520engages%2520the%2520enteroinsular%2520axis%2520to%2520promote%2520glucose%2520control%2520in%2520rodents%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D10%26spage%3De46300%26doi%3D10.1371%2Fjournal.pone.0046300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hauge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestmar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husted, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinglass, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelstoft, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span> <span class="citation_source-journal">Mol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/j.molmet.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.molmet.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=25685685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=3-14&issue=1&author=M.+Haugeauthor=M.+A.+Vestmarauthor=A.+S.+Hustedauthor=J.+P.+Ekbergauthor=M.+J.+Wrightauthor=J.+Di+Salvoauthor=A.+B.+Weinglassauthor=M.+S.+Engelstoftauthor=A.+N.+Madsenauthor=M.+Luckmannauthor=M.+W.+Millerauthor=M.+E.+Trujilloauthor=T.+M.+Frimurerauthor=B.+Holstauthor=A.+D.+Howardauthor=T.+W.+Schwartz&title=GPR40+%28FFAR1%29+-+Combined+Gs+and+Gq+signaling+in+vitro+is+associated+with+robust+incretin+secretagogue+action+ex+vivo+and+in+vivo&doi=10.1016%2Fj.molmet.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span></div><div class="casAuthors">Hauge, Maria; Vestmar, Marie A.; Husted, Anna S.; Ekberg, Jeppe P.; Wright, Michael J.; Di Salvo, Jerry; Weinglass, Adam B.; Engelstoft, Maja S.; Madsen, Andreas N.; Luckmann, Michael; Miller, Michael W.; Trujillo, Maria E.; Frimurer, Thomas M.; Holst, Birgitte; Howard, Andrew D.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">GPR40 (FFAR1), a clin. proven anti-diabetes target, is a Gq-coupled receptor for long chain fatty acids (LCFA) stimulating insulin secretion directly and mediating a major part of the dietary triglyceride-induced secretion of the incretins GLP-1 and GIP.  In phase-II studies the GPR40 agonist TAK-875 decreased blood glucose but surprisingly without stimulating incretins.  Here we find that GPR40 can signal through not only Gq and IP3 but also Gs and cAMP when stimulated with certain agonists such as AM-1638 and AM-5262 in contrast to the endogenous LCFA ligands and agonists such as TAK-875 and AM-837, which only signal through Gq.  In competition binding against [3H]AM-1638 and [3H]L358 the Gq + Gs and the Gq-only agonists either competed for or showed pos. cooperativity by increasing the binding of the two different radio-ligands, in opposite ways.  Nevertheless, both the Gq-only and the Gq + Gs agonists all docked surprisingly well into the binding site for TAK-875 in the X-ray structure of GPR40.  In murine intestinal primary cell-cultures the endogenous LCFAs and the Gq-only agonists stimulated GLP-1 secretion with rather poor efficacy as compared with the high efficacy Gq + Gs GPR40 agonists and a prototype GPR119 agonist.  Similarly, in fasting both male and female mice the Gq + Gs agonists showed significantly higher efficacy than the Gq-only agonists in respect of increasing plasma GLP-1 and plasma GIP in a GPR40-dependent manner.  It is concluded that stimulation of GPR40 by endogenous LCFAs or by Gq-only synthetic agonists result in a rather limited incretin response, whereas Gq + Gs GPR40 agonists stimulate incretin secretion robustly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZyjcjTNd0QbVg90H21EOLACvtfcHk0lhWfOm-YDKmRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN&md5=895136bef8c9542711e6daf5fa57219c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DHauge%26aufirst%3DM.%26aulast%3DVestmar%26aufirst%3DM.%2BA.%26aulast%3DHusted%26aufirst%3DA.%2BS.%26aulast%3DEkberg%26aufirst%3DJ.%2BP.%26aulast%3DWright%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DWeinglass%26aufirst%3DA.%2BB.%26aulast%3DEngelstoft%26aufirst%3DM.%2BS.%26aulast%3DMadsen%26aufirst%3DA.%2BN.%26aulast%3DLuckmann%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DM.%2BW.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DGPR40%2520%2528FFAR1%2529%2520-%2520Combined%2520Gs%2520and%2520Gq%2520signaling%2520in%2520vitro%2520is%2520associated%2520with%2520robust%2520incretin%2520secretagogue%2520action%2520ex%2520vivo%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Metab.%26date%3D2015%26volume%3D4%26issue%3D1%26spage%3D3%26epage%3D14%26doi%3D10.1016%2Fj.molmet.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birdsall, N. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span> </span><span class="NLM_article-title">Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span><span class="refDoi"> DOI: 10.1124/mol.112.079640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1124%2Fmol.112.079640" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=843-859&issue=5&author=D.+C.+H.+Linauthor=Q.+Guoauthor=J.+Luoauthor=J.+N.+Zhangauthor=K.+Nguyenauthor=M.+Chenauthor=T.+Tranauthor=P.+J.+Dransfieldauthor=S.+P.+Brownauthor=J.+Houzeauthor=M.+Vimolratanaauthor=X.+Y.+Jiaoauthor=Y.+C.+Wangauthor=N.+J.+M.+Birdsallauthor=G.+Swaminath&title=Identification+and+pharmacological+characterization+of+multiple+allosteric+binding+sites+on+the+free+fatty+acid+1+receptor&doi=10.1124%2Fmol.112.079640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.079640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.079640%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BN.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DBirdsall%26aufirst%3DN.%2BJ.%2BM.%26aulast%3DSwaminath%26aufirst%3DG.%26atitle%3DIdentification%2520and%2520pharmacological%2520characterization%2520of%2520multiple%2520allosteric%2520binding%2520sites%2520on%2520the%2520free%2520fatty%2520acid%25201%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26issue%3D5%26spage%3D843%26epage%3D859%26doi%3D10.1124%2Fmol.112.079640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mikami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3756</span><span class="NLM_x">–</span> <span class="NLM_lpage">3776</span><span class="refDoi"> DOI: 10.1021/jm2016123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2016123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3756-3776&issue=8&author=S.+Mikamiauthor=S.+Kitamuraauthor=N.+Negoroauthor=S.+Sasakiauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=T.+Miyazakiauthor=R.+Itoauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=N.+Kanzakiauthor=M.+Funamiauthor=T.+Tanakaauthor=T.+Yasumaauthor=Y.+Momose&title=Discovery+of+phenylpropanoic+acid+derivatives+containing+polar+functionalities+as+potent+and+orally+bioavailable+G+protein-coupled+receptor+40+agonists+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm2016123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm2016123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016123%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520phenylpropanoic%2520acid%2520derivatives%2520containing%2520polar%2520functionalities%2520as%2520potent%2520and%2520orally%2520bioavailable%2520G%2520protein-coupled%2520receptor%252040%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D8%26spage%3D3756%26epage%3D3776%26doi%3D10.1021%2Fjm2016123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Du, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span> </span><span class="NLM_article-title">Improving the pharmacokinetics of GPR40/FFA1 full agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1021/ml4005123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4005123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=384-389&issue=4&author=X.+H.+Duauthor=P.+J.+Dransfieldauthor=D.+C.+H.+Linauthor=S.+Wongauthor=Y.+C.+Wangauthor=Z.+Y.+Wangauthor=T.+Kohnauthor=M.+Yuauthor=S.+P.+Brownauthor=M.+Vimolratanaauthor=L.+S.+Zhuauthor=A.+R.+Liauthor=Y.+L.+Suauthor=X.+Y.+Jiaoauthor=J.+W.+Liuauthor=G.+Swaminathauthor=T.+Tranauthor=J.+Luoauthor=R.+Zhuangauthor=J.+Zhangauthor=Q.+Guoauthor=F.+Liauthor=R.+Connorsauthor=J.+C.+Medinaauthor=J.+B.+Houze&title=Improving+the+pharmacokinetics+of+GPR40%2FFFA1+full+agonists&doi=10.1021%2Fml4005123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml4005123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4005123%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%2BH.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DKohn%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%2BS.%26aulast%3DLi%26aufirst%3DA.%2BR.%26aulast%3DSu%26aufirst%3DY.%2BL.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DImproving%2520the%2520pharmacokinetics%2520of%2520GPR40%252FFFA1%2520full%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D4%26spage%3D384%26epage%3D389%26doi%3D10.1021%2Fml4005123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tikhonova, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sum, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaka, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershengorn, M. C.</span><span> </span><span class="NLM_article-title">Bidirectional, iterative approach to the structural delineation of the functional ″chemoprint″ in GPR40 for agonist recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2981</span><span class="NLM_x">–</span> <span class="NLM_lpage">2989</span><span class="refDoi"> DOI: 10.1021/jm0614782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0614782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2981-2989&issue=13&author=I.+G.+Tikhonovaauthor=C.+S.+Sumauthor=S.+Neumannauthor=C.+J.+Thomasauthor=B.+M.+Raakaauthor=S.+Costanziauthor=M.+C.+Gershengorn&title=Bidirectional%2C+iterative+approach+to+the+structural+delineation+of+the+functional+%E2%80%B3chemoprint%E2%80%B3+in+GPR40+for+agonist+recognition&doi=10.1021%2Fjm0614782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0614782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0614782%26sid%3Dliteratum%253Aachs%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DSum%26aufirst%3DC.%2BS.%26aulast%3DNeumann%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DRaaka%26aufirst%3DB.%2BM.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DGershengorn%26aufirst%3DM.%2BC.%26atitle%3DBidirectional%252C%2520iterative%2520approach%2520to%2520the%2520structural%2520delineation%2520of%2520the%2520functional%2520%25E2%2580%25B3chemoprint%25E2%2580%25B3%2520in%2520GPR40%2520for%2520agonist%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D13%26spage%3D2981%26epage%3D2989%26doi%3D10.1021%2Fjm0614782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirozane, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kefala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruswitz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivetac, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span> </span><span class="NLM_article-title">High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x"> (</span><span class="NLM_issue">7516</span><span class="NLM_x">) </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1038/nature13494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1038%2Fnature13494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=124-127&issue=7516&author=A.+Srivastavaauthor=J.+Yanoauthor=Y.+Hirozaneauthor=G.+Kefalaauthor=F.+Gruswitzauthor=G.+Snellauthor=W.+Laneauthor=A.+Ivetacauthor=K.+Aertgeertsauthor=J.+Nguyenauthor=A.+Jenningsauthor=K.+Okada&title=High-resolution+structure+of+the+human+GPR40+receptor+bound+to+allosteric+agonist+TAK-875&doi=10.1038%2Fnature13494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature13494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13494%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DHirozane%26aufirst%3DY.%26aulast%3DKefala%26aufirst%3DG.%26aulast%3DGruswitz%26aufirst%3DF.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DHigh-resolution%2520structure%2520of%2520the%2520human%2520GPR40%2520receptor%2520bound%2520to%2520allosteric%2520agonist%2520TAK-875%26jtitle%3DNature%26date%3D2014%26volume%3D513%26issue%3D7516%26spage%3D124%26epage%3D127%26doi%3D10.1038%2Fnature13494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span> </span><span class="NLM_article-title">Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1080/13543784.2016.1189530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1080%2F13543784.2016.1189530" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=871-890&issue=8&author=Z.+Liauthor=Q.+Qiuauthor=X.+Gengauthor=J.+Yangauthor=W.+Huangauthor=H.+Qian&title=Free+fatty+acid+receptor+agonists+for+the+treatment+of+type+2+diabetes%3A+drugs+in+preclinical+to+phase+II+clinical+development&doi=10.1080%2F13543784.2016.1189530"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1080%2F13543784.2016.1189530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2016.1189530%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DH.%26atitle%3DFree%2520fatty%2520acid%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%253A%2520drugs%2520in%2520preclinical%2520to%2520phase%2520II%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26issue%3D8%26spage%3D871%26epage%3D890%26doi%3D10.1080%2F13543784.2016.1189530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Altman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtor, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An improved Cu-based catalyst system for the reactions of alcohols with aryl halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1021/jo702024p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo702024p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=284-286&issue=1&author=R.+A.+Altmanauthor=A.+Shafirauthor=A.+Choiauthor=P.+A.+Lichtorauthor=S.+L.+Buchwald&title=An+improved+Cu-based+catalyst+system+for+the+reactions+of+alcohols+with+aryl+halides&doi=10.1021%2Fjo702024p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo702024p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo702024p%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DR.%2BA.%26aulast%3DShafir%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DA.%26aulast%3DLichtor%26aufirst%3DP.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520improved%2520Cu-based%2520catalyst%2520system%2520for%2520the%2520reactions%2520of%2520alcohols%2520with%2520aryl%2520halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D1%26spage%3D284%26epage%3D286%26doi%3D10.1021%2Fjo702024p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mohite, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R. G.</span><span> </span><span class="NLM_article-title">A practical and convenient protocol for the synthesis of (E)-alpha,beta-unsaturated acids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">4564</span><span class="NLM_x">–</span> <span class="NLM_lpage">4567</span><span class="refDoi"> DOI: 10.1021/ol402130t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol402130t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=4564-4567&issue=17&author=A.+R.+Mohiteauthor=R.+G.+Bhat&title=A+practical+and+convenient+protocol+for+the+synthesis+of+%28E%29-alpha%2Cbeta-unsaturated+acids&doi=10.1021%2Fol402130t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fol402130t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol402130t%26sid%3Dliteratum%253Aachs%26aulast%3DMohite%26aufirst%3DA.%2BR.%26aulast%3DBhat%26aufirst%3DR.%2BG.%26atitle%3DA%2520practical%2520and%2520convenient%2520protocol%2520for%2520the%2520synthesis%2520of%2520%2528E%2529-alpha%252Cbeta-unsaturated%2520acids%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26issue%3D17%26spage%3D4564%26epage%3D4567%26doi%3D10.1021%2Fol402130t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span> </span><span class="NLM_article-title">Optimization of GPR40 agonists for type 2 diabetes</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span><span class="refDoi"> DOI: 10.1021/ml400501x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400501x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=517-521&issue=5&author=J.+W.+Liuauthor=Y.+C.+Wangauthor=Z.+H.+Maauthor=M.+Schmittauthor=L.+S.+Zhuauthor=S.+P.+Brownauthor=P.+J.+Dransfieldauthor=Y.+Sunauthor=R.+Sharmaauthor=Q.+Guoauthor=R.+Zhuangauthor=J.+Zhangauthor=J.+Luoauthor=G.+R.+Tonnauthor=S.+Wongauthor=G.+Swaminathauthor=J.+C.+Medinaauthor=D.+C.+H.+Linauthor=J.+B.+Houze&title=Optimization+of+GPR40+agonists+for+type+2+diabetes&doi=10.1021%2Fml400501x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml400501x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400501x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DZ.%2BH.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%2BS.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DOptimization%2520of%2520GPR40%2520agonists%2520for%2520type%25202%2520diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D5%26spage%3D517%26epage%3D521%26doi%3D10.1021%2Fml400501x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fujii, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashiguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uematsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikariya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noyori, R.</span><span> </span><span class="NLM_article-title">Ruthenium(II)-catalyzed asymmetric transfer hydrogenation of ketones using a formic acid-triethylamine mixture</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2521</span><span class="NLM_x">–</span> <span class="NLM_lpage">2522</span><span class="refDoi"> DOI: 10.1021/ja954126l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja954126l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADyaK28Xht1Wnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=2521-2522&issue=10&author=A.+Fujiiauthor=S.+Hashiguchiauthor=N.+Uematsuauthor=T.+Ikariyaauthor=R.+Noyori&title=Ruthenium%28II%29-catalyzed+asymmetric+transfer+hydrogenation+of+ketones+using+a+formic+acid-triethylamine+mixture&doi=10.1021%2Fja954126l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation of Ketones Using a Formic Acid-Triethylamine Mixture</span></div><div class="casAuthors">Fujii, Akio; Hashiguchi, Shohei; Uematsu, Nobuyuki; Ikariya, Takao; Noyori, Ryoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2521-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(R)-RuCl[(1S,2S)-p-CH3C6H4SO2NCHPhCHPhNH2](η6-mesitylene) or the enantiomer efficiently catalyzes asym. redn. of prochiral ketones in a 5:2 formic acid-NEt3 azeotropic mixt. with a substrate:catalyst molar ratio of 200-1000 to give the corresponding secondary alcs. with a high enantiomeric purity.  This transfer hydrogenation can be characterized by irreversibility, which contrasts with the conventional reaction that uses iso-PrOH as a H donor.  The reaction proceeds with truly kinetic enantioface discrimination to completion with a substrate concn. ≤2-10 M.  A variety of arom. ketones including p-methoxyacetophenone and 2,3-benzo-2-cycloalkenones are usable as substrates.  The redn. occurs preferentially at a keto function without affecting an olefinic linkage, ester, furan ring, sulfide and sulfone group, aryl chloride and cyanide, thiophene and quinoline ring.  The utility was demonstrated by enantioselective synthesis of some chiral alcs. which serve as key intermediates for biol. significant compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJdf6_6eL1kbVg90H21EOLACvtfcHk0ljm_GUjGl4E1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1Wnu78%253D&md5=0d47b75e8884d1695fc7158776b4e622</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja954126l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja954126l%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DA.%26aulast%3DHashiguchi%26aufirst%3DS.%26aulast%3DUematsu%26aufirst%3DN.%26aulast%3DIkariya%26aufirst%3DT.%26aulast%3DNoyori%26aufirst%3DR.%26atitle%3DRuthenium%2528II%2529-catalyzed%2520asymmetric%2520transfer%2520hydrogenation%2520of%2520ketones%2520using%2520a%2520formic%2520acid-triethylamine%2520mixture%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26issue%3D10%26spage%3D2521%26epage%3D2522%26doi%3D10.1021%2Fja954126l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1378</span><span class="refDoi"> DOI: 10.1021/jm101405t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101405t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1365-1378&issue=5&author=S.+Sasakiauthor=S.+Kitamuraauthor=N.+Negoroauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=N.+Suzukiauthor=T.+Santouauthor=N.+Kanzakiauthor=M.+Haradaauthor=Y.+Tanakaauthor=M.+Kobayashiauthor=N.+Tadaauthor=M.+Funamiauthor=T.+Tanakaauthor=Y.+Yamamotoauthor=K.+Fukatsuauthor=T.+Yasumaauthor=Y.+Momose&title=Design%2C+synthesis%2C+and+biological+activity+of+potent+and+orally+available+G+protein-coupled+receptor+40+agonists&doi=10.1021%2Fjm101405t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm101405t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101405t%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520potent%2520and%2520orally%2520available%2520G%2520protein-coupled%2520receptor%252040%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D5%26spage%3D1365%26epage%3D1378%26doi%3D10.1021%2Fjm101405t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1538</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span><span class="refDoi"> DOI: 10.1021/jm2012968</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2012968" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1538-1552&issue=4&author=N.+Negoroauthor=S.+Sasakiauthor=M.+Itoauthor=S.+Kitamuraauthor=Y.+Tsujihataauthor=R.+Itoauthor=M.+Suzukiauthor=K.+Takeuchiauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=T.+Odaniauthor=N.+Kanzakiauthor=M.+Funamiauthor=T.+Tanakaauthor=T.+Yasumaauthor=Y.+Momose&title=Identification+of+fused-ring+alkanoic+acids+with+improved+pharmacokinetic+profiles+that+act+as+G+protein-coupled+receptor+40%2Ffree+fatty+acid+receptor+1+agonists&doi=10.1021%2Fjm2012968"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2012968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2012968%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520fused-ring%2520alkanoic%2520acids%2520with%2520improved%2520pharmacokinetic%2520profiles%2520that%2520act%2520as%2520G%2520protein-coupled%2520receptor%252040%252Ffree%2520fatty%2520acid%2520receptor%25201%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D4%26spage%3D1538%26epage%3D1552%26doi%3D10.1021%2Fjm2012968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Optimization of (2,3-Dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3974</span><span class="refDoi"> DOI: 10.1021/jm300170m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300170m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3960-3974&issue=8&author=N.+Negoroauthor=S.+Sasakiauthor=S.+Mikamiauthor=M.+Itoauthor=Y.+Tsujihataauthor=R.+Itoauthor=M.+Suzukiauthor=K.+Takeuchiauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=T.+Odaniauthor=N.+Kanzakiauthor=M.+Funamiauthor=A.+Morohashiauthor=M.+Nonakaauthor=S.+Matsunagaauthor=T.+Yasumaauthor=Y.+Momose&title=Optimization+of+%282%2C3-Dihydro-1-benzofuran-3-yl%29acetic+acids%3A+discovery+of+a+non-free+fatty+acid-like%2C+highly+bioavailable+G+protein-coupled+receptor+40%2Ffree+fatty+acid+receptor+1+agonist+as+a+glucose-dependent+insulinotropic+agent&doi=10.1021%2Fjm300170m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300170m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300170m%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DMorohashi%26aufirst%3DA.%26aulast%3DNonaka%26aufirst%3DM.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DOptimization%2520of%2520%25282%252C3-Dihydro-1-benzofuran-3-yl%2529acetic%2520acids%253A%2520discovery%2520of%2520a%2520non-free%2520fatty%2520acid-like%252C%2520highly%2520bioavailable%2520G%2520protein-coupled%2520receptor%252040%252Ffree%2520fatty%2520acid%2520receptor%25201%2520agonist%2520as%2520a%2520glucose-dependent%2520insulinotropic%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D8%26spage%3D3960%26epage%3D3974%26doi%3D10.1021%2Fjm300170m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due-Hansen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaibi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markussen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagesaether, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1021/jm301470a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301470a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=982-992&issue=3&author=E.+Christiansenauthor=M.+E.+Due-Hansenauthor=C.+Urbanauthor=M.+Grundmannauthor=J.+Schmidtauthor=S.+V.+F.+Hansenauthor=B.+D.+Hudsonauthor=M.+Zaibiauthor=S.+B.+Markussenauthor=E.+Hagesaetherauthor=G.+Milliganauthor=M.+A.+Cawthorneauthor=E.+Kostenisauthor=M.+U.+Kassackauthor=T.+Ulven&title=Discovery+of+a+potent+and+selective+free+fatty+acid+receptor+1+agonist+with+low+lipophilicity+and+high+oral+bioavailability&doi=10.1021%2Fjm301470a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301470a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301470a%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DS.%2BV.%2BF.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DZaibi%26aufirst%3DM.%26aulast%3DMarkussen%26aufirst%3DS.%2BB.%26aulast%3DHagesaether%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520free%2520fatty%2520acid%2520receptor%25201%2520agonist%2520with%2520low%2520lipophilicity%2520and%2520high%2520oral%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D3%26spage%3D982%26epage%3D992%26doi%3D10.1021%2Fjm301470a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hamdouchi, C.; Lineswala, J. P.; Maiti, P.; Haemdeochi, C.; Rinneseuwalra, J. P.; Lineswala, J.</span><span> </span><span class="NLM_article-title">New spiropiperidine compound useful in the treatment of diabetes in a mammal</span>. WO2011046851-A1, Apr 21,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Hamdouchi&author=J.+P.+Lineswala&author=P.+Maiti&author=C.+Haemdeochi&author=J.+P.+Rinneseuwalra&author=J.+Lineswala&title=New+spiropiperidine+compound+useful+in+the+treatment+of+diabetes+in+a+mammal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHamdouchi%26aufirst%3DC.%26atitle%3DNew%2520spiropiperidine%2520compound%2520useful%2520in%2520the%2520treatment%2520of%2520diabetes%2520in%2520a%2520mammal%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due-Hansen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagesaether, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">6691</span><span class="NLM_x">–</span> <span class="NLM_lpage">6703</span><span class="refDoi"> DOI: 10.1021/jm2005699</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2005699" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6691-6703&issue=19&author=E.+Christiansenauthor=C.+Urbanauthor=M.+Grundmannauthor=M.+E.+Due-Hansenauthor=E.+Hagesaetherauthor=J.+Schmidtauthor=L.+Pardoauthor=S.+Ullrichauthor=E.+Kostenisauthor=M.+Kassackauthor=T.+Ulven&title=Identification+of+a+potent+and+selective+free+fatty+acid+receptor+1+%28FFA1%2FGPR40%29+agonist+with+favorable+physicochemical+and+in+vitro+ADME+properties&doi=10.1021%2Fjm2005699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm2005699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2005699%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DHagesaether%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DUllrich%26aufirst%3DS.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKassack%26aufirst%3DM.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520free%2520fatty%2520acid%2520receptor%25201%2520%2528FFA1%252FGPR40%2529%2520agonist%2520with%2520favorable%2520physicochemical%2520and%2520in%2520vitro%2520ADME%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D19%26spage%3D6691%26epage%3D6703%26doi%3D10.1021%2Fjm2005699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Takano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span> </span><span class="NLM_article-title">Discovery of DS-1558: a potent and orally bioavailable GPR40 agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1021/ml500391n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500391n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=266-270&issue=3&author=R.+Takanoauthor=M.+Yoshidaauthor=M.+Inoueauthor=T.+Hondaauthor=R.+Nakashimaauthor=K.+Matsumotoauthor=T.+Yanoauthor=T.+Ogataauthor=N.+Watanabeauthor=M.+Hirouchiauthor=T.+Yoneyamaauthor=S.+Itoauthor=N.+Toda&title=Discovery+of+DS-1558%3A+a+potent+and+orally+bioavailable+GPR40+agonist&doi=10.1021%2Fml500391n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml500391n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500391n%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DOgata%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DHirouchi%26aufirst%3DM.%26aulast%3DYoneyama%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DToda%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520DS-1558%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520GPR40%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D3%26spage%3D266%26epage%3D270%26doi%3D10.1021%2Fml500391n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due-Hansen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">6624</span><span class="NLM_x">–</span> <span class="NLM_lpage">6628</span><span class="refDoi"> DOI: 10.1021/jm3002026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6624-6628&issue=14&author=E.+Christiansenauthor=M.+E.+Due-Hansenauthor=C.+Urbanauthor=M.+Grundmannauthor=R.+Schroderauthor=B.+D.+Hudsonauthor=G.+Milliganauthor=M.+A.+Cawthorneauthor=E.+Kostenisauthor=M.+U.+Kassackauthor=T.+Ulven&title=Free+fatty+acid+receptor+1+%28FFA1%2FGPR40%29+agonists%3A+mesylpropoxy+appendage+lowers+lipophilicity+and+improves+ADME+properties&doi=10.1021%2Fjm3002026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm3002026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002026%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DSchroder%26aufirst%3DR.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DFree%2520fatty%2520acid%2520receptor%25201%2520%2528FFA1%252FGPR40%2529%2520agonists%253A%2520mesylpropoxy%2520appendage%2520lowers%2520lipophilicity%2520and%2520improves%2520ADME%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D14%26spage%3D6624%26epage%3D6628%26doi%3D10.1021%2Fjm3002026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Takano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span> </span><span class="NLM_article-title">Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2949</span><span class="NLM_x">–</span> <span class="NLM_lpage">2953</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.bmcl.2014.04.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2949-2953&issue=13&author=R.+Takanoauthor=M.+Yoshidaauthor=M.+Inoueauthor=T.+Hondaauthor=R.+Nakashimaauthor=K.+Matsumotoauthor=T.+Yanoauthor=T.+Ogataauthor=N.+Watanabeauthor=N.+Toda&title=Discovery+of+3-aryl-3-ethoxypropanoic+acids+as+orally+active+GPR40+agonists&doi=10.1016%2Fj.bmcl.2014.04.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DOgata%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DToda%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25203-aryl-3-ethoxypropanoic%2520acids%2520as%2520orally%2520active%2520GPR40%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D13%26spage%3D2949%26epage%3D2953%26doi%3D10.1016%2Fj.bmcl.2014.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Fasiglifam (TAK-875) inhibits hepatobiliary transporters: a possible factor contributing to fasiglifam-induced liver injury</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1751</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span><span class="refDoi"> DOI: 10.1124/dmd.115.064121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1124%2Fdmd.115.064121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1751-1759&issue=11&author=X.+Liauthor=K.+Zhongauthor=Z.+Guoauthor=D.+Zhongauthor=X.+Chen&title=Fasiglifam+%28TAK-875%29+inhibits+hepatobiliary+transporters%3A+a+possible+factor+contributing+to+fasiglifam-induced+liver+injury&doi=10.1124%2Fdmd.115.064121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.064121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.064121%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DFasiglifam%2520%2528TAK-875%2529%2520inhibits%2520hepatobiliary%2520transporters%253A%2520a%2520possible%2520factor%2520contributing%2520to%2520fasiglifam-induced%2520liver%2520injury%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26issue%3D11%26spage%3D1751%26epage%3D1759%26doi%3D10.1124%2Fdmd.115.064121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Rumi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadowaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Cava, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazumori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, Y.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumour cells</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1111/j.1365-2443.2004.00793.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1111%2Fj.1365-2443.2004.00793.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=15507122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvV2gur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1113-1123&issue=11&author=M.+A.+Rumiauthor=S.+Ishiharaauthor=Y.+Kadowakiauthor=C.+F.+Ortega-Cavaauthor=H.+Kazumoriauthor=K.+Kawashimaauthor=N.+Yoshinoauthor=T.+Yukiauthor=N.+Ishimuraauthor=Y.+Kinoshita&title=Peroxisome+proliferator-activated+receptor+gamma-dependent+and+-independent+growth+inhibition+of+gastrointestinal+tumour+cells&doi=10.1111%2Fj.1365-2443.2004.00793.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ-dependent and -independent growth inhibition of gastrointestinal tumour cells</span></div><div class="casAuthors">Rumi, M. Azharul Karim; Ishihara, Shunji; Kadowaki, Yasunori; Ortega-Cava, C. F.; Kazumori, Hideaki; Kawashima, Kousaku; Yoshino, Nagisa; Yuki, Takafumi; Ishimura, Norihisa; Kinoshita, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1113-1123</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor γ (PPARγ) acts as a ligand-activated transcription factor.  Although ligand-induced cellular differentiation and growth inhibition were mostly studied on human cancers expressing PPARγ, it is unclear if the transcriptional activation of PPARγ is the main mechanism of growth inhibition.  In this study, the authors investigated whether there is a link between growth inhibitory effect and transcriptional activation of PPARγ in several gastrointestinal tumor cell lines.  The transcriptional activation potential of PPARγ was assessed by reporter gene assay employing a PPRE-luciferase vector, and growth inhibitory effect of PPARγ was investigated by 3H-thymidine incorporation assay, in the presence or absence of thiazolidinedione ligands, rosiglitazone and troglitazone.  As expected, in the case of cell lines pos. for the transcriptional activation potential of PPARγ (T.Tn, MKN-45, and LoVo), both the ligands induced growth inhibition.  However, in case of some other cell lines neg. for the transcriptional activation potential of PPARγ (TT, AGS, and HCT-15), troglitazone still showed a growth inhibitory effect.  Administration of the PPARγ antagonist GW9662 did not reverse this growth inhibitory activity of troglitazone.  The introduction of dominant neg. mutants of PPARγ did not suppress the activity either.  These observations suggest that while rosiglitazone inhibits cellular growth predominantly through transcriptional activation of PPARγ, troglitazone can induce it both in PPARγ-dependent and -independent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgLRxAgGst17Vg90H21EOLACvtfcHk0ljwk_9kOA6kaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvV2gur4%253D&md5=51288bd81c1214d808b71476aba22178</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2004.00793.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2004.00793.x%26sid%3Dliteratum%253Aachs%26aulast%3DRumi%26aufirst%3DM.%2BA.%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DKadowaki%26aufirst%3DY.%26aulast%3DOrtega-Cava%26aufirst%3DC.%2BF.%26aulast%3DKazumori%26aufirst%3DH.%26aulast%3DKawashima%26aufirst%3DK.%26aulast%3DYoshino%26aufirst%3DN.%26aulast%3DYuki%26aufirst%3DT.%26aulast%3DIshimura%26aufirst%3DN.%26aulast%3DKinoshita%26aufirst%3DY.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma-dependent%2520and%2520-independent%2520growth%2520inhibition%2520of%2520gastrointestinal%2520tumour%2520cells%26jtitle%3DGenes%2520Cells%26date%3D2004%26volume%3D9%26issue%3D11%26spage%3D1113%26epage%3D1123%26doi%3D10.1111%2Fj.1365-2443.2004.00793.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeCluyse, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L.</span><span> </span><span class="NLM_article-title">Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1592</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10336557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1592-1599&issue=3&author=X.+Liuauthor=E.+L.+LeCluyseauthor=K.+R.+Brouwerauthor=R.+M.+Lightfootauthor=J.+I.+Leeauthor=K.+L.+Brouwer&title=Use+of+Ca2%2B+modulation+to+evaluate+biliary+excretion+in+sandwich-cultured+rat+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes</span></div><div class="casAuthors">Liu, Xingrong; Lecluyse, Edward L.; Brouwer, Kenneth R.; Lightfoot, Ruth M.; Lee, Jacqueline I.; Brouwer, Kim L. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1592-1599</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous work in our lab. has indicated that biliary excretion of a substrate in sandwich-cultured hepatocytes can be quantitated by measurement of substrate accumulation in the presence and absence of extracellular Ca2+.  The present study was designed to examine the effects of Ca2+ on taurocholate accumulation and tight junction integrity in cultured hepatocytes.  Kinetic modeling was used to characterize taurocholate disposition in the hepatocyte monolayers in the presence and absence of extracellular Ca2+.  The accumulation of taurocholate in freshly isolated hepatocytes, which lack an intact canalicular network, was the same in the presence and absence of extracellular Ca2+.  Electron microscopy studies showed that Ca2+ depletion increased the permeability of the tight junctions to ruthenium red, demonstrating that tight junctions were the major diffusional barrier between the canalicular lumen and the extracellular space.  Cell morphol. and substrate accumulation studies in the monolayers indicated that Ca2+, depletion disrupted the tight junctions in 1 to 2 min.  The integrity of the disrupted tight junctions was not re-established completely after reincubation in the presence of Ca2+ for 1 h.  The accumulation of taurocholate was described best by a two-compartment model (cytosol and bile) with Michaelis-Menten kinetics for both uptake and biliary excretion.  In summary, Ca2+ depletion does not alter hepatocyte transport properties of taurocholate.  Ca2+ modulation may be a useful approach to study biliary excretion of substrates in sandwich-cultured hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS7Ker5rbMErVg90H21EOLACvtfcHk0lgAkysSuMxLlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGntrY%253D&md5=0301cba7b60237f1a4b6fbb5e89b0eb1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeCluyse%26aufirst%3DE.%2BL.%26aulast%3DBrouwer%26aufirst%3DK.%2BR.%26aulast%3DLightfoot%26aufirst%3DR.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BI.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26atitle%3DUse%2520of%2520Ca2%252B%2520modulation%2520to%2520evaluate%2520biliary%2520excretion%2520in%2520sandwich-cultured%2520rat%2520hepatocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26issue%3D3%26spage%3D1592%26epage%3D1599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Swift, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L.</span><span> </span><span class="NLM_article-title">Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.3109/03602530903491881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.3109%2F03602530903491881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=20109035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=446-471&issue=3&author=B.+Swiftauthor=N.+D.+Pfeiferauthor=K.+L.+Brouwer&title=Sandwich-cultured+hepatocytes%3A+an+in+vitro+model+to+evaluate+hepatobiliary+transporter-based+drug+interactions+and+hepatotoxicity&doi=10.3109%2F03602530903491881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity</span></div><div class="casAuthors">Swift, Brandon; Pfeifer, Nathan D.; Brouwer, Kim L. R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">446-471</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review..  Sandwich-cultured hepatocytes (SCH) are a powerful in vitro tool that can be utilized to study hepatobiliary drug transport, species differences in drug transport, transport protein regulation, drug-drug interactions, and hepatotoxicity.  This review provides an up-to-date summary of the SCH model, including a brief history of, and introduction to, the use of SCH, as well as methodol. to evaluate hepatobiliary drug disposition.  A summary of the literature that has utilized this model to examine the interplay between drug-metabolizing enzymes and transport proteins, drug-drug interactions at the transport level, and hepatotoxicity as a result of altered hepatic transport also is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJbUKO6x6g9rVg90H21EOLACvtfcHk0lgAkysSuMxLlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSmt78%253D&md5=6f3e5d6554df5012a858b5d0bc30537e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3109%2F03602530903491881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602530903491881%26sid%3Dliteratum%253Aachs%26aulast%3DSwift%26aufirst%3DB.%26aulast%3DPfeifer%26aufirst%3DN.%2BD.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26atitle%3DSandwich-cultured%2520hepatocytes%253A%2520an%2520in%2520vitro%2520model%2520to%2520evaluate%2520hepatobiliary%2520transporter-based%2520drug%2520interactions%2520and%2520hepatotoxicity%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2010%26volume%3D42%26issue%3D3%26spage%3D446%26epage%3D471%26doi%3D10.3109%2F03602530903491881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Wu, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G. Y.</span><span> </span><span class="NLM_article-title">Timosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transporters</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1198</span><span class="refDoi"> DOI: 10.1038/aps.2014.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1038%2Faps.2014.65" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1188-1198&issue=9&author=Z.+T.+Wuauthor=X.+M.+Qiauthor=J.+J.+Shengauthor=L.+L.+Maauthor=X.+Niauthor=J.+Renauthor=C.+G.+Huangauthor=G.+Y.+Pan&title=Timosaponin+A3+induces+hepatotoxicity+in+rats+through+inducing+oxidative+stress+and+down-regulating+bile+acid+transporters&doi=10.1038%2Faps.2014.65"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Faps.2014.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2014.65%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%2BT.%26aulast%3DQi%26aufirst%3DX.%2BM.%26aulast%3DSheng%26aufirst%3DJ.%2BJ.%26aulast%3DMa%26aufirst%3DL.%2BL.%26aulast%3DNi%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DC.%2BG.%26aulast%3DPan%26aufirst%3DG.%2BY.%26atitle%3DTimosaponin%2520A3%2520induces%2520hepatotoxicity%2520in%2520rats%2520through%2520inducing%2520oxidative%2520stress%2520and%2520down-regulating%2520bile%2520acid%2520transporters%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26issue%3D9%26spage%3D1188%26epage%3D1198%26doi%3D10.1038%2Faps.2014.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Assessment of biliary clearance in early drug discovery using sandwich-cultured hepatocyte model</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1908</span><span class="refDoi"> DOI: 10.1002/jps.23070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1002%2Fjps.23070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=1898-1908&issue=5&author=G.+Panauthor=C.+Boiselleauthor=J.+Wang&title=Assessment+of+biliary+clearance+in+early+drug+discovery+using+sandwich-cultured+hepatocyte+model&doi=10.1002%2Fjps.23070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fjps.23070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23070%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DG.%26aulast%3DBoiselle%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DAssessment%2520of%2520biliary%2520clearance%2520in%2520early%2520drug%2520discovery%2520using%2520sandwich-cultured%2520hepatocyte%2520model%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26issue%3D5%26spage%3D1898%26epage%3D1908%26doi%3D10.1002%2Fjps.23070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylene Group, Friend or Foe in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5625-5663. <a href="https://doi.org/10.1021/acs.jmedchem.9b01617" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01617%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcetylene%252BGroup%25252C%252BFriend%252Bor%252BFoe%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29092019%26date%3D19022020%26date%3D07022020%26volume%3D63%26issue%3D11%26spage%3D5625%26epage%3D5663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cristina Trujillo, Pilar Goya, <span class="NLM_string-name hlFld-ContribAuthor">Isabel Rozas</span>. </span><span class="cited-content_cbyCitation_article-title">Study of Meldrum’s Acid Cyclization Reactions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry A</span><span> <strong>2018,</strong> <em>122 </em>
                                    (9)
                                     , 2535-2541. <a href="https://doi.org/10.1021/acs.jpca.7b11818" title="DOI URL">https://doi.org/10.1021/acs.jpca.7b11818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpca.7b11818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpca.7b11818%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520A%26atitle%3DStudy%252Bof%252BMeldrum%2525E2%252580%252599s%252BAcid%252BCyclization%252BReactions%26aulast%3DTrujillo%26aufirst%3DCristina%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D30112017%26date%3D20022018%26date%3D27022018%26date%3D21022018%26volume%3D122%26issue%3D9%26spage%3D2535%26epage%3D2541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. O.  Kuranov</span>, <span class="hlFld-ContribAuthor ">O. A.  Luzina</span>, <span class="hlFld-ContribAuthor ">N. F.  Salakhutdinov</span>. </span><span class="cited-content_cbyCitation_article-title">FFA1 (GPR40) Receptor Agonists Based on Phenylpropanoic Acid as Hypoglycemic Agents: Structure–Activity Relationship. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>46 </em>
                                    (6)
                                     , 972-988. <a href="https://doi.org/10.1134/S1068162020060151" title="DOI URL">https://doi.org/10.1134/S1068162020060151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1068162020060151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1068162020060151%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Bioorganic%2520Chemistry%26atitle%3DFFA1%252B%252528GPR40%252529%252BReceptor%252BAgonists%252BBased%252Bon%252BPhenylpropanoic%252BAcid%252Bas%252BHypoglycemic%252BAgents%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%26aulast%3DKuranov%26aufirst%3DS.%2BO.%26date%3D2020%26date%3D2020%26volume%3D46%26issue%3D6%26spage%3D972%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiwen  Ye</span>, <span class="hlFld-ContribAuthor ">Chunxia  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Zou</span>, <span class="hlFld-ContribAuthor ">Yan  Cai</span>, <span class="hlFld-ContribAuthor ">Bin  Chen</span>, <span class="hlFld-ContribAuthor ">Yuxing  Zou</span>, <span class="hlFld-ContribAuthor ">Jiaxian  Mo</span>, <span class="hlFld-ContribAuthor ">Ting  Han</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Qianqian  Qiu</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel potent GPR40 agonists containing imidazo[1,2-a]pyridine core as antidiabetic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (13)
                                     , 115574. <a href="https://doi.org/10.1016/j.bmc.2020.115574" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115574%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bpotent%252BGPR40%252Bagonists%252Bcontaining%252Bimidazo%25255B1%25252C2-a%25255Dpyridine%252Bcore%252Bas%252Bantidiabetic%252Bagents%26aulast%3DYe%26aufirst%3DZhiwen%26date%3D2020%26volume%3D28%26issue%3D13%26spage%3D115574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Ren</span>, <span class="hlFld-ContribAuthor ">Xuekun  Wang</span>, <span class="hlFld-ContribAuthor ">Zongtao  Zhou</span>, <span class="hlFld-ContribAuthor ">Lijun  Hu</span>, <span class="hlFld-ContribAuthor ">Liming  Deng</span>, <span class="hlFld-ContribAuthor ">Li  Guan</span>, <span class="hlFld-ContribAuthor ">Qianqian  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of HWL-088: A highly potent FFA1/GPR40 agonist bearing a phenoxyacetic acid scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103209. <a href="https://doi.org/10.1016/j.bioorg.2019.103209" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103209%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHWL-088%25253A%252BA%252Bhighly%252Bpotent%252BFFA1%25252FGPR40%252Bagonist%252Bbearing%252Ba%252Bphenoxyacetic%252Bacid%252Bscaffold%26aulast%3DLi%26aufirst%3DZheng%26date%3D2019%26volume%3D92%26spage%3D103209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Chunxia  Liu</span>, <span class="hlFld-ContribAuthor ">Jianyong  Yang</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhiwen  Ye</span>, <span class="hlFld-ContribAuthor ">Dazhi  Feng</span>, <span class="hlFld-ContribAuthor ">Na  Yue</span>, <span class="hlFld-ContribAuthor ">Jiayi  Tong</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 608-622. <a href="https://doi.org/10.1016/j.ejmech.2019.06.087" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.087%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BFFA1%25252FGPR40%252Bagonists%25253A%252BNew%252Bbreakthrough%252Bin%252Ban%252Bold%252Bscaffold%26aulast%3DLi%26aufirst%3DZheng%26date%3D2019%26volume%3D179%26spage%3D608%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Guo</span>, <span class="hlFld-ContribAuthor ">Shimeng  Guo</span>, <span class="hlFld-ContribAuthor ">Jing  Huang</span>, <span class="hlFld-ContribAuthor ">Jingya  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Chen</span>, <span class="hlFld-ContribAuthor ">Xianli  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin  Xie</span>, <span class="hlFld-ContribAuthor ">Yushe  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (22)
                                     , 5780-5791. <a href="https://doi.org/10.1016/j.bmc.2018.10.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.10.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.10.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Boptimization%252Bof%252B2%25252C3-dihydrobenzo%25255Bb%25255D%25255B1%25252C4%25255Ddioxine%252Bpropanoic%252Bacids%252Bas%252Bnovel%252BGPR40%252Bagonists%252Bwith%252Bimproved%252Bpharmacokinetic%252Band%252Bsafety%252Bprofiles%26aulast%3DGuo%26aufirst%3DBin%26date%3D2018%26volume%3D26%26issue%3D22%26spage%3D5780%26epage%3D5791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaozhu  Sun</span>, <span class="hlFld-ContribAuthor ">Tian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xuan  Pan</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Yi  Huan</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhufang  Shen</span>, <span class="hlFld-ContribAuthor ">Zhanzhu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of a series of novel GPR40 agonists containing nitrogen heterocyclic rings. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (18)
                                     , 3050-3056. <a href="https://doi.org/10.1016/j.bmcl.2018.07.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.07.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.07.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.07.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252BGPR40%252Bagonists%252Bcontaining%252Bnitrogen%252Bheterocyclic%252Brings%26aulast%3DSun%26aufirst%3DZhaozhu%26date%3D2018%26volume%3D28%26issue%3D18%26spage%3D3050%26epage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chinedum  Eleazu</span>, <span class="hlFld-ContribAuthor ">Ayogu  Charles</span>, <span class="hlFld-ContribAuthor ">Kate  Eleazu</span>, <span class="hlFld-ContribAuthor ">Ngozi  Achi</span>. </span><span class="cited-content_cbyCitation_article-title">Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2018,</strong> <em>289 </em>, 32-39. <a href="https://doi.org/10.1016/j.cbi.2018.04.026" title="DOI URL">https://doi.org/10.1016/j.cbi.2018.04.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2018.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2018.04.026%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DFree%252Bfatty%252Bacid%252Breceptor%252B1%252Bas%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bfor%252Btype%252B2%252Bdiabetes%252Bmellitus-current%252Bstatus%26aulast%3DEleazu%26aufirst%3DChinedum%26date%3D2018%26volume%3D289%26spage%3D32%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariateresa  Badolato</span>, <span class="hlFld-ContribAuthor ">Gabriele  Carullo</span>, <span class="hlFld-ContribAuthor ">Mariarita  Perri</span>, <span class="hlFld-ContribAuthor ">Erika  Cione</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>, <span class="hlFld-ContribAuthor ">Maria Luisa  Di Gioia</span>, <span class="hlFld-ContribAuthor ">Antonella  Brizzi</span>, <span class="hlFld-ContribAuthor ">Maria Cristina  Caroleo</span>, <span class="hlFld-ContribAuthor ">Francesca  Aiello</span>. </span><span class="cited-content_cbyCitation_article-title">Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (16)
                                     , 1873-1885. <a href="https://doi.org/10.4155/fmc-2017-0113" title="DOI URL">https://doi.org/10.4155/fmc-2017-0113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0113%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DQuercetin%25252Foleic%252Bacid-based%252BG-protein-coupled%252Breceptor%252B40%2525C2%2525A0ligands%252Bas%252Bnew%252Binsulin%252Bsecretion%252Bmodulators%26aulast%3DBadolato%26aufirst%3DMariateresa%26date%3D2017%26volume%3D9%26issue%3D16%26spage%3D1873%26epage%3D1885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative GPR40 partial agonists and full agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Typical pharmacophore model for GPR40 agonist and our design of new structure GPR40 full agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural exploration of the new structure GPR40 full agonists starting from a model compound <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, NaI, (chloromethyl) (methyl)sulfane, DMF, 0 °C–rt, 72%; (b) SO<sub>2</sub>Cl<sub>2</sub>, DCM, −78 °C; (c) NaN<sub>3</sub>, DMSO, rt; (d) pent-4-ynoic acid, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <sup><i>t</i></sup>BuOH/H<sub>2</sub>O = 1:1, MW. 80 °C, 75%; (e) 2,6-dimethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O = 3:1, 100 °C; (f) 3-bromoprop-1-yne, K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 78%; (g) methyl 3-azidopropanoate, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <sup><i>t</i></sup>BuOH/H<sub>2</sub>O = 1:1, MW 80 °C, 84% for <b>12</b>, 28% for <b>15</b>; (h) PBr<sub>3</sub>, DCM, 0 °C (i) BBr<sub>3</sub>, DCM, rt, 94%; (j) Cs<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 73%; (k) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt, 78%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, 3,4,7,8-tetramethyl-1,10-phenanthroline, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C; (b) 2,6-dimethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O = 3:1, 100 °C; (c) <sup><i>n</i></sup>BuLi, DMF, THF, −78 °C; (d) methyl (triphenylphosphoranylidene) acetate, DMF, 60 °C; (e) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH/THF = 1:2, rt; (f) LiOH·H<sub>2</sub>O, THF/MeOH/H<sub>2</sub>O = 2:2:1, rt; (g) POCl<sub>3</sub>, DMF, 100 °C, 43%; (h) NaBH<sub>4</sub>, MeOH/toluene = 1:1, 0 °C–rt, 72%; (i) SOCl<sub>2</sub>, DCM, 0–50 °C; (j) 2′,6′-dimethylbiphenyl-3-ol, NaI, K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 34% yield over three steps of i, j, and f; (k) I<sub>2</sub>, PhI(O<sub>2</sub>CCF<sub>3</sub>)<sub>2</sub>, CCl<sub>4</sub>, rt, 62%; (l) Na<sub>2</sub>PdCl<sub>4</sub>, CuI, 2-(di-<i>tert</i>-butylphosphino)-1-phenylindole, TMEDA/H<sub>2</sub>O = 9:1, 80 °C, 65%; (m) triethoxymethane, NH<sub>4</sub>Cl, EtOH, 60 °C, 90%; (n) 2,2-dimethyl-1,3-dioxane-4,6-dione, DMAP, THF, rt, 64%; (o) 1-propynylmagnesium bromide, THF, −1 0°C–rt; (p) HCl (aq), rt; (q) DMF/H<sub>2</sub>O = 10:1, 90 °C, 52% over three steps; (r) spiro[indene-1,4′-piperidine], NaB(OAc)<sub>3</sub>H, HOAc, DCE, rt, 25%; (s) thiazolidine-2,4-dione, piperidine, EtOH, 120 °C, 48%; (t) Mg, MeOH, rt, 36%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, DMF, THF, −78 °C, 48%; (b) ethyl (triphenylphosphoranylidene) acetate, DMF, 60 °C, 82%; (c) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH/THF = 1:2, rt, 73%; (d) R-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O = 3:1, 100 °C.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, DCE, 90 °C, 59%; (b) methyl (triphenylphoranylidene)acetate, THF/H<sub>2</sub>O = 2:1, rt, 72%; (c) NaClO<sub>2</sub>, NaH<sub>2</sub>PO<sub>4</sub>, 2-methyl-2-butene, <sup><i>t</i></sup>BuOH, 77%; (d) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, THF/MeOH = 2:1, rt, 83%; (e) EDCI, HOBt, MeOH, DIEA, DCM; (f) PIFA, I<sub>2</sub>, CCl<sub>4</sub>, rt; (g) <b>13</b>, CuI, Me<sub>4</sub>Phen, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 80 °C; (h) 0.5 M NaOH in MeOH/THF/H<sub>2</sub>O = 2:2:1, rt.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Meldrum’s acid, DMAP, THF, 45 °C, 72%; (b) RMgX, THF, −10 °C; (c) DMF/H<sub>2</sub>O = 10:1, 90 °C; (d) KCN, MeOH, rt, 89%; (e) FeCl<sub>3</sub>·6H<sub>2</sub>O, MeNO<sub>2</sub>/DMF = 3:2, H<sub>2</sub>O, MW 110 °C, 46%; (f) MeOH, EDCI, HOBt, Et<sub>3</sub>N, DCM, rt, 75%; (g) TMSN<sub>3</sub>, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <sup><i>t</i></sup>BuOH/H<sub>2</sub>O = 1:1, MW 80 °C, 39%; (h) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt; (i) (2-ethoxy-2-oxoethyl)zinc(II) bromide, THF, 0 °C, 52%; (j) RI, Ag<sub>2</sub>O, toluene, 80 °C; (k) MeNO<sub>2</sub>, NH<sub>4</sub>OAc, THF, 70 °C, 44%; (l) (<i>S</i>)-3-acetyl-4-benzyloxazolidin-2-one, TiCl<sub>4</sub>, DIEA, DCM, −78 °C, 40%; (m) vinyl bromide, (Boc)<sub>2</sub>O, DMAP, Et<sub>3</sub>N, THF, rt, 46%; (n) LiOH·H<sub>2</sub>O, H<sub>2</sub>O<sub>2</sub>, THF/H<sub>2</sub>O, 0 °C, 25%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>n</i></sup>BuLi, CO<sub>2</sub> (g), THF, −78 °C, 84%; (b) CDI, THF (c) potassium ethyl malonate, MgCl<sub>2</sub>, Et<sub>3</sub>N, MeCN, 52% over two steps; (d) HCO<sub>2</sub>H, Et<sub>3</sub>N, RuCl[(<i>R</i>,<i>R</i>)-Tsdpen](mesitylene), 38 °C, 90%, 98% ee; (e) EtI, Ag<sub>2</sub>O, toluene, 80 °C; (f) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>n</i></sup>BuLi, B(O<sup><i>i</i></sup>Pr)<sub>3</sub>, THF, −78 °C, 54%; (b) 4-bromo-3,5-dimethylphenol, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O = 3:1, 100 °C, 68%; (c) TBSCl, Et<sub>3</sub>N, DCM, rt, 89%; (d) <sup><i>n</i></sup>BuLi, DMF, THF, −78 °C, 77%; (e) Meldrum’s acid, DMAP, THF, 45 °C, 86%; (f) 1-propynyl magnesium bromide, THF, −10 °C; (g) DMF/H<sub>2</sub>O = 10:1, 90 °C; (h) MeOH, EDCI, HOBt, Et<sub>3</sub>N, DCM, rt 64% over three steps; (i) TBAF, THF, rt, 98%; (j) 3-(methylsulfonyl)propyl 4-methylbenzenesulfonate, K<sub>3</sub>PO<sub>4</sub>, DMF, 90 °C, 88%; (k) 3-(chloromethyl)-3-methyloxetane, KI, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 69%; (l) 1-methylpiperidin-4-ol, DEAD, PPh<sub>3</sub>, THF, 0 °C–rt, 54%; (m) LiOH·H<sub>2</sub>O, MeOH/THF/H<sub>2</sub>O = 2:2:1, rt; (n) (<i>S</i>)-2-methylbutan-1-ol, EDCI, HOBt, Et<sub>3</sub>N, DCM, rt, 56%; (o) resolution on chiral AD-H column; (p) 0.25 M NaOH in MeOH/THF/H<sub>2</sub>O = 2:2:1, rt.</p></p></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plasmid titration experiments. (A) Effect of DHA, <b>1</b>, and (<i>R</i>)-<b>7k</b> in HEK293T cells transfected with 5 μg of GPR40 expression plasmid. (B) Effect of DHA, <b>1</b>, and (<i>R</i>)-<b>7k</b> in HEK293T cells transfected with 0.05 μg of GPR40 expression plasmid. Data are expressed as mean values with standard deviation from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Activity of compounds <b>5d</b>, (<i>R</i>)-<b>7g</b>, (<i>R</i>)-<b>7k</b>, and <b>1</b> in glucose-stimulated insulin secretion (GSIS) in MIN6 cell line. (B) The dose–GSIS activity relationship of <b>1</b> and (<i>R</i>)-<b>7k</b> at different concentrations of glucose; *, <i>p</i> < 0.05; **, <i>p</i> < 0.01, compared to DMSO; #, <i>p</i> < 0.05, compared to 0.3 μM <b>1</b> in the presence of 25 mM glucose. Data are expressed as mean values with standard deviation from four independent experiments (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo efficacy of (<i>R</i>)-<b>7k</b> during an OGTT in ICR mice. (A) Time-dependent changes of glucose levels. (B) Area under the curve (AUC<sub>0–120min</sub>) of plasma glucose. **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001, compared to Vehicle. Data are expressed as mean values with standard deviation from ten independent experiments (<i>n</i> = 10).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/medium/jm-2016-01357z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitory effects of (<i>R</i>)-<b>7k</b> on hepatobiliary transporters. (A) Effect on hepatobiliary transporters. (B) Effect on BEI of d8-TCA. Data are expressed as mean values with standard deviation from three independent experiments (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01357/20170407/images/large/jm-2016-01357z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01357&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukusumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uejima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">422</span><span class="NLM_x"> (</span><span class="NLM_issue">6928</span><span class="NLM_x">) </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span><span class="refDoi"> DOI: 10.1038/nature01478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1038%2Fnature01478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=422&publication_year=2003&pages=173-176&issue=6928&author=Y.+Itohauthor=Y.+Kawamataauthor=M.+Haradaauthor=M.+Kobayashiauthor=R.+Fujiiauthor=S.+Fukusumiauthor=K.+Ogiauthor=M.+Hosoyaauthor=Y.+Tanakaauthor=H.+Uejimaauthor=H.+Tanakaauthor=M.+Maruyamaauthor=R.+Satohauthor=S.+Okuboauthor=H.+Kizawaauthor=H.+Komatsuauthor=F.+Matsumuraauthor=Y.+Noguchiauthor=T.+Shinoharaauthor=S.+Hinumaauthor=Y.+Fujisawaauthor=M.+Fujino&title=Free+fatty+acids+regulate+insulin+secretion+from+pancreatic+beta+cells+through+GPR40&doi=10.1038%2Fnature01478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01478%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DFukusumi%26aufirst%3DS.%26aulast%3DOgi%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DUejima%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DSatoh%26aufirst%3DR.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DKizawa%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DF.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DY.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DFree%2520fatty%2520acids%2520regulate%2520insulin%2520secretion%2520from%2520pancreatic%2520beta%2520cells%2520through%2520GPR40%26jtitle%3DNature%26date%3D2003%26volume%3D422%26issue%3D6928%26spage%3D173%26epage%3D176%26doi%3D10.1038%2Fnature01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Edfalk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steneberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, H.</span><span> </span><span class="NLM_article-title">GPR40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2287</span><span class="refDoi"> DOI: 10.2337/db08-0307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.2337%2Fdb08-0307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=2280-2287&issue=9&author=S.+Edfalkauthor=P.+Stenebergauthor=H.+Edlund&title=GPR40+is+expressed+in+enteroendocrine+cells+and+mediates+free+fatty+acid+stimulation+of+incretin+secretion&doi=10.2337%2Fdb08-0307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdb08-0307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb08-0307%26sid%3Dliteratum%253Aachs%26aulast%3DEdfalk%26aufirst%3DS.%26aulast%3DSteneberg%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DH.%26atitle%3DGPR40%2520is%2520expressed%2520in%2520enteroendocrine%2520cells%2520and%2520mediates%2520free%2520fatty%2520acid%2520stimulation%2520of%2520incretin%2520secretion%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26issue%3D9%26spage%3D2280%26epage%3D2287%26doi%3D10.2337%2Fdb08-0307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y.-Q.</span><span> </span><span class="NLM_article-title">GPR40 agonists for the treatment of type 2 diabetes mellitus: the biological characteristics and the chemical space</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">5603</span><span class="NLM_x">–</span> <span class="NLM_lpage">5612</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.bmcl.2016.10.074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5603-5612&issue=23&author=C.+Chenauthor=H.+Liauthor=Y.-Q.+Long&title=GPR40+agonists+for+the+treatment+of+type+2+diabetes+mellitus%3A+the+biological+characteristics+and+the+chemical+space&doi=10.1016%2Fj.bmcl.2016.10.074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLong%26aufirst%3DY.-Q.%26atitle%3DGPR40%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%253A%2520the%2520biological%2520characteristics%2520and%2520the%2520chemical%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5603%26epage%3D5612%26doi%3D10.1016%2Fj.bmcl.2016.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. Q.</span><span> </span><span class="NLM_article-title">Advances in small-molecule GPR40 agonists for treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Youji Huaxue</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span><span class="refDoi"> DOI: 10.6023/cjoc201511011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.6023%2Fcjoc201511011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFGrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=736-743&issue=4&author=H.+Liauthor=Y.+Q.+Long&title=Advances+in+small-molecule+GPR40+agonists+for+treatment+of+type+2+diabetes+mellitus&doi=10.6023%2Fcjoc201511011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in small-molecule GPR40 agonists for treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Li, He; Long, Yaqiu</div><div class="citationInfo"><span class="NLM_cas:title">Youji Huaxue</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">736-743</span>CODEN:
                <span class="NLM_cas:coden">YCHHDX</span>;
        ISSN:<span class="NLM_cas:issn">0253-2786</span>.
    
            (<span class="NLM_cas:orgname">Youji Huaxue Bianjibu</span>)
        </div><div class="casAbstract">A review.  Currently, the majority of the chemotherapy for type 2 diabetes mellitus (T2DM) functions through glycemic control by administration of oral or injectable hypoglycemic drugs.  Though a range of anti-diabetic drugs with different modes of action has been launched, there still is a significant need for development of effective and highly safe anti-diabetic agents for the increasing diabetic population.  GPR40 belongs to the GPCR family and the activation of GPR40 can amplify glucose-stimulated insulin secretion (GSIS).  Due to the advantage of minimizing the hypoglycemia risk, GPR40 has drawn more and more attention and emerged as a promising new target for T2DM treatment.  Therefore, the recent progress on the structural optimization and further development of small mol. GPR40 agonists as novel treatment for T2DM is reviewed, focusing on those under clin. trials or at preclin. stage.  A variety of small mol. GPR40 agonists are summarized from the literatures and patents based on the pharmacophore model, including the crit. phenylpropanoic acid core, the hydrophobic terminus and the linker.  The structural features and advantages of different sources of GPR40 agonists are analyzed and highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDtlDXl6JG1rVg90H21EOLACvtfcHk0liQwjDl3JSC5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFGrtr4%253D&md5=c51646ead4d989fda7f2fa369db175a4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.6023%2Fcjoc201511011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6023%252Fcjoc201511011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DAdvances%2520in%2520small-molecule%2520GPR40%2520agonists%2520for%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DYouji%2520Huaxue%26date%3D2016%26volume%3D36%26issue%3D4%26spage%3D736%26epage%3D743%26doi%3D10.6023%2Fcjoc201511011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Defossa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, M.</span><span> </span><span class="NLM_article-title">Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2991</span><span class="NLM_x">–</span> <span class="NLM_lpage">3000</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.bmcl.2014.05.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2991-3000&issue=14&author=E.+Defossaauthor=M.+Wagner&title=Recent+developments+in+the+discovery+of+FFA1+receptor+agonists+as+novel+oral+treatment+for+type+2+diabetes+mellitus&doi=10.1016%2Fj.bmcl.2014.05.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DDefossa%26aufirst%3DE.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DRecent%2520developments%2520in%2520the%2520discovery%2520of%2520FFA1%2520receptor%2520agonists%2520as%2520novel%2520oral%2520treatment%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D14%26spage%3D2991%26epage%3D3000%26doi%3D10.1016%2Fj.bmcl.2014.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Discovery of TAK-875: a potent, selective, and orally bioavailable GPR40 agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1021/ml1000855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=290-294&issue=6&author=N.+Negoroauthor=S.+Sasakiauthor=S.+Mikamiauthor=M.+Itoauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=R.+Itoauthor=A.+Haradaauthor=K.+Takeuchiauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=T.+Odaniauthor=N.+Kanzakiauthor=M.+Funamiauthor=T.+Tanakaauthor=A.+Kogameauthor=S.+Matsunagaauthor=T.+Yasumaauthor=Y.+Momose&title=Discovery+of+TAK-875%3A+a+potent%2C+selective%2C+and+orally+bioavailable+GPR40+agonist&doi=10.1021%2Fml1000855"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fml1000855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000855%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKogame%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520TAK-875%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520GPR40%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26issue%3D6%26spage%3D290%26epage%3D294%26doi%3D10.1021%2Fml1000855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yabuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda-Nagasumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span> </span><span class="NLM_article-title">A novel antidiabetic drug, Fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e76280</span><span class="refDoi"> DOI: 10.1371/journal.pone.0076280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1371%2Fjournal.pone.0076280" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76280&issue=10&author=C.+Yabukiauthor=H.+Komatsuauthor=Y.+Tsujihataauthor=R.+Maedaauthor=R.+Itoauthor=K.+Matsuda-Nagasumiauthor=K.+Sakumaauthor=K.+Miyawakiauthor=N.+Kikuchiauthor=K.+Takeuchiauthor=Y.+Habataauthor=M.+Mori&title=A+novel+antidiabetic+drug%2C+Fasiglifam%2FTAK-875%2C+acts+as+an+ago-allosteric+modulator+of+FFAR1&doi=10.1371%2Fjournal.pone.0076280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0076280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0076280%26sid%3Dliteratum%253Aachs%26aulast%3DYabuki%26aufirst%3DC.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DR.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DMatsuda-Nagasumi%26aufirst%3DK.%26aulast%3DSakuma%26aufirst%3DK.%26aulast%3DMiyawaki%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DHabata%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26atitle%3DA%2520novel%2520antidiabetic%2520drug%252C%2520Fasiglifam%252FTAK-875%252C%2520acts%2520as%2520an%2520ago-allosteric%2520modulator%2520of%2520FFAR1%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D10%26spage%3De76280%26doi%3D10.1371%2Fjournal.pone.0076280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. Y. N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reagan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span> </span><span class="NLM_article-title">AMG 837: A novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">e27270</span><span class="refDoi"> DOI: 10.1371/journal.pone.0027270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1371%2Fjournal.pone.0027270" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27270&issue=11&author=D.+C.+H.+Linauthor=J.+Zhangauthor=R.+Zhuangauthor=F.+Liauthor=K.+Nguyenauthor=M.+Chenauthor=T.+Tranauthor=E.+Lopezauthor=J.+Y.+L.+Luauthor=X.+Y.+N.+N.+Liauthor=L.+Tangauthor=G.+R.+Tonnauthor=G.+Swaminathauthor=J.+D.+Reaganauthor=J.+L.+Chenauthor=H.+Tianauthor=Y.+J.+Linauthor=J.+B.+Houzeauthor=J.+Luo&title=AMG+837%3A+A+novel+GPR40%2FFFA1+agonist+that+enhances+insulin+secretion+and+lowers+glucose+levels+in+rodents&doi=10.1371%2Fjournal.pone.0027270"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0027270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0027270%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DJ.%2BY.%2BL.%26aulast%3DLi%26aufirst%3DX.%2BY.%2BN.%2BN.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DReagan%26aufirst%3DJ.%2BD.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.%2BJ.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DLuo%26aufirst%3DJ.%26atitle%3DAMG%2520837%253A%2520A%2520novel%2520GPR40%252FFFA1%2520agonist%2520that%2520enhances%2520insulin%2520secretion%2520and%2520lowers%2520glucose%2520levels%2520in%2520rodents%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D11%26spage%3De27270%26doi%3D10.1371%2Fjournal.pone.0027270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span> </span><span class="NLM_article-title">Discovery of AM-1638: a potent and orally bioavailable GPR40/FFA1 full agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1021/ml300133f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300133f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=726-730&issue=9&author=S.+P.+Brownauthor=P.+J.+Dransfieldauthor=M.+Vimolratanaauthor=X.+Y.+Jiaoauthor=L.+Zhuauthor=V.+Pattaropongauthor=Y.+Sunauthor=J.+Q.+Liuauthor=J.+Luoauthor=J.+Zhangauthor=S.+Wongauthor=R.+Zhuangauthor=Q.+Guoauthor=F.+Liauthor=J.+C.+Medinaauthor=G.+Swaminathauthor=D.+C.+H.+Linauthor=J.+B.+Houze&title=Discovery+of+AM-1638%3A+a+potent+and+orally+bioavailable+GPR40%2FFFA1+full+agonist&doi=10.1021%2Fml300133f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml300133f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300133f%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520AM-1638%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520GPR40%252FFFA1%2520full%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D9%26spage%3D726%26epage%3D730%26doi%3D10.1021%2Fml300133f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasparian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent GPR40 full agonists containing tricyclic spirocycles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1021/ml300427u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300427u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=551-555&issue=6&author=Y.+C.+Wangauthor=J.+W.+Liuauthor=P.+J.+Dransfieldauthor=L.+S.+Zhuauthor=Z.+Y.+Wangauthor=X.+H.+Duauthor=X.+Y.+Jiaoauthor=Y.+L.+Suauthor=A.+R.+Liauthor=S.+P.+Brownauthor=A.+Kasparianauthor=M.+Vimolratanaauthor=M.+Yuauthor=V.+Pattaropongauthor=J.+B.+Houzeauthor=G.+Swaminathauthor=T.+Tranauthor=K.+Nguyenauthor=Q.+Guoauthor=J.+Zhangauthor=R.+Zhuangauthor=F.+Liauthor=L.+Miaoauthor=M.+D.+Bartbergerauthor=T.+L.+Correllauthor=D.+Chowauthor=S.+Wongauthor=J.+Luoauthor=D.+C.+H.+Linauthor=J.+C.+Medina&title=Discovery+and+optimization+of+potent+GPR40+full+agonists+containing+tricyclic+spirocycles&doi=10.1021%2Fml300427u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles</span></div><div class="casAuthors">Wang, Yingcai; Liu, Jiwen; Dransfield, Paul J.; Zhu, Liusheng; Wang, Zhongyu; Du, Xiaohui; Jiao, Xianyun; Su, Yongli; Li, An-rong; Brown, Sean P.; Kasparian, Annie; Vimolratana, Marc; Yu, Ming; Pattaropong, Vatee; Houze, Jonathan B.; Swaminath, Gayathri; Tran, Thanhvien; Nguyen, Khanh; Guo, Qi; Zhang, Jane; Zhuang, Run; Li, Frank; Miao, Lynn; Bartberger, Michael D.; Correll, Tiffany L.; Chow, David; Wong, Simon; Luo, Jian; Lin, Daniel C.-H.; Medina, Julio C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">551-555</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR40 (FFAR1 or FFA1) is a target of high interest being pursued to treat type II diabetes due to its unique mechanism leading to little risk of hypoglycemia.  The authors recently reported the discovery of AM-1638 (I), a potent full agonist of GPR40.  In this report, they present the discovery of GPR40 full agonists contg. conformationally constrained tricyclic spirocycles and their structure-activity relationships leading to more potent agonists such as AM-5262 (II) with improved rat PK profile and general selectivity profile.  AM-5262 enhanced glucose stimulated insulin secretion (mouse and human islets) and improved glucose homeostasis in vivo (OGTT in HF/STZ mice) when compared to AM-1638.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgX9JpdxT4OrVg90H21EOLACvtfcHk0liDUc3Wub6ZzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOktLY%253D&md5=7f4681a65e80ba0f45642f63c6a33b22</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml300427u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300427u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DZhu%26aufirst%3DL.%2BS.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DDu%26aufirst%3DX.%2BH.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DSu%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DA.%2BR.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DKasparian%26aufirst%3DA.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520GPR40%2520full%2520agonists%2520containing%2520tricyclic%2520spirocycles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D6%26spage%3D551%26epage%3D555%26doi%3D10.1021%2Fml300427u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.</span><span> </span><span class="NLM_article-title">A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e46300</span><span class="refDoi"> DOI: 10.1371/journal.pone.0046300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1371%2Fjournal.pone.0046300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e46300&issue=10&author=J.+Luoauthor=G.+Swaminathauthor=S.+P.+Brownauthor=J.+Zhangauthor=Q.+Guoauthor=M.+Chenauthor=K.+Nguyenauthor=T.+Tranauthor=L.+Miaoauthor=P.+J.+Dransfieldauthor=M.+Vimolratanaauthor=J.+B.+Houzeauthor=S.+Wongauthor=M.+Totevaauthor=B.+Shanauthor=F.+Liauthor=R.+Zhuangauthor=D.+C.+Lin&title=A+potent+class+of+GPR40+full+agonists+engages+the+enteroinsular+axis+to+promote+glucose+control+in+rodents&doi=10.1371%2Fjournal.pone.0046300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046300%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.%26atitle%3DA%2520potent%2520class%2520of%2520GPR40%2520full%2520agonists%2520engages%2520the%2520enteroinsular%2520axis%2520to%2520promote%2520glucose%2520control%2520in%2520rodents%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D10%26spage%3De46300%26doi%3D10.1371%2Fjournal.pone.0046300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hauge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestmar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husted, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinglass, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelstoft, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span> <span class="citation_source-journal">Mol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/j.molmet.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.molmet.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=25685685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=3-14&issue=1&author=M.+Haugeauthor=M.+A.+Vestmarauthor=A.+S.+Hustedauthor=J.+P.+Ekbergauthor=M.+J.+Wrightauthor=J.+Di+Salvoauthor=A.+B.+Weinglassauthor=M.+S.+Engelstoftauthor=A.+N.+Madsenauthor=M.+Luckmannauthor=M.+W.+Millerauthor=M.+E.+Trujilloauthor=T.+M.+Frimurerauthor=B.+Holstauthor=A.+D.+Howardauthor=T.+W.+Schwartz&title=GPR40+%28FFAR1%29+-+Combined+Gs+and+Gq+signaling+in+vitro+is+associated+with+robust+incretin+secretagogue+action+ex+vivo+and+in+vivo&doi=10.1016%2Fj.molmet.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span></div><div class="casAuthors">Hauge, Maria; Vestmar, Marie A.; Husted, Anna S.; Ekberg, Jeppe P.; Wright, Michael J.; Di Salvo, Jerry; Weinglass, Adam B.; Engelstoft, Maja S.; Madsen, Andreas N.; Luckmann, Michael; Miller, Michael W.; Trujillo, Maria E.; Frimurer, Thomas M.; Holst, Birgitte; Howard, Andrew D.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">GPR40 (FFAR1), a clin. proven anti-diabetes target, is a Gq-coupled receptor for long chain fatty acids (LCFA) stimulating insulin secretion directly and mediating a major part of the dietary triglyceride-induced secretion of the incretins GLP-1 and GIP.  In phase-II studies the GPR40 agonist TAK-875 decreased blood glucose but surprisingly without stimulating incretins.  Here we find that GPR40 can signal through not only Gq and IP3 but also Gs and cAMP when stimulated with certain agonists such as AM-1638 and AM-5262 in contrast to the endogenous LCFA ligands and agonists such as TAK-875 and AM-837, which only signal through Gq.  In competition binding against [3H]AM-1638 and [3H]L358 the Gq + Gs and the Gq-only agonists either competed for or showed pos. cooperativity by increasing the binding of the two different radio-ligands, in opposite ways.  Nevertheless, both the Gq-only and the Gq + Gs agonists all docked surprisingly well into the binding site for TAK-875 in the X-ray structure of GPR40.  In murine intestinal primary cell-cultures the endogenous LCFAs and the Gq-only agonists stimulated GLP-1 secretion with rather poor efficacy as compared with the high efficacy Gq + Gs GPR40 agonists and a prototype GPR119 agonist.  Similarly, in fasting both male and female mice the Gq + Gs agonists showed significantly higher efficacy than the Gq-only agonists in respect of increasing plasma GLP-1 and plasma GIP in a GPR40-dependent manner.  It is concluded that stimulation of GPR40 by endogenous LCFAs or by Gq-only synthetic agonists result in a rather limited incretin response, whereas Gq + Gs GPR40 agonists stimulate incretin secretion robustly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZyjcjTNd0QbVg90H21EOLACvtfcHk0lj3Q39V-7Tt3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN&md5=895136bef8c9542711e6daf5fa57219c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DHauge%26aufirst%3DM.%26aulast%3DVestmar%26aufirst%3DM.%2BA.%26aulast%3DHusted%26aufirst%3DA.%2BS.%26aulast%3DEkberg%26aufirst%3DJ.%2BP.%26aulast%3DWright%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DWeinglass%26aufirst%3DA.%2BB.%26aulast%3DEngelstoft%26aufirst%3DM.%2BS.%26aulast%3DMadsen%26aufirst%3DA.%2BN.%26aulast%3DLuckmann%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DM.%2BW.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DGPR40%2520%2528FFAR1%2529%2520-%2520Combined%2520Gs%2520and%2520Gq%2520signaling%2520in%2520vitro%2520is%2520associated%2520with%2520robust%2520incretin%2520secretagogue%2520action%2520ex%2520vivo%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Metab.%26date%3D2015%26volume%3D4%26issue%3D1%26spage%3D3%26epage%3D14%26doi%3D10.1016%2Fj.molmet.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birdsall, N. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span> </span><span class="NLM_article-title">Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span><span class="refDoi"> DOI: 10.1124/mol.112.079640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1124%2Fmol.112.079640" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=843-859&issue=5&author=D.+C.+H.+Linauthor=Q.+Guoauthor=J.+Luoauthor=J.+N.+Zhangauthor=K.+Nguyenauthor=M.+Chenauthor=T.+Tranauthor=P.+J.+Dransfieldauthor=S.+P.+Brownauthor=J.+Houzeauthor=M.+Vimolratanaauthor=X.+Y.+Jiaoauthor=Y.+C.+Wangauthor=N.+J.+M.+Birdsallauthor=G.+Swaminath&title=Identification+and+pharmacological+characterization+of+multiple+allosteric+binding+sites+on+the+free+fatty+acid+1+receptor&doi=10.1124%2Fmol.112.079640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.079640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.079640%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BN.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DBirdsall%26aufirst%3DN.%2BJ.%2BM.%26aulast%3DSwaminath%26aufirst%3DG.%26atitle%3DIdentification%2520and%2520pharmacological%2520characterization%2520of%2520multiple%2520allosteric%2520binding%2520sites%2520on%2520the%2520free%2520fatty%2520acid%25201%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26issue%3D5%26spage%3D843%26epage%3D859%26doi%3D10.1124%2Fmol.112.079640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mikami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3756</span><span class="NLM_x">–</span> <span class="NLM_lpage">3776</span><span class="refDoi"> DOI: 10.1021/jm2016123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2016123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3756-3776&issue=8&author=S.+Mikamiauthor=S.+Kitamuraauthor=N.+Negoroauthor=S.+Sasakiauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=T.+Miyazakiauthor=R.+Itoauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=N.+Kanzakiauthor=M.+Funamiauthor=T.+Tanakaauthor=T.+Yasumaauthor=Y.+Momose&title=Discovery+of+phenylpropanoic+acid+derivatives+containing+polar+functionalities+as+potent+and+orally+bioavailable+G+protein-coupled+receptor+40+agonists+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm2016123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm2016123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016123%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520phenylpropanoic%2520acid%2520derivatives%2520containing%2520polar%2520functionalities%2520as%2520potent%2520and%2520orally%2520bioavailable%2520G%2520protein-coupled%2520receptor%252040%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D8%26spage%3D3756%26epage%3D3776%26doi%3D10.1021%2Fjm2016123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Du, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span> </span><span class="NLM_article-title">Improving the pharmacokinetics of GPR40/FFA1 full agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1021/ml4005123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4005123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=384-389&issue=4&author=X.+H.+Duauthor=P.+J.+Dransfieldauthor=D.+C.+H.+Linauthor=S.+Wongauthor=Y.+C.+Wangauthor=Z.+Y.+Wangauthor=T.+Kohnauthor=M.+Yuauthor=S.+P.+Brownauthor=M.+Vimolratanaauthor=L.+S.+Zhuauthor=A.+R.+Liauthor=Y.+L.+Suauthor=X.+Y.+Jiaoauthor=J.+W.+Liuauthor=G.+Swaminathauthor=T.+Tranauthor=J.+Luoauthor=R.+Zhuangauthor=J.+Zhangauthor=Q.+Guoauthor=F.+Liauthor=R.+Connorsauthor=J.+C.+Medinaauthor=J.+B.+Houze&title=Improving+the+pharmacokinetics+of+GPR40%2FFFA1+full+agonists&doi=10.1021%2Fml4005123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml4005123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4005123%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%2BH.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DKohn%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%2BS.%26aulast%3DLi%26aufirst%3DA.%2BR.%26aulast%3DSu%26aufirst%3DY.%2BL.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DImproving%2520the%2520pharmacokinetics%2520of%2520GPR40%252FFFA1%2520full%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D4%26spage%3D384%26epage%3D389%26doi%3D10.1021%2Fml4005123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tikhonova, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sum, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaka, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershengorn, M. C.</span><span> </span><span class="NLM_article-title">Bidirectional, iterative approach to the structural delineation of the functional ″chemoprint″ in GPR40 for agonist recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2981</span><span class="NLM_x">–</span> <span class="NLM_lpage">2989</span><span class="refDoi"> DOI: 10.1021/jm0614782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0614782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2981-2989&issue=13&author=I.+G.+Tikhonovaauthor=C.+S.+Sumauthor=S.+Neumannauthor=C.+J.+Thomasauthor=B.+M.+Raakaauthor=S.+Costanziauthor=M.+C.+Gershengorn&title=Bidirectional%2C+iterative+approach+to+the+structural+delineation+of+the+functional+%E2%80%B3chemoprint%E2%80%B3+in+GPR40+for+agonist+recognition&doi=10.1021%2Fjm0614782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0614782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0614782%26sid%3Dliteratum%253Aachs%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DSum%26aufirst%3DC.%2BS.%26aulast%3DNeumann%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DRaaka%26aufirst%3DB.%2BM.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DGershengorn%26aufirst%3DM.%2BC.%26atitle%3DBidirectional%252C%2520iterative%2520approach%2520to%2520the%2520structural%2520delineation%2520of%2520the%2520functional%2520%25E2%2580%25B3chemoprint%25E2%2580%25B3%2520in%2520GPR40%2520for%2520agonist%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D13%26spage%3D2981%26epage%3D2989%26doi%3D10.1021%2Fjm0614782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirozane, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kefala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruswitz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivetac, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span> </span><span class="NLM_article-title">High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x"> (</span><span class="NLM_issue">7516</span><span class="NLM_x">) </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1038/nature13494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1038%2Fnature13494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=124-127&issue=7516&author=A.+Srivastavaauthor=J.+Yanoauthor=Y.+Hirozaneauthor=G.+Kefalaauthor=F.+Gruswitzauthor=G.+Snellauthor=W.+Laneauthor=A.+Ivetacauthor=K.+Aertgeertsauthor=J.+Nguyenauthor=A.+Jenningsauthor=K.+Okada&title=High-resolution+structure+of+the+human+GPR40+receptor+bound+to+allosteric+agonist+TAK-875&doi=10.1038%2Fnature13494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature13494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13494%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DHirozane%26aufirst%3DY.%26aulast%3DKefala%26aufirst%3DG.%26aulast%3DGruswitz%26aufirst%3DF.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DHigh-resolution%2520structure%2520of%2520the%2520human%2520GPR40%2520receptor%2520bound%2520to%2520allosteric%2520agonist%2520TAK-875%26jtitle%3DNature%26date%3D2014%26volume%3D513%26issue%3D7516%26spage%3D124%26epage%3D127%26doi%3D10.1038%2Fnature13494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span> </span><span class="NLM_article-title">Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1080/13543784.2016.1189530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1080%2F13543784.2016.1189530" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=871-890&issue=8&author=Z.+Liauthor=Q.+Qiuauthor=X.+Gengauthor=J.+Yangauthor=W.+Huangauthor=H.+Qian&title=Free+fatty+acid+receptor+agonists+for+the+treatment+of+type+2+diabetes%3A+drugs+in+preclinical+to+phase+II+clinical+development&doi=10.1080%2F13543784.2016.1189530"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1080%2F13543784.2016.1189530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2016.1189530%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DH.%26atitle%3DFree%2520fatty%2520acid%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%253A%2520drugs%2520in%2520preclinical%2520to%2520phase%2520II%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26issue%3D8%26spage%3D871%26epage%3D890%26doi%3D10.1080%2F13543784.2016.1189530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Altman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtor, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An improved Cu-based catalyst system for the reactions of alcohols with aryl halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1021/jo702024p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo702024p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=284-286&issue=1&author=R.+A.+Altmanauthor=A.+Shafirauthor=A.+Choiauthor=P.+A.+Lichtorauthor=S.+L.+Buchwald&title=An+improved+Cu-based+catalyst+system+for+the+reactions+of+alcohols+with+aryl+halides&doi=10.1021%2Fjo702024p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo702024p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo702024p%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DR.%2BA.%26aulast%3DShafir%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DA.%26aulast%3DLichtor%26aufirst%3DP.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520improved%2520Cu-based%2520catalyst%2520system%2520for%2520the%2520reactions%2520of%2520alcohols%2520with%2520aryl%2520halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D1%26spage%3D284%26epage%3D286%26doi%3D10.1021%2Fjo702024p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mohite, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R. G.</span><span> </span><span class="NLM_article-title">A practical and convenient protocol for the synthesis of (E)-alpha,beta-unsaturated acids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">4564</span><span class="NLM_x">–</span> <span class="NLM_lpage">4567</span><span class="refDoi"> DOI: 10.1021/ol402130t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol402130t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=4564-4567&issue=17&author=A.+R.+Mohiteauthor=R.+G.+Bhat&title=A+practical+and+convenient+protocol+for+the+synthesis+of+%28E%29-alpha%2Cbeta-unsaturated+acids&doi=10.1021%2Fol402130t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fol402130t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol402130t%26sid%3Dliteratum%253Aachs%26aulast%3DMohite%26aufirst%3DA.%2BR.%26aulast%3DBhat%26aufirst%3DR.%2BG.%26atitle%3DA%2520practical%2520and%2520convenient%2520protocol%2520for%2520the%2520synthesis%2520of%2520%2528E%2529-alpha%252Cbeta-unsaturated%2520acids%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26issue%3D17%26spage%3D4564%26epage%3D4567%26doi%3D10.1021%2Fol402130t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J. B.</span><span> </span><span class="NLM_article-title">Optimization of GPR40 agonists for type 2 diabetes</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span><span class="refDoi"> DOI: 10.1021/ml400501x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400501x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=517-521&issue=5&author=J.+W.+Liuauthor=Y.+C.+Wangauthor=Z.+H.+Maauthor=M.+Schmittauthor=L.+S.+Zhuauthor=S.+P.+Brownauthor=P.+J.+Dransfieldauthor=Y.+Sunauthor=R.+Sharmaauthor=Q.+Guoauthor=R.+Zhuangauthor=J.+Zhangauthor=J.+Luoauthor=G.+R.+Tonnauthor=S.+Wongauthor=G.+Swaminathauthor=J.+C.+Medinaauthor=D.+C.+H.+Linauthor=J.+B.+Houze&title=Optimization+of+GPR40+agonists+for+type+2+diabetes&doi=10.1021%2Fml400501x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml400501x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400501x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DZ.%2BH.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%2BS.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26aulast%3DHouze%26aufirst%3DJ.%2BB.%26atitle%3DOptimization%2520of%2520GPR40%2520agonists%2520for%2520type%25202%2520diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D5%26spage%3D517%26epage%3D521%26doi%3D10.1021%2Fml400501x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fujii, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashiguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uematsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikariya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noyori, R.</span><span> </span><span class="NLM_article-title">Ruthenium(II)-catalyzed asymmetric transfer hydrogenation of ketones using a formic acid-triethylamine mixture</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2521</span><span class="NLM_x">–</span> <span class="NLM_lpage">2522</span><span class="refDoi"> DOI: 10.1021/ja954126l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja954126l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADyaK28Xht1Wnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=2521-2522&issue=10&author=A.+Fujiiauthor=S.+Hashiguchiauthor=N.+Uematsuauthor=T.+Ikariyaauthor=R.+Noyori&title=Ruthenium%28II%29-catalyzed+asymmetric+transfer+hydrogenation+of+ketones+using+a+formic+acid-triethylamine+mixture&doi=10.1021%2Fja954126l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation of Ketones Using a Formic Acid-Triethylamine Mixture</span></div><div class="casAuthors">Fujii, Akio; Hashiguchi, Shohei; Uematsu, Nobuyuki; Ikariya, Takao; Noyori, Ryoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2521-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(R)-RuCl[(1S,2S)-p-CH3C6H4SO2NCHPhCHPhNH2](η6-mesitylene) or the enantiomer efficiently catalyzes asym. redn. of prochiral ketones in a 5:2 formic acid-NEt3 azeotropic mixt. with a substrate:catalyst molar ratio of 200-1000 to give the corresponding secondary alcs. with a high enantiomeric purity.  This transfer hydrogenation can be characterized by irreversibility, which contrasts with the conventional reaction that uses iso-PrOH as a H donor.  The reaction proceeds with truly kinetic enantioface discrimination to completion with a substrate concn. ≤2-10 M.  A variety of arom. ketones including p-methoxyacetophenone and 2,3-benzo-2-cycloalkenones are usable as substrates.  The redn. occurs preferentially at a keto function without affecting an olefinic linkage, ester, furan ring, sulfide and sulfone group, aryl chloride and cyanide, thiophene and quinoline ring.  The utility was demonstrated by enantioselective synthesis of some chiral alcs. which serve as key intermediates for biol. significant compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJdf6_6eL1kbVg90H21EOLACvtfcHk0lgbNxpeGvDScA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1Wnu78%253D&md5=0d47b75e8884d1695fc7158776b4e622</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja954126l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja954126l%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DA.%26aulast%3DHashiguchi%26aufirst%3DS.%26aulast%3DUematsu%26aufirst%3DN.%26aulast%3DIkariya%26aufirst%3DT.%26aulast%3DNoyori%26aufirst%3DR.%26atitle%3DRuthenium%2528II%2529-catalyzed%2520asymmetric%2520transfer%2520hydrogenation%2520of%2520ketones%2520using%2520a%2520formic%2520acid-triethylamine%2520mixture%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26issue%3D10%26spage%3D2521%26epage%3D2522%26doi%3D10.1021%2Fja954126l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1378</span><span class="refDoi"> DOI: 10.1021/jm101405t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101405t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1365-1378&issue=5&author=S.+Sasakiauthor=S.+Kitamuraauthor=N.+Negoroauthor=M.+Suzukiauthor=Y.+Tsujihataauthor=N.+Suzukiauthor=T.+Santouauthor=N.+Kanzakiauthor=M.+Haradaauthor=Y.+Tanakaauthor=M.+Kobayashiauthor=N.+Tadaauthor=M.+Funamiauthor=T.+Tanakaauthor=Y.+Yamamotoauthor=K.+Fukatsuauthor=T.+Yasumaauthor=Y.+Momose&title=Design%2C+synthesis%2C+and+biological+activity+of+potent+and+orally+available+G+protein-coupled+receptor+40+agonists&doi=10.1021%2Fjm101405t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm101405t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101405t%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520potent%2520and%2520orally%2520available%2520G%2520protein-coupled%2520receptor%252040%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D5%26spage%3D1365%26epage%3D1378%26doi%3D10.1021%2Fjm101405t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1538</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span><span class="refDoi"> DOI: 10.1021/jm2012968</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2012968" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1538-1552&issue=4&author=N.+Negoroauthor=S.+Sasakiauthor=M.+Itoauthor=S.+Kitamuraauthor=Y.+Tsujihataauthor=R.+Itoauthor=M.+Suzukiauthor=K.+Takeuchiauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=T.+Odaniauthor=N.+Kanzakiauthor=M.+Funamiauthor=T.+Tanakaauthor=T.+Yasumaauthor=Y.+Momose&title=Identification+of+fused-ring+alkanoic+acids+with+improved+pharmacokinetic+profiles+that+act+as+G+protein-coupled+receptor+40%2Ffree+fatty+acid+receptor+1+agonists&doi=10.1021%2Fjm2012968"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2012968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2012968%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520fused-ring%2520alkanoic%2520acids%2520with%2520improved%2520pharmacokinetic%2520profiles%2520that%2520act%2520as%2520G%2520protein-coupled%2520receptor%252040%252Ffree%2520fatty%2520acid%2520receptor%25201%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D4%26spage%3D1538%26epage%3D1552%26doi%3D10.1021%2Fjm2012968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Negoro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujihata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, Y.</span><span> </span><span class="NLM_article-title">Optimization of (2,3-Dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3974</span><span class="refDoi"> DOI: 10.1021/jm300170m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300170m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3960-3974&issue=8&author=N.+Negoroauthor=S.+Sasakiauthor=S.+Mikamiauthor=M.+Itoauthor=Y.+Tsujihataauthor=R.+Itoauthor=M.+Suzukiauthor=K.+Takeuchiauthor=N.+Suzukiauthor=J.+Miyazakiauthor=T.+Santouauthor=T.+Odaniauthor=N.+Kanzakiauthor=M.+Funamiauthor=A.+Morohashiauthor=M.+Nonakaauthor=S.+Matsunagaauthor=T.+Yasumaauthor=Y.+Momose&title=Optimization+of+%282%2C3-Dihydro-1-benzofuran-3-yl%29acetic+acids%3A+discovery+of+a+non-free+fatty+acid-like%2C+highly+bioavailable+G+protein-coupled+receptor+40%2Ffree+fatty+acid+receptor+1+agonist+as+a+glucose-dependent+insulinotropic+agent&doi=10.1021%2Fjm300170m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300170m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300170m%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DTsujihata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DMorohashi%26aufirst%3DA.%26aulast%3DNonaka%26aufirst%3DM.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DY.%26atitle%3DOptimization%2520of%2520%25282%252C3-Dihydro-1-benzofuran-3-yl%2529acetic%2520acids%253A%2520discovery%2520of%2520a%2520non-free%2520fatty%2520acid-like%252C%2520highly%2520bioavailable%2520G%2520protein-coupled%2520receptor%252040%252Ffree%2520fatty%2520acid%2520receptor%25201%2520agonist%2520as%2520a%2520glucose-dependent%2520insulinotropic%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D8%26spage%3D3960%26epage%3D3974%26doi%3D10.1021%2Fjm300170m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due-Hansen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaibi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markussen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagesaether, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1021/jm301470a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301470a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=982-992&issue=3&author=E.+Christiansenauthor=M.+E.+Due-Hansenauthor=C.+Urbanauthor=M.+Grundmannauthor=J.+Schmidtauthor=S.+V.+F.+Hansenauthor=B.+D.+Hudsonauthor=M.+Zaibiauthor=S.+B.+Markussenauthor=E.+Hagesaetherauthor=G.+Milliganauthor=M.+A.+Cawthorneauthor=E.+Kostenisauthor=M.+U.+Kassackauthor=T.+Ulven&title=Discovery+of+a+potent+and+selective+free+fatty+acid+receptor+1+agonist+with+low+lipophilicity+and+high+oral+bioavailability&doi=10.1021%2Fjm301470a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301470a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301470a%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DS.%2BV.%2BF.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DZaibi%26aufirst%3DM.%26aulast%3DMarkussen%26aufirst%3DS.%2BB.%26aulast%3DHagesaether%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520free%2520fatty%2520acid%2520receptor%25201%2520agonist%2520with%2520low%2520lipophilicity%2520and%2520high%2520oral%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D3%26spage%3D982%26epage%3D992%26doi%3D10.1021%2Fjm301470a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hamdouchi, C.; Lineswala, J. P.; Maiti, P.; Haemdeochi, C.; Rinneseuwalra, J. P.; Lineswala, J.</span><span> </span><span class="NLM_article-title">New spiropiperidine compound useful in the treatment of diabetes in a mammal</span>. WO2011046851-A1, Apr 21,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Hamdouchi&author=J.+P.+Lineswala&author=P.+Maiti&author=C.+Haemdeochi&author=J.+P.+Rinneseuwalra&author=J.+Lineswala&title=New+spiropiperidine+compound+useful+in+the+treatment+of+diabetes+in+a+mammal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHamdouchi%26aufirst%3DC.%26atitle%3DNew%2520spiropiperidine%2520compound%2520useful%2520in%2520the%2520treatment%2520of%2520diabetes%2520in%2520a%2520mammal%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due-Hansen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagesaether, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">6691</span><span class="NLM_x">–</span> <span class="NLM_lpage">6703</span><span class="refDoi"> DOI: 10.1021/jm2005699</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2005699" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6691-6703&issue=19&author=E.+Christiansenauthor=C.+Urbanauthor=M.+Grundmannauthor=M.+E.+Due-Hansenauthor=E.+Hagesaetherauthor=J.+Schmidtauthor=L.+Pardoauthor=S.+Ullrichauthor=E.+Kostenisauthor=M.+Kassackauthor=T.+Ulven&title=Identification+of+a+potent+and+selective+free+fatty+acid+receptor+1+%28FFA1%2FGPR40%29+agonist+with+favorable+physicochemical+and+in+vitro+ADME+properties&doi=10.1021%2Fjm2005699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm2005699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2005699%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DHagesaether%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DUllrich%26aufirst%3DS.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKassack%26aufirst%3DM.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520free%2520fatty%2520acid%2520receptor%25201%2520%2528FFA1%252FGPR40%2529%2520agonist%2520with%2520favorable%2520physicochemical%2520and%2520in%2520vitro%2520ADME%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D19%26spage%3D6691%26epage%3D6703%26doi%3D10.1021%2Fjm2005699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Takano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span> </span><span class="NLM_article-title">Discovery of DS-1558: a potent and orally bioavailable GPR40 agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1021/ml500391n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500391n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=266-270&issue=3&author=R.+Takanoauthor=M.+Yoshidaauthor=M.+Inoueauthor=T.+Hondaauthor=R.+Nakashimaauthor=K.+Matsumotoauthor=T.+Yanoauthor=T.+Ogataauthor=N.+Watanabeauthor=M.+Hirouchiauthor=T.+Yoneyamaauthor=S.+Itoauthor=N.+Toda&title=Discovery+of+DS-1558%3A+a+potent+and+orally+bioavailable+GPR40+agonist&doi=10.1021%2Fml500391n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml500391n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500391n%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DOgata%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DHirouchi%26aufirst%3DM.%26aulast%3DYoneyama%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DToda%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520DS-1558%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520GPR40%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D3%26spage%3D266%26epage%3D270%26doi%3D10.1021%2Fml500391n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due-Hansen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">6624</span><span class="NLM_x">–</span> <span class="NLM_lpage">6628</span><span class="refDoi"> DOI: 10.1021/jm3002026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6624-6628&issue=14&author=E.+Christiansenauthor=M.+E.+Due-Hansenauthor=C.+Urbanauthor=M.+Grundmannauthor=R.+Schroderauthor=B.+D.+Hudsonauthor=G.+Milliganauthor=M.+A.+Cawthorneauthor=E.+Kostenisauthor=M.+U.+Kassackauthor=T.+Ulven&title=Free+fatty+acid+receptor+1+%28FFA1%2FGPR40%29+agonists%3A+mesylpropoxy+appendage+lowers+lipophilicity+and+improves+ADME+properties&doi=10.1021%2Fjm3002026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm3002026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002026%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DSchroder%26aufirst%3DR.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DFree%2520fatty%2520acid%2520receptor%25201%2520%2528FFA1%252FGPR40%2529%2520agonists%253A%2520mesylpropoxy%2520appendage%2520lowers%2520lipophilicity%2520and%2520improves%2520ADME%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D14%26spage%3D6624%26epage%3D6628%26doi%3D10.1021%2Fjm3002026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Takano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span> </span><span class="NLM_article-title">Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2949</span><span class="NLM_x">–</span> <span class="NLM_lpage">2953</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1016%2Fj.bmcl.2014.04.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2949-2953&issue=13&author=R.+Takanoauthor=M.+Yoshidaauthor=M.+Inoueauthor=T.+Hondaauthor=R.+Nakashimaauthor=K.+Matsumotoauthor=T.+Yanoauthor=T.+Ogataauthor=N.+Watanabeauthor=N.+Toda&title=Discovery+of+3-aryl-3-ethoxypropanoic+acids+as+orally+active+GPR40+agonists&doi=10.1016%2Fj.bmcl.2014.04.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DOgata%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DToda%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25203-aryl-3-ethoxypropanoic%2520acids%2520as%2520orally%2520active%2520GPR40%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D13%26spage%3D2949%26epage%3D2953%26doi%3D10.1016%2Fj.bmcl.2014.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Fasiglifam (TAK-875) inhibits hepatobiliary transporters: a possible factor contributing to fasiglifam-induced liver injury</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1751</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span><span class="refDoi"> DOI: 10.1124/dmd.115.064121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1124%2Fdmd.115.064121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1751-1759&issue=11&author=X.+Liauthor=K.+Zhongauthor=Z.+Guoauthor=D.+Zhongauthor=X.+Chen&title=Fasiglifam+%28TAK-875%29+inhibits+hepatobiliary+transporters%3A+a+possible+factor+contributing+to+fasiglifam-induced+liver+injury&doi=10.1124%2Fdmd.115.064121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.064121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.064121%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DFasiglifam%2520%2528TAK-875%2529%2520inhibits%2520hepatobiliary%2520transporters%253A%2520a%2520possible%2520factor%2520contributing%2520to%2520fasiglifam-induced%2520liver%2520injury%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26issue%3D11%26spage%3D1751%26epage%3D1759%26doi%3D10.1124%2Fdmd.115.064121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Rumi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadowaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Cava, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazumori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, Y.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumour cells</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1111/j.1365-2443.2004.00793.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1111%2Fj.1365-2443.2004.00793.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=15507122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvV2gur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1113-1123&issue=11&author=M.+A.+Rumiauthor=S.+Ishiharaauthor=Y.+Kadowakiauthor=C.+F.+Ortega-Cavaauthor=H.+Kazumoriauthor=K.+Kawashimaauthor=N.+Yoshinoauthor=T.+Yukiauthor=N.+Ishimuraauthor=Y.+Kinoshita&title=Peroxisome+proliferator-activated+receptor+gamma-dependent+and+-independent+growth+inhibition+of+gastrointestinal+tumour+cells&doi=10.1111%2Fj.1365-2443.2004.00793.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ-dependent and -independent growth inhibition of gastrointestinal tumour cells</span></div><div class="casAuthors">Rumi, M. Azharul Karim; Ishihara, Shunji; Kadowaki, Yasunori; Ortega-Cava, C. F.; Kazumori, Hideaki; Kawashima, Kousaku; Yoshino, Nagisa; Yuki, Takafumi; Ishimura, Norihisa; Kinoshita, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1113-1123</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor γ (PPARγ) acts as a ligand-activated transcription factor.  Although ligand-induced cellular differentiation and growth inhibition were mostly studied on human cancers expressing PPARγ, it is unclear if the transcriptional activation of PPARγ is the main mechanism of growth inhibition.  In this study, the authors investigated whether there is a link between growth inhibitory effect and transcriptional activation of PPARγ in several gastrointestinal tumor cell lines.  The transcriptional activation potential of PPARγ was assessed by reporter gene assay employing a PPRE-luciferase vector, and growth inhibitory effect of PPARγ was investigated by 3H-thymidine incorporation assay, in the presence or absence of thiazolidinedione ligands, rosiglitazone and troglitazone.  As expected, in the case of cell lines pos. for the transcriptional activation potential of PPARγ (T.Tn, MKN-45, and LoVo), both the ligands induced growth inhibition.  However, in case of some other cell lines neg. for the transcriptional activation potential of PPARγ (TT, AGS, and HCT-15), troglitazone still showed a growth inhibitory effect.  Administration of the PPARγ antagonist GW9662 did not reverse this growth inhibitory activity of troglitazone.  The introduction of dominant neg. mutants of PPARγ did not suppress the activity either.  These observations suggest that while rosiglitazone inhibits cellular growth predominantly through transcriptional activation of PPARγ, troglitazone can induce it both in PPARγ-dependent and -independent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgLRxAgGst17Vg90H21EOLACvtfcHk0ljXN37RLJdItw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvV2gur4%253D&md5=51288bd81c1214d808b71476aba22178</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2004.00793.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2004.00793.x%26sid%3Dliteratum%253Aachs%26aulast%3DRumi%26aufirst%3DM.%2BA.%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DKadowaki%26aufirst%3DY.%26aulast%3DOrtega-Cava%26aufirst%3DC.%2BF.%26aulast%3DKazumori%26aufirst%3DH.%26aulast%3DKawashima%26aufirst%3DK.%26aulast%3DYoshino%26aufirst%3DN.%26aulast%3DYuki%26aufirst%3DT.%26aulast%3DIshimura%26aufirst%3DN.%26aulast%3DKinoshita%26aufirst%3DY.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma-dependent%2520and%2520-independent%2520growth%2520inhibition%2520of%2520gastrointestinal%2520tumour%2520cells%26jtitle%3DGenes%2520Cells%26date%3D2004%26volume%3D9%26issue%3D11%26spage%3D1113%26epage%3D1123%26doi%3D10.1111%2Fj.1365-2443.2004.00793.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeCluyse, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L.</span><span> </span><span class="NLM_article-title">Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1592</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10336557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1592-1599&issue=3&author=X.+Liuauthor=E.+L.+LeCluyseauthor=K.+R.+Brouwerauthor=R.+M.+Lightfootauthor=J.+I.+Leeauthor=K.+L.+Brouwer&title=Use+of+Ca2%2B+modulation+to+evaluate+biliary+excretion+in+sandwich-cultured+rat+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes</span></div><div class="casAuthors">Liu, Xingrong; Lecluyse, Edward L.; Brouwer, Kenneth R.; Lightfoot, Ruth M.; Lee, Jacqueline I.; Brouwer, Kim L. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1592-1599</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous work in our lab. has indicated that biliary excretion of a substrate in sandwich-cultured hepatocytes can be quantitated by measurement of substrate accumulation in the presence and absence of extracellular Ca2+.  The present study was designed to examine the effects of Ca2+ on taurocholate accumulation and tight junction integrity in cultured hepatocytes.  Kinetic modeling was used to characterize taurocholate disposition in the hepatocyte monolayers in the presence and absence of extracellular Ca2+.  The accumulation of taurocholate in freshly isolated hepatocytes, which lack an intact canalicular network, was the same in the presence and absence of extracellular Ca2+.  Electron microscopy studies showed that Ca2+ depletion increased the permeability of the tight junctions to ruthenium red, demonstrating that tight junctions were the major diffusional barrier between the canalicular lumen and the extracellular space.  Cell morphol. and substrate accumulation studies in the monolayers indicated that Ca2+, depletion disrupted the tight junctions in 1 to 2 min.  The integrity of the disrupted tight junctions was not re-established completely after reincubation in the presence of Ca2+ for 1 h.  The accumulation of taurocholate was described best by a two-compartment model (cytosol and bile) with Michaelis-Menten kinetics for both uptake and biliary excretion.  In summary, Ca2+ depletion does not alter hepatocyte transport properties of taurocholate.  Ca2+ modulation may be a useful approach to study biliary excretion of substrates in sandwich-cultured hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS7Ker5rbMErVg90H21EOLACvtfcHk0ljXN37RLJdItw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGntrY%253D&md5=0301cba7b60237f1a4b6fbb5e89b0eb1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeCluyse%26aufirst%3DE.%2BL.%26aulast%3DBrouwer%26aufirst%3DK.%2BR.%26aulast%3DLightfoot%26aufirst%3DR.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BI.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26atitle%3DUse%2520of%2520Ca2%252B%2520modulation%2520to%2520evaluate%2520biliary%2520excretion%2520in%2520sandwich-cultured%2520rat%2520hepatocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26issue%3D3%26spage%3D1592%26epage%3D1599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Swift, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L.</span><span> </span><span class="NLM_article-title">Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.3109/03602530903491881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.3109%2F03602530903491881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=20109035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=446-471&issue=3&author=B.+Swiftauthor=N.+D.+Pfeiferauthor=K.+L.+Brouwer&title=Sandwich-cultured+hepatocytes%3A+an+in+vitro+model+to+evaluate+hepatobiliary+transporter-based+drug+interactions+and+hepatotoxicity&doi=10.3109%2F03602530903491881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity</span></div><div class="casAuthors">Swift, Brandon; Pfeifer, Nathan D.; Brouwer, Kim L. R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">446-471</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review..  Sandwich-cultured hepatocytes (SCH) are a powerful in vitro tool that can be utilized to study hepatobiliary drug transport, species differences in drug transport, transport protein regulation, drug-drug interactions, and hepatotoxicity.  This review provides an up-to-date summary of the SCH model, including a brief history of, and introduction to, the use of SCH, as well as methodol. to evaluate hepatobiliary drug disposition.  A summary of the literature that has utilized this model to examine the interplay between drug-metabolizing enzymes and transport proteins, drug-drug interactions at the transport level, and hepatotoxicity as a result of altered hepatic transport also is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJbUKO6x6g9rVg90H21EOLACvtfcHk0ljtJVpBldUFzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSmt78%253D&md5=6f3e5d6554df5012a858b5d0bc30537e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3109%2F03602530903491881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602530903491881%26sid%3Dliteratum%253Aachs%26aulast%3DSwift%26aufirst%3DB.%26aulast%3DPfeifer%26aufirst%3DN.%2BD.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26atitle%3DSandwich-cultured%2520hepatocytes%253A%2520an%2520in%2520vitro%2520model%2520to%2520evaluate%2520hepatobiliary%2520transporter-based%2520drug%2520interactions%2520and%2520hepatotoxicity%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2010%26volume%3D42%26issue%3D3%26spage%3D446%26epage%3D471%26doi%3D10.3109%2F03602530903491881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Wu, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G. Y.</span><span> </span><span class="NLM_article-title">Timosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transporters</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1198</span><span class="refDoi"> DOI: 10.1038/aps.2014.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1038%2Faps.2014.65" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1188-1198&issue=9&author=Z.+T.+Wuauthor=X.+M.+Qiauthor=J.+J.+Shengauthor=L.+L.+Maauthor=X.+Niauthor=J.+Renauthor=C.+G.+Huangauthor=G.+Y.+Pan&title=Timosaponin+A3+induces+hepatotoxicity+in+rats+through+inducing+oxidative+stress+and+down-regulating+bile+acid+transporters&doi=10.1038%2Faps.2014.65"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Faps.2014.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2014.65%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%2BT.%26aulast%3DQi%26aufirst%3DX.%2BM.%26aulast%3DSheng%26aufirst%3DJ.%2BJ.%26aulast%3DMa%26aufirst%3DL.%2BL.%26aulast%3DNi%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DC.%2BG.%26aulast%3DPan%26aufirst%3DG.%2BY.%26atitle%3DTimosaponin%2520A3%2520induces%2520hepatotoxicity%2520in%2520rats%2520through%2520inducing%2520oxidative%2520stress%2520and%2520down-regulating%2520bile%2520acid%2520transporters%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26issue%3D9%26spage%3D1188%26epage%3D1198%26doi%3D10.1038%2Faps.2014.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Assessment of biliary clearance in early drug discovery using sandwich-cultured hepatocyte model</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1908</span><span class="refDoi"> DOI: 10.1002/jps.23070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;key=10.1002%2Fjps.23070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=1898-1908&issue=5&author=G.+Panauthor=C.+Boiselleauthor=J.+Wang&title=Assessment+of+biliary+clearance+in+early+drug+discovery+using+sandwich-cultured+hepatocyte+model&doi=10.1002%2Fjps.23070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fjps.23070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23070%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DG.%26aulast%3DBoiselle%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DAssessment%2520of%2520biliary%2520clearance%2520in%2520early%2520drug%2520discovery%2520using%2520sandwich-cultured%2520hepatocyte%2520model%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26issue%3D5%26spage%3D1898%26epage%3D1908%26doi%3D10.1002%2Fjps.23070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i117"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01357">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13880"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01357">10.1021/acs.jmedchem.6b01357</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic procedures and characterization data of target compounds <b>5j</b>–<b>l</b> and (<i>S</i>)-<b>7g</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_001.pdf">jm6b01357_si_001.pdf (1.06 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01357/suppl_file/jm6b01357_si_002.csv">jm6b01357_si_002.csv (2.87 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01357&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01357%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01357" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c4769d353c6a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
